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General Introduction 
Until the first half of the 19"' century, the anatomy of 
the nervous system was studied mainly by means of 
macroscopic methods, like dissection, while 
microscopy was hampered by the lack of adequate 
staining techniques. However, when reliable fixation 
and staining techniques (like the Weigert and Golgi 
stains and the silver impregnation technique for 
degenerating fibers) became available, the knowledge 
of the nervous system rapidly increased. Since then a 
multitude of new research methods employed by an 
ever increasing number of scientists involved in 
studying the nervous system, have led to a rapid 
progress in our knowledge and - to some extent - our 
understanding of the nervous system. 
The classical anatomical studies and especially the 
findings of Ramon y Cajal (1909), the great advocate of 
the neuron theory, have laid the foundation of our 
present knowledge of the nervous system. 
Cytoarchitectonic studies of this period, made a big 
impact on neuroscience and served as the basis of the 
nomenclature of the central nervous system as it is still 
used today. Data on the chemical identity and the 
specific function of (groups of) nerve cells became 
available more recently. Often the data complemented, 
but sometimes it conflicted with, the cytoarchitecture 
based subdivisions of the brain. This induced the 
introduction of alternative nomenclatures, not based on 
cytoarchitecture, but on pharmacological or functional 
characteristics. This thesis, which describes an 
anatomical study of the dopamine innervation of the 
brain stem and spinal cord and one of the receptors 
involved, i.e. of a chemically identified system 
characterized by containing the transmitter dopamine, 
reflects some of these great changes, which transformed 
classical neuroanatomy into a dynamic, functional 
science. In this chapter the subject will be introduced by 
a short description of the anatomy of the spinal cord and 
the brainstem, followed by a description of the chemical 
anatomy of the nervous system, with the main emphasis 
on the doparninergic system and its receptors. 
Subsequently, we will provide insight into the scope of 
this thesis. 
Anatomy of the spinal cord and brain stem 
The central nervous system is composed of the spinal 
cord, the brain stem (which consists of the 
myelencephalon, the metencephalon and the 
mesencephalon) and the forebrain (cerebrum, which 
consists of the telencephalon and diencephalon). The 
spinal cord, the most caudal part of the central nervous 
system, receives sensory information from the entire 
body below the face, by way of the dorsal divisions (the 
dorsal roots) of the spinal nerves, and activates muscle 
fibers as part of a motor command for reflex or 
voluntary movement, by way of the ventral divisions 
(the ventral roots) of the spinal nerves. The brain stem 
is a complex rostral continuation of the spinal cord and 
contains several collections of cell bodies, among which 
the cranial nerve nuclei. Similar to the spinal cord, the 
brain stem receives sensory infonnation from the face, 
and contains the motor nuclei innervating the muscles 
of the face, eyes, and the cranial parasympathetic 
system. In addition, much of the specialized sensory 
information originating from the cochlea and vestibular 
labyrinth, the eyes, the taste buds, the cardiovascular, 
respiratory, and digestive systems directly reaches the 
brain stem, where it is further processed. Both the brain 
stem and spinal cord have a dual function: on the one 
hand they distribute afferent sensory information to 
higher centers, thereby detennining levels of arousal, 
and execute the motor commands from these higher 
centers, while on the other hand they are capable of 
independently organizing and executing a basic motor 
response on the basis of afferent sensory information. 
Anatomy of the spinal cord 
The spinal cord represents the most caudal part of the 
central nervous system. It is located within the canal of 
the vertebral column surrounded by cerebrospinal fluid. 
During its embryonic development there is surprisingly 
little change in the internal anatomical organization of 
the spinal cord. Its peripheral nerve fibers are grouped 
into segmental spinal nerves that emerge from the 
vertebral canal between the individual vertebrae. As a 
result, the rat spinal cord is subdivided into 8 cervical 
(CI-C8), 13 thoracic (Thl-Th13), 6 lumbar (Ll-L6), 4 
sacral (S I-S4) and 3 coccygeal segments. In the center 
of the spinal cord lies the central canal, which is a 
remnant of the space within the primitive neural tube. 
The spinal cord is bilaterally symmetrical. It consists of 
a centrally located gray matter, which is characterized 
by a large number of neuronal cell bodies, and is 
surrounded by white matter, which is characterized by a 
large nwnber of nerve fibers. Sensory information from 
the skin, joints, muscles and, to some extent, the viscera 
of the trunk and limbs enters the spinal cord by way of 
the dorsal roots. The motoneurons in the spinal cord 
constitute the final common pathway for issuing 
commands for muscle contraction by way of the ventral 
roots. In the spinal cord there is an orderly arrangement 
of the sensory and motor nuclei controlling the limbs 
and trunk. ill addition, the spinal cord contains various 
ascending pathways, that convey sensory information 
towards the brain, and descending pathways which 
originate in higher parts of the brain and terminate 
within the spinal cord. 
The spinal gray matter 
The spinal gray matter, in cross section, is more or less 
butterfly-shaped. The dorsal protrusions on each side 
are known as dorsal horns and the ventral protusions as 
the ventral horns. The area in between the ventral and 
dorsal horns, where the left and right side of the spinal 
cord are interconnected, is termed the intermediate 
zone. Based on cytoarchitectonic criteria, first presented 
by Rexed in cat (1952, 1954), the gray matter can be 
further subdivided into ten different cell layers or 
lantinae, numbered I to IX from dorsal to ventral, with 
lamina X representing the area that surrounds the 
central canal (fig. I). 
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Figure 1: Diagrams of cross-sections of the spinal cord at cervical (C), thoracic (Th), lumbar (L) and sacral (8) 
levels. CeC, central cervical nucleus; LCN, lateral cervical nucleus; PHR, phrenic nucleus; 0, dorsal nucleus 
(Clarke); IML, intermediolateral cell column; CRE, cremaster nucleus; OM, dorsomedial motor nucleus (8NB, spinal 
nucleus of the bulbocavernosus); VE, ventral motor nucleus; DL, dorsolateral nucleus; numerals I-X show the layers 
of Rexed. 
In the classical nomenclature, lamina I is known as 
the marginal zone, lamina II as the substantia 
gelatinosa. laminae III and IV as the nucleus proprius, 
laminae V-VI as the base of the dorsal hom, laminae 
VII and VIII as the intermediate zone and lamina IX as 
the motoneuronal cell groups. Rexed's original 
description was based on the spinal cord of cat, but the 
lamination scheme has subsequently been adapted and 
applied to the spinal cords of other mammals, including 
the rat (Molander et al., 1984; Molander et aI., 1989), 
and is now generally accepted as the standard 
subdivision of the vertebrate spinal cord. A potential 
problem with the laminar subdivision are the 
boundaries between laminae, which are zones of 
transition rather than exact lines of separation, since the 
laminar characteristics change sometimes gradually, 
sometimes more abruptly. The delineation is, therefore, 
open to considerable subjective interpretation as 
evidenced by the many minor differences in the various 
spinal lamination schemes proposed for the rat (see 
Molander et aI., 1984; Brichta and Grant, 1985; 
Molander et al., 1989; Verburgh, 1990). 
Lamina I, or marginal zone, covers the dorsal 
surface of the dorsal horn, of which it fonns the upper 
most part, and curves smoothly around its apex, 
appearing largely as a thin layer of gray matter between 
the overlying zone of white matter (named the tract of 
Lissauer, containing many small myelinated axons), 
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and the underlying gray matter of the dorsal horn. 
Lamina I contains many relatively small neurons of 
various types as well as large horizontal neurons (the 
marginal cells ofWaldeyer), which are relatively sparse 
and directly project to the thalamus (Ribeiro-da-Silva, 
1995). Functionally, lamina I serves as an important 
relay for nociception and temperature sense, but cells 
also respond to non-nociceptive primary afferent input. 
Lamina I cells project, mainly contralaterally, to the 
thalamus, hypothalamus and brainstem, apart from 
projections within the spinal cord (Willis et al., 1995). 
Dorsal root fibers constitute the large majority of the 
afferent input to lamina I, consisting of both thinly 
myelinated and unmyelinated fibers, but there are also 
projections to lamina I that are derived from supraspinal 
levels, including the cortex, the hypothalamus (among 
which dopaminergic fibers, see chapter II), 
noracirenergic fibers from the locus coeruleus and 
serotonergic fibers from the raphe nuclei (Tracey, 1995; 
Willis et aI., 1995). 
Lamina Il, or substantia gelatinosa, is situated 
parallel to lamina I and is covered by that layer dorsally 
and laterally, but not medially. It is characterized by a 
scarcity of myelinated fibers, giving it a translucent 
(gelatinous) appearance in fresh tissue, staining darkly 
in cresyl violet preparations. Lamina II can be 
subdivided into an intensely stained outer zone (110) 
with densely packed cells and a less compact inner zone 
(II,) (Ribeiro-da-Silva, 1995), This subdivision is 
relevant, since subdivisions of the unmyelinated dorsal 
root afferents, as well as some supraspinal projections, 
appear to tenninate preferentially in lamina IIi or IIo 
(see also chapter II), which is also reflected in the 
chemical heterogeneity of this area (Todd and Spike, 
1993). The functional meaning of the subdivisions in 
lamina II is at present unclear. Lamina II neurons 
respond to nociceptive and non-nociceptive inputs and 
project primarily within the spinal cord (Willis ef al., 
1995). 
Lamina III is the widest layer and runs parallel to 
both lamina I and II. In contrast to lamina II, it receives 
a substantial number of myelinated dorsal root axons, 
which carry proprioceptive and cutaneous sensory 
information, but are not involved in the relay of pain 
and temperature information. Projections of lamina III 
are mainly within the spinal cord but some neurons 
project to the dorsal column nuclei or the thalamus 
(Molander and Grant, 1995). 
Lamina IV forms a band beneath laminae II and III, 
but does not posses their characteristic lateral curvature. 
Lamina IV is broader than lamina III and its neurons are 
heterogeneous in size, including several large cells, 
which are not found in lamina III. Some of these cells 
may receive nociceptive input and contribute to the 
spinothalamic tract (Burstein ef al., 1990). Similar to 
lamina Ill, lamina IV receives many myelinated dorsal 
root afferents (Grant, 1995). 
Lamina V forms the neck of the dorsal hom. It is 
characterized by the presence of many myelinated 
fibers in its lateral part, which gives this part a 
reticulated appearance. The general structure of the 
neuropil is not greatly different from lamina N, hence 
the border between lamina IV and lamina V is unclear, 
especially medially. In comparison with lamina N, 
lamina V contains a more heterogeneous population of 
cells (Molander and Grant, 1995). A relatively large 
number of neurons in lamina V contribute to the 
spinothalamic tract (Burstein ef al., 1990), in line with 
the input of, mainly thinly myelinated, nociceptive 
afferents to this lamina. Similar to lamina III and N, 
lamina V receives proprioceptive and cutaneous 
sensory afferents and contains several cells projecting to 
the dorsal column nuclei and spinocervical tract. 
Medially in laminae N and V, adjacent to the dorsal 
columns, there is longitudinal column of cells in the 
segments Thl-L2, known as the dorsal nucleus of 
Clarke, which relays information about limb position 
and movement to the cerebellum via the dorsal 
spinocerebellar tract (Matsushita and Hosoya, 1979) 
Lamina VI exists only within the cervical and 
lumbar enlargements and forms the base of the dorsal 
hom (Verburgh, 1990). The input and projections of the 
cells in this lamina appear similar as those in lamina V. 
The border between lamina VI and lamina VII is 
demarcated by the transition from an area of cellular 
diversity to one of relative homogeneity. 
Lamina VIl constitutes most of the intermediate 
zone of the gray matter throughout the entire spinal 
cord, and regularly extends into the ventral hom. It 
contains a large variety of cells that receive a complex 
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mixture of information from both primary afferent, 
spinal and supraspinal sources. Neurons in the 
intermediate zone may project to motoneurons, to many 
supraspinal nuclei or to other neurons throughout the 
spinal cord. In many cases they project to several 
different target areas through collaterals. Neurons in the 
intermediate zone have been subdivided based on 
specific criteria (like inhibitory versus excitatory or 
projecting preferentially to medial or lateral 
motoneurons or receiving a specific type of primary 
afferent input or on the basis of their chemical identity), 
which subcategories all overlap to a large extent. 
Therefore a comprehensive subdivision of the 
intermediate zone has not been identified (for review 
see Iankowska, 1992). An exception to this rule are 
autonomic preganglionic neurons, located laterally in 
lamina VII at the border of the gray and white matter in 
the segments Thl-L2, which form a longitudinal 
column also known as the lateral horn or the 
intermediolateral nucleus (Strack ef al., 1988). These 
neurons project to sympathetic ganglion cells in the 
sympathetic chain alongside the vertebral column, from 
where the sympathetic innervation of the entire body 
arises (GabeIla, 1995). Some of these sympathetic 
preganglionic neurons are not located in the lateral 
hom, but more medially up to the central canal area in 
the intermediomedial nucleus (Strack ef al., 1988). At 
sacral levels (SI-S3), also laterally in the intermediate 
zone, preganglionic parasympathetic neurons are 
located that innervate the lower part of the trunk and the 
lower extremities . The parasympathetic innervation of 
the upper part of the body is derived from the brainstem 
(Haines, 1997). 
Lamina VIII can be distinguished from lamina VII 
by the darker staining and more variable size of its cells. 
It is located in the ventromedial part of the ventral hom 
and contains commissural neurons, which project to the 
contralateral side. 
Lamina IX is not a true layer, but consist of several 
groups of large motoneurons innervating the striated 
muscles of the limbs and the trunk. It can be subdivided 
into medial and lateral groups (for review see Kuypers, 
1981). The medial motoneuronal groups innervate axial 
muscles, whereas lateral cell groups innervate the 
muscles of the body waIl and the extremities. The spinal 
motoneurons of the lateral cell group are 
somatotopically organized. Thus, in the lateral 
motoneuronal cell group the motoneurons to flexor 
muscles are located dorsally, the motoneurons to 
extensor muscles are located more ventrally and 
laterally, and those supplying the muscles of the girdle 
and the proximal part of the upper limbs are located 
ventromedially. Motoneurons innervating proximal 
limb muscles are located more rostrally than those of 
distal muscles. Motor commands for voluntary 
movement reach the ventral horn via descending 
pathways from supraspinal levels, and connect to 
motoneurons primarily by way of interneurons, except 
for the projections to the medial motoneurons and, 
mainly in primates, the cortical projections to the lateral 
motoneuronal cell groups, which are especially 
important for steering distal extremity muscles involved 
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in fine manipulative movements. Reflex motor activity 
is also effectuated mainly by relay of sensory 
infonnation via interneurons within the intennediate 
zone, with the exception of the Ia afferents derived from 
muscle spindles, that project directly onto rnotoneurons 
of the same (or functionally similar) muscles, from 
which they are derived. 
Lamina X fOnTIS the area around the central canal 
and comprises most of the dorsal and ventral gray 
commissures. It seems to contact the ventral white 
commissure at all levels of the spinal cord. However, 
the borders of lamina X are ambiguous. Cells in lamina 
X receive primary afferent fibers, possibly with the 
emphasis on nociceptive and visceral input (Molander 
and Grant, 1995). In addition there are also supraspinal 
projections terminating within lamina X, including a 
prominent projection from the monoaminergic cell 
groups. The role of lamina X in the spinal cord is 
unclear. In view of its inputs (visceral, nociceptive and 
monoaminergic) and its chemical heterogeneity with 
many different neuropeptides, it may be regarded as the 
internal autonomic or limbic core region of the spinal 
cord. 
Outside the gray matter, just lateral to the apex of 
the dorsal horn, a group of small cells is present, 
throughout the length of the spinal cord. In the first 
three cervicaIlevels, this nucleus is known as the lateral 
cervical nucleus (Molander and Grant, 1995), which is 
also seen in other species, including human, and 
projects to the ntidbrain and the thalamus (Burstein et 
aI., 1990). Below the high cervical segments, the 
nucleus is known as lateral spinal nucleus, which is not 
nonnally seen in other vertebrates. It consist of neurons 
of varying size and form, projects to the midbrain 
tegmentum, hypothalamus and thalamus and receives 
both nociceptive and non-nociceptive sensory input. 
The spinal white matter 
The white matter surrounding the spinal gray matter is 
subdivided into different fiber zones or funiculi (see 
Haines, 1997 for review). The dorsal funiculi are 
located dorsal to the dorsal root entry zone. The lefr and 
right dorsal funiculi are separated by the dorsal septum. 
The ventral funiculi are located ventrally and largely 
separated by the anterior median fissure. However, 
fibers traversing these funiculi may cross to the 
contralateral side through the ventral commissure 
located just dorsal of the anterior median fissure. The 
lateral funiculi, subdivided into dorsolateral and 
ventrolateral funiculi, are located in the lateral parts of 
the spinal white matter. The various funiculi not only 
contain the ascending and descending fibers connecting 
the spinal cord with supraspinal levels, but also contain 
many propriospinal fibers that interconnect different 
spinal levels. The area occupied by these fibers is 
tenned the fasciculus proprius and is located close to 
the spinal gray matter in all the funiculi throughout the 
length of the spinal cord (Kuypers, 1981). These 
proprio-spinal fibers are important for intersegmental 
communication as part of a large number of spinal 
reflexes. 
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Ascending systems in the spinal cord 
There are several ascending fiber tracts for conveying 
information to supraspinal levels, which are located in 
different areas of the spinal white matter. These systems 
relay afferent information to the brain for three 
purposes: perception, arousal, and motor control. Three 
groups of fiber tracts are usually distinguished: (I) the 
dorsal column system, (2) the anterolateral system and 
(3) the spino-cerebellar system (Haines, 1997). 
The dorsal column system contains myelinated and 
urunyelinated fibers derived from the ipsilateral spinal 
ganglia, although fibers originating from neurons in the 
ipsilateral spinal cord (mainly laminae ill-V) also 
contribute significantly to this system. The dorsal 
column fibers convey sensory information, including 
proprioception, discriminative touch and vibration 
sense, and are strongly somatotopically organized 
(Grant, 1995). Some of the fibers, originating from 
spinal neurons, also contribute nociceptive infonnation. 
Two main subdivisions of the dorsal column nuclei can 
be distinguished, especially at higher levels of the spinal 
cord: the gracile and cuneate fasciculi. The cuneate 
fasciculus contains infonnation from sacral, lumbar and 
lower thoracic ganglia and spinal levels and terminates 
in the cuneate nucleus in the lower brainstem, while the 
gracile fasciculus contains information from high 
thoracic and cervical levels and terminates in the gracile 
nucleus. From these dorsal column nuclei, the medial 
lemniscus arises, which tenninates in the contra-lateral 
thalamus, where they synapse mainly on neurons in the 
ventral posterior lateral nucleus, which, in turn, send 
their axons to synapse mainly in the somatic sensory 
cortex. Because somatotopic relationships are preserved 
throughout the system, the somatic sensory cortex 
contains an orderly representation of the body surface. 
The anterolateral system is the second major 
ascending system that mediates somatic sensation 
(Haines, 1997; Willis et aI., 1995). It is actually 
composed of various ascending pathways, including 
spinoreticular, spinomesencephalic, spinothalamic and 
spinohypothalamic fibers (see Tracey, 1995 for review) 
and is located in the ventral and ventrolateral funiculus, 
i.e. the anterolateral portions of the spinal cord white 
matter. The fibers in the antera-Iateral system are 
derived from neurons from both sides of the spinal cord, 
but with a contralateral predominance, and from several 
different laminae (mainly lamina I, and V -Vll), 
although the relative contributions of the various 
laminae depend on the exact site of tennination in the 
various brainstem areas. In addition it seems likely that 
individual fibers project to different brainstem areas 
through collateral projections. Fibers involved in 
contralateral projections cross in the ventral white 
commissure to reach the anterolateral system. There is a 
rough somatotopic organization of the anterolateral 
system with fibers from progressively more rostral 
spinal cord segments assuming a more ventral and 
medial position. The anterolateral system is the main 
pathway for conveying nociceptive and temperature 
information to the brainstem and thalamus (Willis et at., 
1995). Projections to the medulla are focussed on the 
reticular formation, especially its medial part. A similar 
projection exists to the medial pontine reticular 
formation, in addition to a prominent projection to the 
parabrachial nuclei in the dorsolateral pons. The 
mesencephalic projections terminate in the superior 
colliculus, the periaqueductal gray and the reticular 
formation. The spinothalamic projection is the main 
pathway by which nociceptive and temperature 
information reaches the thalamus. It terminates in the 
ventropostero-lateral nucleus, the intralaminar nuclei 
and the posterior nuclear group of the thalamus. 
Interestingly in the rat, an important part from the 
spino-thalamic projections are derived from the upper 
cervical levels (Willis et al., 1995). There are also 
spinal projections to the hypothalamus and more 
rostrally located areas of the telencephalon, like the 
septum, the nucleus accumbens, the amygdala, the bed 
nucleus of the stria tenninalis and other areas generally 
considered as a part of the limbic system (Willis ef al., 
1995). The number of these projections are of similar 
magnitude as those projecting to the thalamus and they 
may provide a direct input of nociceptive information 
into (mainly limbic) telencephalic areas, and thus may 
play a role in the affective components of pain 
sensation. 
There are two major fiber tracts in the spinal cord 
that project to the cerebellum: the dorsal spinocerebellar 
tract and the ventral spinocerebellar tract, which are 
both located on the ventrolateral surface of the spinal 
cord (Tracey, 1995; Voogd, 1995). Fibers in the dorsal 
spinocerebellar tract are mainly derived from neurons 
of the dorsal nucleus of Clarke, which is located slightly 
dorsolaterally of the central canal bilaterally at spinal 
segments Th I - L2 and receives proprioceptive (and 
some cutaneous) information from the lower 
extremities and the trunk. Most fibers in the dorsal 
spinocerebellar tract reach the cerebellum via the 
restifonn body. Fibers in the ventral spinocerebellar 
tract are derived from neurons in the intermediate zone, 
including some cells at the ventrolateral border of the 
ventral horn, called spinal border cells, which all 
receive proprioceptive information especially from the 
lower extremities. These fibers project mainly via the 
brachium conjunctivum. Information from the forepaw 
and neck regions reaches the cerebellum via dorsal 
column projections to the external cuneate nucleus via 
the rostral spinocerebellar tract from the cervical 
enlargement or from neurons at the CI-C3 segments, 
which are located in the central cervical nucleus, which 
occupies the same position in the cervical spinal cord as 
the column of Clarke neurons in the ThI-L2 segments. 
In addition there are neurons in the cervical 
intermediate zone projecting to the cerebellum via the 
''rostral spinocerebellar tract" of Oscarsson. 
Spinocerebellar cells terminate as mossy fibers in the 
cerebellum and their projections are usually bilateral, 
with an ipsilateral predominance. In this respect, the 
spino-olivary projections may also be mentioned, since 
these projections may influence climbing fiber activity 
in the cerebellum. 
Descending systems in the spinal cord 
The descending fiber tracts in the spinal cord may be 
subdivided in two groups: those originating from the 
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cortex and those originating from the brainstem (for 
review see Kuypers, 1981). 
The corticospinal axons ongmate from pyramidal 
cells in layer V of the somatosensory cortex, which 
includes not only the primary motor and sensory cortex, 
but also various areas in the prefrontal cortex in the rat 
(corresponding to premotor and supplementary motor 
areas) and in the parietal cortex (corresponding to 
sensory and visual aSSOCIatIon cortex). The 
corticospinal fibers run through the corona radiata, the 
internal capsule and the pedunculus cerebri to form the 
pyramidal tract in the medulla. At the transition of the 
medulla oblongata and the spinal cord the pyramidal 
tract crosses to the contralateral side. In the rat spinal 
cord the cortico-spinal fibers are located in the ventral 
part of the dorsal funiculus, in contrast to its localization 
in the dorsolateral funiculus like in most higher 
mammals like the human. Fibers originating from the 
sensory areas of the cortex terminate in all laminae of 
the dorsal horn, while fibers originating from motor 
areas of the cortex terminate in the intermediate zone 
and the ventral hom, mostly on interneurons. However, 
direct projections to motoneurons also exist in the rat, 
especially at low cervical levels, from where the distal 
forepaw muscles, involved in fine manipulative 
movements, are innervated. A few fibers do not cross at 
the pyramidal decussation but stay on the ipsilateral 
side to run as the anterior corticospinal tract in the 
ventral funiculus. Fibers from this tract terminate 
bilaterally in the medial part of the ventral horn, both on 
interneurons and motoneurons, which are primarily 
involved in axial movements. 
The descending pathways from the brain stem to the 
spinal gray matter may be divided in two main groups: 
diffuse projections to all lantinae of the spinal cord 
originating from monoaminergic cell groups in the 
brainstem and projections involved primarily in motor 
coordination and focussed mainly on neurons in the 
intermediate zone (Holstege, 1991). The diffuse 
monoaminergic projections to the spinal cord may be 
divided in three groups: serotonergic projections 
originating from the caudal raphe nuclei and adjacent 
ventromedial reticular fonnation, noradrenergic 
projections from the nucleus coeruleus and 
subcoeruleus and the A5 cell group and dopaminergic 
projections from the posterior hypothalamus. These 
diffuse projections are characterized by a high degree of 
collateralization, such that neurons innervating cervical 
segments may, through collaterals, also innervate 
lumbar segments. In spite of the diffuse character of the 
descending monoaminergic projections, some topical 
relations have been identified in these systems 
(Holstege and Kuypers, 1987), such that the rostral part 
of the caudal raphe nuclei (i.e. the raphe maguus) seems 
to project predominantly to the dorsal hom, while more 
caudal parts (i.e. the raphe pa11idus and obscurus) 
projects predominantly to the ventral horn, including 
the motoneuronal cell groups. Similarly, the locus 
coeruleus may project to the dorsal horn, while the 
subcoeruleus may project predominantly to the ventral 
horn and the A5 nucleus projects specifically to the 
preganglionic neurons in the lateral hom. For the 
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dopaminergic projection such a topical organization has 
not been identified as yet. Although the various 
monoaminergic cell groups in the brainstem project to 
virtually all the layers throughout the spinal cord, their 
projections are not completely identical and some 
differences exist (for details see Chapter II) 
The brainstem areas that project mainly to the 
intennediate zone and show a very low degree of 
collateralization can be subdivided in a medial and a 
lateral group, based on their tennination site in the 
spinal cord (Kuypers, 1981). The medial group 
terminates in the ventromedial part of the spinal gray 
matter. both on interneurons and motoneurons, thus 
controlling the muscles of the trunk and proximal 
extremities. These projections are important for 
maintaining balance and in postural fixation. The main 
components of the medial group are the reticulospinal 
tract (originating in the dorsal part of the caudal pons 
and medullary reticular formation), the medial 
vestibulospinal tract (originating in the medial and 
caudal vestibular nuclei), the lateral vestibulospinal 
tract (originating in the lateral vestibular nucleus), and 
the tectospinal tract (originating from the superior 
colliculus), which all descend in the ventral funiculus. 
The lateral group projects to the dorsolateral part of the 
intennediate zone where the intemeurons are located 
that project to motoneurons of muscles of the distal 
extremities. The main component of this group is the 
rubrospinal tract, which originates in the caudal, 
magnocellular portion of the red nucleus. The 
rubrospinal tract descends in the contralateral 
dorsolateral funiculus. Some neurons in the dorsolateral 
pontine reticular formation also contribute to the lateral 
group of descending brainstem pathways. 
Anatomy of the brain stem 
The brain stem (truncus cerebri) is located between the 
spinal cord and the diencephalon (see Haines, 1997). 
This part of the brain can be divided into three major 
regions: the medulla oblongata (myelencephalon), the 
pons with the cerebellum (metencephalon) and the 
midbrain (mesencephalon). Although the pons and 
cerebellum together constitute the metencephalon, only 
the pons and not the cerebellum is considered a segment 
of the brainstem. The transition zone between the 
medulla and spinal cord is located approximately at the 
level of the foramen magnum. This is also the level of 
the pyramidal decussation. The cranial nerves that 
emerge from the medulla are the hypoglossal nerve 
(XII), leaving the medulla ventromedially, and the 
laterally emerging accessory (XI), vagus (X) and the 
glossopharyngeal (IX) nerves. The abducens (VI), 
facial (VII) and vestibulo-cochlear (VIII) nerves exit the 
brainstem at the junction of the pons and medulla. The 
medulla oblongata is the rostral extension of the spinal 
cord. The pons lies rostral to the medulla and appears as 
a protuberance on the ventral surlace of the brain stem. 
It contains a massive set of neurons that relay 
information from the cerebral hemispheres to the 
cerebellum. The trigeminal nerve (V) enters the pons 
laterally at the middle level. The trochlear nerve (IV) 
leaves the brainstem at the dorsal side, at the transition 
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between pons and mesencephalon. The midbrain is 
located rostral to the pons and is the smallest part of the 
brain stem. The oculomotor nerve (III) leaves the 
mesencephalon ventromedially. 
As the rostral continuation of the spinal cord, the 
brain stem follows a developmental plan that is much 
like that of the spinal cord. The sensory input and motor 
output of the brain stem is canied by cranial nerves. 
Most of the cranial nerves arise from, or tenninate on, 
nuclear groups in the brain stem and innervate 
structures of the head and neck, except for the vagus 
nerve, which innervates viscera in the rostral half of the 
body. The motor nuclei of the brainstem are located 
medially and ventrally and are derived from the 
embryonic basal plate, while the sensory nuclei of the 
brain stem are located mostly dorsally and laterally and 
are derived from the alar plate. 
The motor nuclei of the brain stem can be 
subdivided into three sets of nuclei. One set of motor 
nuclei is located dorsomedially and innervates striated 
muscles of the head, that are derived from occipital 
myotomes (the tongue muscles) or derived from the 
orbit (the eye muscles). These nuclei include the 
hypoglossal nucleus (located in the medulla), 
innervating the tongue muscles and the abducens and 
trochlear nuclei (located in the pons) and the 
oculomotor nuclei Oocated in the mesencephalon), 
innervating the eye muscles. A second set of motor 
nuclei develops to form the preganglionic 
parasympathetic nuclei. These are the dorsal motor 
nucleus of the vagus nerve and the inferior salivatory 
nucleus in the medulla, the superior salivatory nucleus 
in the pons and the Edinger-Westphal nucleus in the 
mesencephalon. More ventrally and laterally, a third 
group of motor nuclei develops to innervate striate 
muscles that originate from the pharyngeal arches. 
These nuclei comprise the ambiguus nucleus of the 
medulla, and the facial nucleus and the motor 
trigeminal nucleus in the pons. 
The sensory nuclei of the medulla, which are 
derived from the alar plate, are located dorsolateral1y. 
They comprise the trigeminal nuclei, the nucleus of the 
solitary tract, the cochlear nuclei, and the vestibular 
nuclei. The trigeminal nuclei, which mainly receive 
general sensory input from the skin, mucosa, muscles 
and joints of the head and neck, consists of several 
subnuclei, which include the spinal trigeminal nucleus, 
located in the medulla and caudal part of the pons, the 
nucleus princeps located in the rostral pons and the 
mesencephalic nucleus of the trigeminal nerve. The 
most caudal part of the spinal trigeminal nucleus, which 
is a rostral continuation of the spinal dorsal horn, 
receives primarily pain and temperature infonnation 
from the head and neck. Proprioceptive and 
exteroceptive sensory information is conveyed to more 
rostral parts of this nucleus and the nucleus princeps. 
The mesencephalic nucleus contains ganglion cells, 
with their peripheral projections terminating as muscle 
spindles in the mastication muscles and their central 
tenninations on motor neurons of the trigeminal motor 
neurons. Other sensory nuclei in the medulla are the 
gracile and cuneate nuclei, which receive general 
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Figure 2: The key steps in the biosynthesis and degradation of dopamine (DA) are shown in this dopaminergic 
synapse (Adapted from Sachar, 1985). (1) Enzymatic synthesis (see also fig. 3). (2) Uptake and storage of 
dopamine by storage granules. (3) Release of dopamine. (4) Receptor interaction. (5) Reuptake. (6) Degradation. 
(7) Inactivation. COMT, catechol-Q.methyltransferase; DA, dopamine; DOPA, dihydroxyphenylalanine; DOPAC, 
dihydrophenylacetic; HVA, homovanillic acid; MAO, monoamine oxydase. 
sensory infonnation from the entire body except the 
head. However, these nuclei do not receive pain and 
temperature information, which, instead, is processed in 
the dorsal horn of the spinal cord. The nucleus of the 
solitary tract is a sensory nucleus receiving visceral 
information from the cardiovascular system (blood 
pressure and heart rate), the digestive system (e.g. 
gastric extension), the respiratory system (e.g. oxygen 
levels, etc.) as well as taste information from the tongue 
and pharynx. The cochlear nuclei are involved in 
processing auditory information. The vestibular nuclei 
receive information from the vestibular labyrinth and 
are involved in the (reflex) control of eye movements, 
head movements and movements of the body as a 
whole (balance and posture). 
Except for the motor and sensory nuclei that 
innervate the peripheral nerves, there are several nuclei 
in the brainstem, which project within the eNS. These 
nuclei include the inferior olive, which is located 
ventrally in the medulla rather than dorsolaterally and is 
a relay center for sensory and motor information to the 
cerebellum, and the lateral reticular nucleus, located 
ventrolaterally in the lower medulla, which projects to 
the cerebellum and receives afferents from a large 
number of brain structures including the cortex and the 
spinal cord. In this respect it is similar to the more 
medially located inferior olive, although their mode of 
termination in the cerebellum (respectively as mossy 
fibers and as climbing fibers) is very different. Another 
conspicuous nucleus is the superior olive, which is 
located ventrolaterally in the pons and is involved in 
processing auditory information. The parabrachial 
nucleus, which is situated around the brachium 
conjunctivum in the dorsolateral pons, is involved in 
processing autonomic (mainly from the nucleus of the 
solitary tract) and nociceptive (derived from the spinal 
and trigeminal dorsal horn) information, with strong 
reciprocal connections with the hypothalamus. A dorsal 
protrusion of the mesencephalon is the inferior 
colliculus, which is specifically involved in processing 
auditory information. Directly rostral to the inferior 
co1liculus a similar, albeit more flattened, protrusion is 
formed by the superior colliculus. Together the inferior 
and superior colliculi can be seen macroscopically as 
four small elevations on top of the rostral brainstem, 
hence the name corpora quadrigemina. Located 
inunediately below the corpora quadrigemina in the 
pons and mesencephalon around the aqueduct is the 
periaqueductal gray (PAG), which plays an important 
role in autonomic control. Ventrolaterally of the PAG 
and dorsolaterally from the substantia nigra in the 
mesencephalon, a large rounded cell group is present, 
termed the red nucleus, which is usually subdivided in 
caudal magnocellular and rostral parvocellular par1s. Its 
main inputs arise from the cerebral cortex and the 
cerebellum, while its efferent projections are to the 
inferior olive (through the central tegmental tract) and 
contralaterally to the spinal intermediate zone, through 
the rubrospinal tract. 
In addition to the various cell groups described 
above, the core of the brain stem is formed by a large 
number of neurons collectively known as the reticular 
formation and comparable to the intermediate zone of 
the spinal cord. The medullary, pontine and 
mesencephalic reticular formation consists of a 
heterogeneous popUlation of cells, traversed by fiber 
bundles of some of the major tracts, giving it the 
reticular appearance. Although the reticular formation 
can be subdivided in different areas on the basis of 
cytoarchitecture (parvocellular and gigantocellular in 
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the medulla) or posltlon (medial, lateral etc), this 
subdivision (and its delineation) is often confusing and 
an increasing number of nuclei in the reticular 
formation are now being defined on functional or 
chemical criteria, rather than on anatomical 
characteristics only (see e.g. Holstege, 1996). Thus 
specific areas in the brainstem reticular formation have 
been described that are involved in producing or 
organizing specific stereotyped behavior (like 
locomotion, balance and posture, respiration, 
vocalization, micturition, vomiting, swallowing etc.), or 
controlling autonomic functions (like cardia-vascular 
control and digestive functioning) or monitoring and 
controlling different types of afferent sensory 
infonnation. Other areas, usually located more rostrally 
in the brainstem, are specifically involved in 
coordinating these basic functions in a context of 
relaxation, fight and flight, sexual arousal or sleep. 
Obviously, a particular brainstem area may be involved 
in several of these functions. These functional 
brainstem areas often coincide with anatomically 
defined areas, but may also be smaller or partly located 
outside such an area. In spite of these developments, the 
anatomical delineations are still most widely used. For 
the description in this thesis of the dopaminergic fibers 
and terminals and the D2 dopamine receptors in the 
brain stem of the rat, the nomenclature used in the atlas 
of the rat brain by Paxinos and Watson has been 
adopted. 
Chemical anatomy ofthe central nervous 
system 
The great majority of the neurons in the central nervous 
system communicate with one another through 
chemical substances, called neurotransmitters, which 
are stored within neurons and released upon 
depolarization of a neuron generally with the purpose to 
act upon one or more other neurons (the target). Most 
neurotransmitters are released at specialized sites 
koown as synapses (fig. 2). A synapse consists of a pre-
and postsynaptic membrane, belonging to two different 
neurons, with an intercellular space, termed the synaptic 
cleft, in between. A neurotransmitter is generally 
released in the syuaptic cleft by exocytosis from 
synaptic vesicles at the presynaptic membrane. It then 
traverses the synaptic cleft to bind at receptors at the 
postsynaptic membrane. In the majority of the cases the 
postsynaptic membrane of a synapse belongs to a 
dendrite or a cell soma, but part of a terminal or the 
axolemma also may serve as the postsynaptic 
membrane. Most transmitters are released by the axon 
tenninals of a presynaptic neuron, but release from 
dendrites or somata also occurs. In addition, there may 
be release of neurotransmitter from non-synaptic sites 
of a neuron, which is known as non-synaptic or volume 
transmission. Neurotransmitters thus released may 
diffuse relatively large distances through the 
intercellular space to act on distal receptor targets. 
These target receptors are usually located on the 
neuronal membranes, but glial cells also display 
receptors on their membrane. The binding of a 
transmitter to a receptor may cause alterations in 
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electrical or biochemical properties or gene expression 
of the cell, depending on the specific properties of the 
transmitter, the receptor and their interaction. A 
particular neurotransmitter may act at different 
(sub )types of receptors, but one receptor (sub )type 
usually interacts with only one transmitter. Substances 
that act on a receptor are tenned ligands and 
neurotransmitters are the natural ligands of their 
cognate receptors. However, ligands that do not 
nonnally occur in the brain (like syuthetic drugs or 
substances from plants) may act on one or more types 
of receptors, if they pass through the blood-brain 
barrier. These non-natural ligands may thus be used as 
tools to influence brain functioning, e.g. as therapeutic 
or experimental pharmaca. If a ligand is labeled (and its 
receptor-binding properties have not been significantly 
compromised), it may be used to identify the location 
(andlor the functional characteristics) of the receptors 
that bind this particular ligand. 
In the past 50 years, an increasing number of 
chemicals that act as a neurotransmitter have been 
identified (see e.g. Nieuwenhuys, 1985). In order to 
determine whether a chemical substance may be 
considered a neurotransmitter three basic conditions 
have to be fulfilled: (1) The transmitter should be 
present in a neuron at its release sites; (2) it should be 
released after stimnlation of the neuron and (3) after 
release it should produce a specific effect on another 
neuron, preferably through a specific receptor, which 
effect can be mimicked by exogenous application of the 
substance (see also Siegel, 1994; Haines, 1997). 
However, these conditions are not absolute and are still 
debated. The neurotransmitters that have been identified 
so far are usually divided in two groups: small 
molecules (with fewer than 10 carbon atoms) and 
neuropeptides (with more than 10 carbon atoms). The 
small molecnles are further subdivided in four groups: 
(1) amino acids (Gaouna-aminobutyric acid -GABA-, 
glycine and glutamate); (2) biogenic amines (acetyl-
choline and the monoamines); (3) nucleosides and 
nucleotides (adenosine and ATP) and (4) the gaseous 
substance nitric oxide (NO). At present over 50 
neuropeptides have been identified and there are several 
subdivisions in use to categorize these neuropeptides, 
mostly based on the area where they were first 
encountered or on the most well known member of a 
particular group e.g. opioid peptides (like enkephaIin 
and dyuorphin); posterior pituitary peptides 
(vasopressin and oxytocin); tachykinins (like substance 
P and neurokinins); glucagon related peptides (e.g. 
vasoactive intestinal peptide); pancreatic polypeptide-
related peptides (e.g. neuropeptide Y) and many others. 
The receptors, associated with the various transmitters, 
also can be subdivided into two groups: those mediating 
fast synaptic transmission, in which case the receptor is 
itself an ion channel, and those mediating slow synaptic 
transmission, in which case the receptor is associated 
with a G-protein. Fast synaptic transmission is 
associated exclusively with small molecule transmitters, 
while G-protein coupled receptors are associated both 
with the group of small molecule transmitters and the 
group of neuropeptides. 
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Figure 3: Key steps in the biosynthesis of monoamines. In dopaminergic neurons tyrosine is converted to the 
neurotransmitter dopamine. In noradrenergic neurons the precursor dopamine is converted to noradrenaline. In 
adrenergic neurons the precursor noradrenaline is converted to the neurotransmitter adrenaline. 
This thesis is focussed on one particular small 
molecule transmitter: the monoamine dopamine and 
one of its receptors: the G-protein coupled dopamine D2 
receptor (see end of this chapter: Scope of the present 
study). Below the current knowledge of dopamine and 
its receptors will be shortly reviewed. 
Monoaminergic transmitters and their 
receptors 
The tenn monoamines is used to collectively address a 
group of substances, which act as transmitters in the 
brain. They are the indolamines, i.e. serotonin and 
histamine, and the catecholamines i.e. adrenaline, 
noradrenaline and dopamine. Monoamine containing 
neurons and their pathways in the brain stem were 
visualized for the first time by Dahlstrom and Fuxe 
(1964) using the Falck-Hillarp formaldehyde 
histofluorescence technique. This technique is based on 
the finding that monoarnines in the brain become 
fluorescent after fonnaldebyde treatment. Fluorescence 
of indolamines (i.e. serotouin) is yellow, while 
catecholamine fluorescence is green. Thus it became 
possible to localize the various serotonergic and 
catecholaminergic cell groups in the rat brain stern, 
which they designated BI-B9 and AI-AI2, 
respectively. Based on previous pharmacological and 
biochemical data it was inferred that the rostrally 
located A9-A12 groups were dopaminergic, while the 
more caudally located cell groups AI-A8 were 
noradrenergic. This basic subdivision of the 
monoaminergic cell groups in the brain is still used 
today with some additions, specifically three adrenergic 
cell groups in the lower brainstem (Cl, C2, and C3) and 
four small dopaminergic cell groups in the diencephalic 
area of the brain (A!3-A16). Since the initial 
experiments by Dahlstrom and Fuxe, more 
sophisticated techniques like immunocytochemistry and 
in situ hybridization have revealed many additional 
details about the morphology of the monoamine-
containing neurons. In addition many data have 
emerged about the function and localization of the 
monoaminergic receptors. 
Indolamines 
Two indoleamines act as transmitters in the brain: 
serotonin and histamine. Serotonin, also known as 
5-hydroxytryptamine (5-HT), was first isolated from 
platelets as the factor in serum with a tonic effect 
(hence: serotouin) on blood vessels (Rapport et al., 
1948). Serotouin belongs to a group of aromatic 
compounds called indoles with a five-membered ring 
containing nitrogen joined to a benzene ring. In the 
brain, serotonin is synthesized from the aminoacid 
tryptophan in two steps. First, a hydroxyl group is 
inserted at the 5 position on the indole ring by means of 
the enzyme tryptophan hydroxylase, which is the rate-
limiting enzyme. The resulting molecule is then 
decarboxylated by 5-hydroxytryptophan decarboxylase 
to form 5-HT or serotonin (Frazer and Hensler, 1994). 
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Interestingly, 5-hydroxytryptophan decarboxylase and 
aromatic L-amino acid decarboxylase (an important 
enzyme in the production of dopamine, see later) appear 
to be identical. Thus the same enzyme is involved in the 
production of dopamine as well as serotonin (Jaeger et 
al., 1984). 
Serotonin-containing neurons in the brain stem are 
located in the mesencephalon, pons and medulla 
oblongata (Dahlstrom and Fuxe, 1964). The serotonin 
cell bodies, located on or near the midline (raphe) of the 
brain stem, can be divided into a rostral (superior) and a 
caudal (inferior) group (reviewed by Jacobs and 
Azmitia, 1992). The superior group consists of four 
main nuclei: the caudal linear nucleus (CLi; B8), the 
median raphe (MnR; B8 and B5) and its laterally 
displaced cells, the B9 neurons lying just dorsal to the 
medial lemniscus (mI), and the dorsal raphe nucleus 
(DR; B7 and B6). The inferior group consists of five 
main nuclei: the nucleus raphe obscurus (ROb; B2), the 
nucleus raphe pallidus (RPa; Bland B4), the nucleus 
raphe magnus (RMg; B3) and a group of neurons 
ventrolaterally adjoiniug B3. B3 neurons are also 
located in the medulla at the level of the nucleus raphe 
obscurus (B2) just dorsal to the inferior olive and, more 
laterally, in the LPGi and the RVL. The few 
serotonergic cells located dorsally in the medulla were 
designated B4. 
Whereas the serotonergic cell bodies are restricted 
to clusters of cells in the brain stem, their fibers 
innervate virtually every area of the brain. However, 
there are significant regional differences in their 
distribution (for details see Steinbusch, 1981; Bjorklund 
and Skagerberg, 1982; Jacobs and Azmitia, 1992; Kolta 
ef aI., 1993; Halliday ef aI., 1995). The superior group 
mainly projects rostrally towards the forebrain, whereas 
the inferior group projects caudally to the brain stem 
and spinal cord. 
Serotonergic receptors 
Originally, two classes of serotonin receptors were 
distinguished, namely 5-HT, and 5-HT, receptors, 
based on their specific affinity for serotonin and 
spiperone respectively. At present, seven major groups 
of serotonin receptors are recognized (5-HT" 5-HT" 5-
HT" 5-HT4, 5-HT" 5-HT6 and 5-HT,), with at least 
seven distinct SUbtypes, each with a unique 
pharmacological and behavioral profile, and a distinct 
anatomical distribution (Jacobs and Azmitia, 1992; 
Halliday ef al., 1995). 
The 5-HT, receptor family consists of four subtypes 
(5-HT1A' 5-HTlB' 5-HT,c, and 5-HTJD). 5-HT'A 
receptors are usually defined using 8-hydroxy-2(di-n-
propylarnino)tetralin (8-0H-DPAT) and are 
concentrated within the raphe nuclei, the neocortex, 
septum and hippocampus. They act as cell body 
autoreceptors, but are also responsible for some of the 
postsynaptic actions of serotonin, especially in the 
hippocampus and cortex. 5-Hf 1B sites only have been 
described in rat brain, by serotoniu binding in the 
presence of the 5-HT'A ligand 8-0H-DPAT. They were 
found to be densely distributed in the substantia nigra 
and globus pallidus. The 5-HT'B receptor is present in 
the membrane of serotonergic axon terminals in rats 
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and primates, where it acts as an autoreceptor with an 
inhibitory effect on the release of serotonin. 5-Hf lA and 
5-HT'B receptors both act by inhibiting adenylate 
cyclase. The highest levels of the 5-HT,c receptor are 
present in the choroid plexus, with much lower but 
detectable levels in the hippocampus and cortex. 5-
HT,c receptors act by stimulating phosphatidylinositol 
hydrolysis. 5-HTJD receptors share many of the 
properties of the 5-HfJB receptors and were identified 
by pharmacological criteria ouly in brains of species 
devoid of the 5-HT'B receptor. 
The 5-HT2 receptor, characterized by its high 
affinity for spiperone, is located postsynaptically and is 
associated with the fine serotonergic fibers in the 
middle layers of the cerebral cortex, mostly in layer IV. 
It is responsible for many of the behavioral effects of 
serotonin. The most recently described serotonin 
receptors are the 5-HT, and 5-HT4 receptors. Both 
receptor types were initially identified in peripheral 
neurons, but subsequently they were also observed in 
the brain. 5-Hf3 receptors accumulate in the substantia 
gelatinosa of the spinal cord (suggesting a possible role 
in nociception) and in the area postrema of the medulla, 
with lower amounts in hippocampus, septum and 
amygdala. 
Histamine 
Histamine is the other indolamine transmitter in the 
brain (Nieuwenhuys, 1985) and is the least studied of 
the monoamines, even though there is a widespread 
histaminergic innervation of nearly all regions of the 
brain, including the spinal cord (Steinbusch, 1991). 
Histaminergic neurons are located primarily in the 
tuberomammillary nucleus of the posterior 
hypothalamus. 
Histamine is formed from the amino acid histidine 
by decarboxylation, a reaction that is catalyzed by the 
enzyme histidine decarboxylase (HDC) or by aromatic 
amino acid decarboxylase (AADC). The effects of 
histamine on neurons are relatively slow in the onset 
and of long duration, similar to the majority of the 
effects of noradrenaline and serotonin. At present, three 
major groups of histamine receptors (H" H2, and H,) 
are recognized (Green, 1994). Stimulation of the H,-
receptor is associated with increased formation of 
cAMP and cGMP, increased phosphoinositide turnover, 
and ion shifts. H2-receptors, on the other hand, are 
directly linked to adenylyl cyclase through a G protein. 
Stimulating the H3 presynaptic receptor reduces release 
of endogenous histamine, indicating a function as 
inhibitory autoreceptor. 
The presence of histamine receptors has been 
described in several brain regions (Green, 1994). High 
densities of Hrreceptors were found in rat 
hippocampus, but the density of H,-receptors in brain 
regions varied among species. Interestingly, there is no 
similarity between the regional distribution of the H,-
receptor and histamine. The striatum of the guinea pig 
and the basal ganglia of primates show especially dense 
concentrations of Hrreceptors as compared to 
hippocampus and cortex. The H3 autoreceptor is 
especially prominent in the cortex and basal ganglia. 
Catecholamines 
Catecholamines are substances that are characterized by 
a catechol ring, i.e. a 3,4-dihydroxylated benzene ring. 
The catecholamine neurotransmitters - dopamine, 
noradrenaline, and adrenaline - are all synthesized from 
the L-amino acid tyrosine in a common biosynthetic 
pathway (see fig. 3). The first enzyme, tyrosine 
hydroxylase (TH), converts the amino acid tyrosine to 
3,4-dihydroxypheny1alanine or L-3,4-
dihydroxypheny1alanine (L-DOPA) and is rate limiring 
for both dopamine and noradrenaline. L-DOPA is next 
decarboxy1ated by aromatic L-amino acid 
decarboxylase (AADC) to yield dopamine. In 
noradrenergic and adrenergic neurons, dopamine-l3-
hydroxylase (DBH) converts dopamine to 
noradrenaline. Lastly, in adrenergic neurons 
pheny1ethano1amine-N-methy1transferase (PNMT) 
methylates noradrenaline to fonn adrenaline, using S-
adenosylmethionine as a methyl donor. Interestingly, 
there is a considerable homology in the nucleic acid 
sequences encoding for TH, DBH and PNMT, which 
appear to be linked on the same chromosome. It has 
therefore been suggested that the genes for these 
enzymes have evolved from a common ancestral gene. 
Widrin neurons (fig. 2), high concentrations of 
catecholamines are stored in vesicles by means of 
amine transporters. After the release of a catecholamine 
from vesicles into the synaptic cleft or another part of 
the extraneuronal space, it will be inactivated by (re)-
uptake into the catecholaminergic neuron by means of a 
cellular transporter, which is highly specific for a 
particular catecholamine. Catecholamines may also be 
inactivated enzymatically. Two main pathways are 
known: methylation of the 3-hydroxyl group of the 
catechol ring, which reaction is catalyzed by catechol-
O-methyltransferase, or oxidative removal of their 
amino group by monoamine oxidase (MAO). Since 
MAO is present within neurons, it will only inactivate 
catecholamines that are not present within vesicles or 
otherwise protected. 
Adrenaline 
In the initial studies of Dahlstrom and Fuxe (1964), the 
amount of adrenaline in the brain was found to be too 
low to detect by spectrofluorometric analysis. 
Subsequent biochemical studies, however, 
demonstrated that the brain stem did contain adrenaline 
(Versteeg, 1976), a finding that was confirmed by 
immunohistochemical evidence showing the existence 
of three adrenaline-containing cell groups in the caudal 
medulla, which have been designated C1, C2, and C3 
(Armstrong ef aI., 1982; Hokfelt el aI., 1984; Kalia ef 
al., 1984). The rostral cell groups C1 and C2 are 
identical to the rostral parts of the catecholaminergic 
cell groups Al and A2, respectively. The cell group C3 
is located in the rostral medulla in the region of the 
medial longitudinal fasciculus. 
Adrenaline-containing tenninals have been 
observed in many areas of the central nervous system, 
including the brain stem and spinal cord (Fleetwood-
Walker and Coote, 1981; Hokfelt ef al., 1984). The 
most prominent temrinal fields in the brain stem and 
spinal cord include the ventral part of the locus 
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coeruleus, the nucleus solitarius, the dorsal nucleus of 
the vagus, and the intennediolateral nucleus of the 
spinal cord, of which the latter three nuclei contain 
especially high levels of adrenaline. Experimental 
evidence suggests that the adrenergic projection to the 
spinal cord originates mainly from cell group C1 (Ross 
el al., 1981; Armstrong ef al., 1982; Hokfelt el al., 
1984). 
Noradrenaline 
Neurons that synthesize noradrenaline are restricted to 
the pontine and medullary tegmental regions. Seven 
noradrenergic cell groups, designated as A1-A7, have 
been described in rat brain (Dahlstrom and Fuxe, 1964). 
The functional significance of the existence of several 
discrete subgroups of noradrenergic neurons in the 
central nervous system, however, has remained a 
controversial issue for a long time. Early anatomical 
studies of the projections of central noradrenergic 
neurons led to the widely accepted view of 
noradrenergic cells as a class of diffusely projecting 
neurons (Moore and Bloom, 1979). Two noradrenaline 
systems were distinguished: the locus coeruleus (LC) 
and the lateral tegmental system. Since then, it became 
increasingly evident that subgroups of central 
noradrenergic neurons have different and mostly non-
overlapping projections and thus should be considered 
separate anatomical entities (Grzanna el aI., 1987; 
Grzanna and Fritchy, 1991; Aston-Iones ef al., 1995). 
In the rat CNS, the differential distribution of 
noradrenergic fibers derived from neurons in the locus 
coeruleus and those derived from non-coerulean 
noradrenergic neurons is particularly striking in the 
spinal cord and brain stem (Bjorklund and Skagerberg, 
1982; Westlund ef al., 1983; Grzanna ef al., 1987; 
Lyons and Grzarma, 1988; Grzanna and Fritchy, 1991). 
In these regions, noradrenergic fibers from the locus 
coeruleus are primarily distributed to sensory nuclei 
while noradrenergic fibers of non-coerulean neurons are 
distributed to motor nuclei and the intermedio-Iateral 
cell column (Grzanna and Fritchy, 1991). 
Adrenaline and Noradrenaline receptors 
Effects of both adrenaline and noradrenaline are 
mediated through adrenergic receptors. Two families of 
a-adrenergic receptors (001 and 00,) and one family of P-
adrenergic receptors exist. At the present time, three 
subtypes of 001- (alA, alB, and aid, three subtypes of 
00,- (oo,A, oo,B, and oo,c), and three subtypes of P- (PI> P2, 
and P,) adrenergic receptors have been identified. 
Each subtype of the a-adrenergic receptor displays 
a unique distribution pattern, the al adrenergic 
receptors being more restricted in their distribution than 
the <lQ adrenergic receptors. Of the arreceptor family, 
the alA-receptor is primarily localized in regions of the 
olfactory system, several hypothalamic nuclei, and 
regions of the brainstem and spinal cord, particularly in 
areas related to motor function. Additional regions 
include the intermediate layers of the cerebral cortex, 
cerebellum, and the hippocampal formation (McCune el 
al., 1993; Day ef al., 1997). The alB-receptor is 
localized in most thalamic nuclei, dorsal and median 
raphe nuclei, and intermediate and deep layers of the 
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Figure 4: Proposed amino acid topography of the rat D,-dopamine receptor, deduced from its cDNA sequence 
(Sibley, 1992). Adapted from Ariano, 1993. 
cortex, hippocampus, cerebellum, and several other 
regions of the brain (McCune et ai., 1993; Day et ai., 
1997). The ale-receptor has not yet been identified in 
tissues. The distribution of the aID-receptor is the most 
discrete of the ai-receptors. It is localized in the 
olfactory bulb, cerebral cortex, hippocampus, reticular 
thalamic nucleus, regions of the amygdala, motor nuclei 
of the brainstem, inferior olivary complex and spinal 
cord (Day et ai., 1997). Of the ",-receptor family, the 
~A -receptor is most abundant in the locus coeruleus, 
but is also found in many other brain areas including the 
brain stem, spinal cord, hippocampus, hypothalamus, 
olfactory bulb, cerebral cortex, pons, and cerebellum 
(McCune et al., 1993; Nicholas et ai., 1993; 
MacDonald and Scheinin, 1995; Scheinin et al., 1994). 
The "'B-receptor is only found in the thalamus 
(McCune et al., 1993; Nicholas et al., 1993; Scheinin et 
al., 1994; MacDonald and Scheinin, 1995) and the "'e-
receptor has been primarily observed in the basal 
ganglia and hippocampus, but it is also found in the 
olfactory bulb, cerebral cortex (particularly the 
cingulate cortex), pons and cerebellum (Nicholas et ai., 
1993; Scheinin et al., 1994; MacDonald and Scheinin, 
1995). 
The brain contains both ~I- and ~,-receptors, which 
cannot be differentiated in terms of their physiological 
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functions. Adrenaline and noradrenaline are equally 
potent agonists for the ~rreceptor, but adrenaline is 
more potent than noradrenaline for ~rreceptors. ~­
receptors act through stimulation of adenylyl cyclase. 
~radrenergic receptors predominate in the cerebral 
cortex, the hippocampus, the Islands of Calleja, and 
several nuclei of the thalamus. Approximately equal 
levels of ~1- and ~rreceptors occur in the substantia 
nigra, the olfactory tubercle, cerebral cortex, the medial 
preoptic nucleus, and all nuclei of the medulla. ~r 
adrenergic receptors predominate in the molecular layer 
of the cerebellum, and in several thalamic nuclei 
(Rainbow et al., 1984). The density of ~l-receptors 
varies in different brain areas to a greater extent than 
that of ~,-receptors. It has been suggested that this is 
due to the presence of ~z-receptors on glia or blood 
vessels. 
Dopamine 
Until the late 1950's dopamine (DA = 3,4-
dibydroxyphenetbylamine; also known as oxytyramine 
or hydroxytyramine) was exclusively thought of as a 
precursor in the biosynthesis of the catecholamines 
noradrenaline and adrenaline (Blascliko, 1939). 
Thereafter, it became clear that there existed an 
important and independent dopamine system, involved 
in the regulation of many CNS functions. 
The brain stem dopamine-containing neurons are 
confined to the mesencephalon and diencephalon as 
originally described by Dahlstrom and Fuxe (1964). 
Most dopaminergic neurons are found in the 
mesencephalic dopamine cell system, which includes 
the retrorubral nucleus (A8), the substantia nigra (A9) 
and the adjacent ventral tegmentum of the midbrain 
(ventral tegmental area of Tsai; AW). The neurons of 
the diencephalic dopamine cell system (groups All-
A14) are considerably fewer in number than the 
mesencephalic dopamine cells. These dopaminergic cell 
groups include (Dahlstrom and Fuxe. 1964; Fuxe, 1965; 
Fuxe and Hokfelt, 1966; Bjorklund and Nobin, 1973): 
(1) The rostral periventricular cell group (AI4) with 
neurons scattered in the periventricular hypothalamic 
region, from the level of the anterior commissure back 
to the rostral border of the median eminence; (2) the 
dorsal hypothalamic cell group (AI3) comprising 
neurons clustered in the medial zona incerta, just 
ventromedial to the marnmillothalamic tract; (3) the 
tuberal cell group (AI2) located in the arcuate nucleus 
and the adjacent pan of the periventricular nucleus; and 
(4) the caudal cell group (All) distributed in the 
posterior and dorsal hypothalamic areas and in the 
periventricular gray matter of the caudal thalamus. 
The best known projection from All-AI4 cell 
groups is the tuberohypophyseal dopamine system, 
which originates in the AI2 cell group and innervates 
the median eminence and the neural lobe and pars 
interrnedia of the pituitary (Fuxe and Hokfelt, 1966; 
Bjorklund and Nobin, 1973; Fuxe et al., 1974). It seems 
likely that neurons in the other cell groups give rise to 
local diencephalic innervations, although these 
projections are less well established. The only 
extradiencephalic projection of the All-AI4 cell 
groups identified so far is the descending 
diencephalospinal dopamine system (Commissiong et 
al., 1978; Bjorklund and Skagerberg, 1979; Blessing 
and Chalmers, 1979; Commissiong and Neff, 1979; 
Hokfelt et al., 1979), which, in the rat, has been found 
to innervate various parts of the spinal cord (Skagerberg 
et aI., 1982). This All group is widely distributed along 
the rostrocaudal axis ranging from the posterior and 
dorsal hypothalamic areas, periventricular gray of the 
caudal thalamus, to the mesencephalic periaqueductaI 
gray. In the frontal plane, neurons of the All group can 
be found along the dorsal and medial aspects of the 
fasciculus marnmillothalamicus and, more caudally, in 
between the fasciculus retroflexus and the ventricle in 
the region ofDarkschewitsch' nucleus. 
Dopamine receptors 
Dopamine exerts its diverse effects by specific, high-
affinity binding to G protein-coupled receptors (for 
reviews see Civelli et al., 1991; Sibley and Monsma, 
1992; Gingrich and Caron, 1993; ODowd, 1993). In the 
late 1970's the neurotransmitter dopamine was thought 
to act through only two types ofreceptors, known as the 
D, and Dz dopamine receptors (Kebabian and Caine, 
1979). Pharmacological and biochemical data showed 
that, the D1-receptor was responsible for the stimulation 
of adenylate cyclase, whereas the Drreceptor mediated 
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the inhibition of adenylate cyclase, or had no effect on 
it. These differential effects on the activity of adenylyl 
cyclase became a major distinguishing feature between 
Dr and Dz-receptors. However, the results obtained 
with molecular biological techniques showed that the 
D 1- and Drreceptors in fact represented two classes of 
dopamine receptors, which may be further subdivided 
on the basis of structural and functional similarities 
(Strange, 1991; Sibley and Monsma, 1992). The rat D,-
receptor was the first dopamine receptor to be cloned 
(Bunzow et al., 1988). This receptor was isolated by 
low stringency screening of a rat brain cDNA library 
using the hamster ~radrenergic receptor cDNA as a 
probe. This cloning strategy, which is based on 
evolutionary conservation of a sequence, is commonly 
referred to as homology screening and has proven to be 
the most effective in identifying new members of the 
dopamine receptor gene family. The probes were 
subsequently used to clone the human Dz dopamine 
receptor gene and a second form of the receptor 
(D2(long)' These discoveries were quickly followed by 
the cloning of the DI dopantine receptor, called the D1-
receptor in rat and D1Kreceptor in human (Dearry et ai., 
1990; Gerfen et al., 1990; Sunahara et al., 1990; Zhou 
et al., 1990). Thereafter, probes based on the DI and Dz 
dopamine receptors have led to the identification of 
other genes coding for the D3 (Sokoloff et al., 1990), D4 
(van Tol et al., 1991; Todd et aI., 1992), D,-receptors 
(Civelli et aI., 1991; Sunahara et al., 1991; Tiberi et al., 
1991; Weinshank et aI., 1991), and two D,-related 
pseudogenes (CiveIli et al., 1991). They are judged to 
be pseudo genes because of the presence of numerous 
in-frame stop codons that would produce truncated 
proteins and, presumably, nonfunctional receptors 
(Civelli et al., 1991). Two additional members of the D2 
family, the rat D,- and D,-receptors have been cloned 
by low stringency hybridization using probes derived 
from the Dz-receptor. Thus, there are two known Dr 
like receptors (DI and D,) and three known D2-like 
receptors (D2, D3, and D,) 
All the presently known dopantine receptor 
isofonns are members of the supergene family of 
receptors that couple to their effectors via guanine 
nucleotide binding proteins, the so-called G-proteins. 
Members of this family posses seven stretches of 
relatively hydrophobic antino acids which have been 
proposed to form alpha-helical transmembrane 
sparnting regions linked by loops of varying size 
(ODowd, 1992) (fig. 4). In this model the amino 
terminal end of the receptor is extracellular, the 
polypeptide chain crosses the cellular membrane seven 
times and the carboxyl terminal end is intracellular (see 
Todd and OMalley, 1993). There is relatively high 
sequence identity between receptor types in the 
transmembrane (Tm) regions, while the hydrophilic 
regions have much more sequence diversity among 
family members. Most of the known receptors have a 
long cytoplasmic loop between transmembrane regions 
5 and 6 (3,d intracellular loop), which is thought to be 
involved in binding to G-proteins, whereas Tm 3 and 5 
(and perhaps Tm 2 and 7) are thought to be involved in 
dopamine binding (Dahl et aI., 1991). The G-protein 
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coupled dopamine receptors respond to the binding of 
their cognate neurotransmitter by changing the 
metabolic machinery of the postsynaptic cell througb a 
mechanism involving the fonnation of intracellular 
second messengers, i.e. cyclic AMP. The receptor and 
the cyclase do not interact directly, but are coupled by 
transducer proteins that shuttle through the membrane, 
There are several kinds of G-proteins: stimulatory (G,) 
or inhibitory (Gi). These proteins bind GTP or GDP. 
When the transmitter is bound to the receptor and the 
complex is associated with G" GTP displaces GDP at 
the nucleotide site on the transducer. The G-protein 
now associates with the catalytic subunit of adenylate 
cyclase, stimulating it to catalyze the conversion of 
ATP to cyclic AMP. The GTP-G-protein and the 
catalytic subunit of the cyclase together constitute the 
active form of cyclase. When GTP is bound to G" the 
complex inhibits cyclase activity. The duration of cyclic 
AMP synthesis is regulated by the GTPase activity of 
Os. Its potency as an activator of the cyclase is again 
restored by interacting with the transmitter-receptor 
complex at the external surface of the cell. 
Numerous G protein-coupled receptors described to 
date have proven to be intronless within their coding 
regions (c.f. Gingrich and Caron, 1993). As far as the 
dopamine receptors are concerned, the receptors of the 
dopamine Drlike family also are intronless. However, 
the receptors of the Dz-like family are an exception to 
this rule and belong to the category of intron-containing 
G protein-coupled receptors (O'Malley et al., 1990). 
The dopamine D,-receptor is interrupted by five to six 
introns (Giros et al., 1989; Monsma et al., 1989), the D3 
by five (Sokoloff et al., 1990), and the D4 by four (van 
Tol et al., 1991). The presence of introns within the 
coding region of the Dz-like receptors allows for the 
possibility of alternate splicing of the exons. Such splice 
variants have been found in other receptor systems, 
where such splice variants fonn functionally different 
receptor proteins. The Drreceptor has been found to 
exist in two isofonns (D2(short), D 2(long»), generated by 
alternate splicing of the 87 base pair exon between 
introns 4 and 5 (GirDS et aI., 1989: Monsma et al., 
1989; O'Malley et aI., 1990; Gandelman et aI., 1991). 
These isoforms differ, therefore, by 29 amino acids in 
the putative third intracellular loop (fig. 4). Despite the 
fact that the 3"' intracellular loop is thought to be 
involved in the function of G protein recognition, thus 
far no functional differences have been reliably ascribed 
to the Dz-receptor splice variants. It has now been 
extensively demonstrated that both the D2(Sbort) and 
D 2(long) forms of the cloned Drreceptor both act through 
the inhibition of adenylate cyclase and the activation of 
K+ channels. So far, no differences in coupling 
efficiency have been observed between the D2(short) and 
D 2(long) forms. The D3 gene can also undergo alternative 
splicing to form several shorter variants (Bouthenet et 
al., 1991). Similar to the D,-receptor, one of these 
variants is 63 bases shorter and codes for a functional 
receptor that lacks a 21 amino acid stretch in the 3rd 
cytoplasmic loop. D3 rnRNA has a unique distribution 
in the brain, including prominent expression in limbic 
areas such as the islands of Calleja, the nucleus 
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accumbens and the mammillary nuclei. It is also 
expressed in many classical Drreceptor rich regions 
such as the striatum (Sokoloff et al., 1990). The D4-
receptor is the most recently described Dz-like sequence 
(van Tol et al., 1991). In contrast to the D2- and D3-
receptor genes, the D4 gene is relatively small 
consisting of 4 known exons and 3 introns spanning 
about 3500 bases. No alternate RNA splicing has been 
detected for the D4-receptor (van Tol et al., 1991). 
However, the (human) D4 gene itself appears to be 
highly polymorphic in human populations (ODowd, 
1992; Seeman et al., 1992). When expressed in 
transfected cell lines the splice variants are functional 
and can be distinguished pharmacologically (Seeman et 
aI., 1992). 
Scope of the present study 
Dopamine is involved in many aspects of brain 
functioning and abnormalities in the function of 
dopaminergic neurons have been implicated in many 
neurologic and psychiatric disorders, like Parkinson's 
disease, Tourette syndrome, schizophrenia, depression, 
and mania. Consequently, the role of dopamine in brain 
functioning has been extensively studied with the focus 
on locomotor activity, positive reinforcement, spatial 
memory, higher cognitive functions and neurohormone 
release. In order to get more insight in the 
(dys)functioning of dopamine in these neurologic 
diseases, there always has been a keen interest in the 
anatomy, physiology, and especially the pharmacology 
of dopaminergic systems in the CNS. Since most of the 
dopamine-linked neurologic and psychiatric disorders 
appear to be associated primarily with the telencephalic 
and diencephalic areas of the brain, the overwhelming 
majority of the dopamine studies have focussed on 
these areas, rather than on the brain stem and spinal 
cord. Furthermore, the majority of the dopaminergic 
neurons are located in these rostral parts of the brain 
and are largely absent in the brainstem and spinal cord. 
The finding that a small group of dopaminergic neurons 
in the caudal diencephalon projected to the spinal cord 
and brainstem indicated that dopamine was also 
involved in modulating the functions of these lower 
parts of the central nervous system. Previous findings 
had shown that other members of the monoamine group 
of transmitters, especially serotonin and noradrenaline, 
exerted strong effects on motor, sensory and autonomic 
transmission in the brain stem and spinal cord. Attempts 
to identify these dopaminergic projections in detail 
proved difficult, since (nor)adrenergic and 
dopaminergic fibers could not be reliably distinguished. 
The development of antibodies that identified 
exclusively dopaminergic fibers and terminals 
combined with data suggesting a close interaction of 
dopamine with other monoamines which are directly 
involved in brain stem and spinal cord functions as well 
as in higher cognitive functions, have prompted the 
initiation of the studies described in this thesis. In these 
studies, we have attempted to compare the dopamine 
distribution with that of (nor)adrena1ine and serotonin, 
since these are chemically related molecules and show a 
similar mode of projection: large parts of the brain are 
innervated through collaterals derived from a relatively 
small number of neurons. Apart from the dopaminergic 
innervation itself, the distribution of the different 
dopamine receptors must also be considered in order to 
understand the role of dopamine in the brainstem and 
spinal cord. In the present studies we have identified the 
localization of the D2 receptors in spinal cord and brain 
stem. The localization of other dopamine receptor 
subtypes was not studied, mainly due to a lack of 
reliable antibodies. However, by comparing our data 
with more recent data from the literature, a 
comprehensive picture of the dopaminergic system in 
brain stem and spinal cord is obtained. 
In the first part of this thesis (chapter II-III), the 
distribution of the neurotransmitter dopamine and its 
D2-receptor is described in spinal cord. In Chapter II, 
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the distribution of dopamine in rat, cat, and monkey 
spinal cord is documented employing an antibody 
directed against glutaraldehyde bound dopamine. In 
chapter III, the distribution of dopamine D2-receptor in 
rat spinal cord is analyzed, using immunocytochemistry 
and in situ hybridization. The localization of its D2-
receptor is established using an anti-peptide antibody 
raised against the putative 3rd intracellular loop of the 
D2-receptor. In the second part of this thesis (chapter 
IV-V), the distributions of dopamine and its D2-receptor 
in rat brain stem are described. For this purpose the 
same immunocytochemical techniques were used as 
described in chapter II-III. In the last chapter (chapter 
VI) the main findings obtained in the studies of this 
thesis are discussed. 
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The Distribution Of Dopamine Immunoreactivity In The Rat, 
Cat And Monkey Spinal Cord 
Abstract 
In the present study, the distribution of dopamine was identified light microscopically in all segments 
of the rat, cat and monkey spinal cord by using immunocytochemistry with antibodies directed 
against dopamine. 
Only fibers and (presumed) terminals were found to be immunoreactive for dopamine. Strongest 
dopamine labeling was present in the sympathetic intermedio-Iateral cell column (IML). Strong 
dopamine labeling, consisting of many varicose fibers, was found in all laminae of the dorsal horn, 
including the central canal area (region X), but with the exception of the substantia gelatinosa, which 
was only sparsely labeled, especially in rat and monkey. In the motoneuronal cell groups dopamine 
labeling was also strong, showing a fine granular appearance. The sexually dimorphic cremaster 
nucleus and Onuf's nucleus (or its homologue ) showed a much stronger labeling than the 
surrounding somatic motoneurons. In the parasympathetic area at sacral levels, labeling was 
moderate. The remaining areas, like the intermediate zone (lamina VI-VIII), were only sparsely 
innervated. The dorsal nucleus (column of Clarke) showed the fewest dopamine fibers as did the 
central cervical nucleus, suggesting that cerebellar projecting cells were avoided by the dopamine 
projection. In all species, the descending fibers were located mostly in the dorsolateral funiculus, but 
laminae I and III also contained many rostro-caudally oriented fibers. 
It is concluded that dopamine is widely distributed within the spinal cord, with few differences 
between species, emphasizing that dopamine plays an important role as one of the monoamines 
that influences sensory input as well as autonomic and motor output at the spinal level. 
Introduction 
The existence of dopamine (DA, also known as 
oxytyramine or hydroxytyramine) in the brain was 
already known for some time (Blaschko, 1939), when it 
was recognized in the late 1950's that dopamine could 
function as an independent catecholamine transmitter 
(Montagu, 1957), possibly involved in Parkinson's 
disease (Carlsson, 1959). Initially dopamine was 
localized with the Falck-Hillarp formaldehyde 
histofluorescence technique, which was used by 
Dahlstrom and Fuxe (1964) for a detailed mapping of 
dopamine cell groups, fibers and terminals in the brain. 
With respect to the spinal cord they concluded that, in 
contrast to noradrenaline, dopamine was not present. 
However, with the histofluorescence technique (and its 
modifications) it is difficult to differentiate between 
noradrenergic and dopaminergic fibers and tenninals, 
especially in areas where they are intermingled. This 
problem does not occur with biochemical techniques, 
which showed that after transecting the rat spinal cord 
(Magnusson, 1973) or traumatizing the spinal cord of 
dogs (Hedeman et al., 1974), the noradrenaline 
concentration caudal to the lesion declined at a different 
rate than the dopamine concentration. These findings 
suggested a transmitter role for dopamine, independent 
from noradrenaline, even though the dopamine 
concentration in the spinal cord is five to ten times 
lower than the concentration of noradrenaline 
(Hedeman et al., 1974; Commissiong et aI., 1978; 
Karoum et al., 1981; Basbaum et al., 1987). 
Furthennore, destruction of the locus coeruleus led to a 
decrease of the noradrenaline concentration in the 
spinal cord, while the concentration of dopamine 
remained unchanged (Commissiong et al., 1978). 
Similarly, (partial) depletion of noradrenaline by 6-
hydroxydopamine did not lead to a change in the 
dopamine concentration in the spinal cord (Mouchet et 
aI., 1982). The use of neurotoxins to deplete 
noradrenaline made it also possible to identify 
dopamine contammg structures with the 
histofluorescence technique, since the labeling observed 
after such treatment could only be attributed to the 
presence of dopamine. Using this approach it was found 
(Skagerberg et aI., 1982) that in the spinal cord, 
dopamine was present only in fibers and varicosities, 
located maiuly in the dorsal hom, the area around the 
central canal and in the IML, with ouly a few scattered 
fibers in the ventral horn. The existence of a dopamine 
projection to the spinal cord, separate from 
noradrenaline, was also suggested by experiments in 
rat, combining the retrograde transport of a fluorescent 
tracer with histofluorescence (Bjorklund and 
Skagerberg, 1979) or tyrosine hydroxylase (TH) 
immunocytochemistry (Hokfelt et al., 1979). These 
experiments showed the existence of a 
catecholaminergic projection from the diencephalon to 
the spinal cord (diencephalospinal tract), originating in 
the All cell group and, in the rabbit, the A13 cell group 
(Blessing and Chalmers, 1979). The existence of a 
dopamine projection from the paraventricular 
hypothalamic nucleus to the spinal cord has also been 
suggested (Swanson et al., 1981), but this was not 
confirmed in later studies (Skagerberg and Lindvall, 
1985; Skagerberg et al., 1988). Since neurons in the 
All cell group do not contain dopamine-~-hydroxylase 
(Swanson and Hartman, 1975), the enzyme 
synthesizing noradrenaline from dopamine, they were 
considered as dopaminergic. Further investigations on 
the diencephalo-spinal system (Skagerberg and 
Lindvall, 1985) showed that relatively few cells in the 
All cell group provided the dopamine innervation for 
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Figure 1: Schematic representation of the dopamine innervation in selected segments of the rat spinal corel. For 
details see text. Abbreviations: CeC, central cervical nucleus; CRE, cremaster nucleus; DJ dorsal nucleus (column 
of Clarke); DL, dorsolateral nucleus; DM, dorsomedial nucleus; IML, intermedio-Iateral nucleus; LCN, lateral 
cervical nucleus; PHR, nucleus of the phrenic nerve; SPN, sacral parasympathetic nucleus; VE, ventral nucleus. 
Dopamine in spinal cord 
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Figure 2: Schematic representation of the dopamine innervation in selected segments of the cat spinal cord. For 
details see text. Abbreviations: CC, column of Clarke (dorsal nucieus); ON, Onuf's nucleus; for other abbreviations 
see fig. 1. 
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the entire spinal cord through a highly collateralized 
system. Thus the presence of dopamine as a transmitter 
in the spinal cord and the existence of a dopamine 
projection to the spinal cord originating in the 
hypothalamus are now well established. 
For an analysis of the laminar distribution of the 
dopamine fibers within the spinal cord, TH 
immunocytochemistry was used after destroying the 
noradrenaline terminals with 6-hydroxydopamine 
treatment (Dietl et al., 1985). This study showed the 
highest density of TH inununoreactive dopamine fibers 
in lamina III, IV, X and the thoracic IML, with few 
fibers elsewhere in the spinal cord. The identification of 
dopamine using high performance liquid 
chromatography (HPLC) with electrochemical 
detection applied to micro-dissected spinal cord areas 
(B asbaum et al., 1987) showed that highest levels of 
dopamine were present in the IML, the dorsal hom and 
the central canal region with somewhat lower levels in 
laminae VI and VII. A limited, but consistent amount of 
dopamine was also found in the motoneuronal cell 
groups, indicating a direct dopamine innervation of 
spinal motoneurons. The latter finding confirmed the 
results obtained with specific uptake of 3H-dopamine, 
which showed radioactively labeled terminals in the 
dorsal as well as the ventral hom (Kondo et aI., 1985). 
When it became possible to produce specific antibodies 
directed against small transmitter molecules (Stonn-
Mathisen et al., 1983), including dopamine and 
noradrenaline (Geffard et al., 1984; Geffard et al., 
1986; Buijs et al., 1989), these transmitters could be 
directly visualized by inununocytochemistry. With this 
technique the presence of dopamine fibers and 
terminals in the spinal cord was confirmed (Yoshida 
and Tanaka, 1988; Shirouzu et aI., 1990; Mouchet et 
al., 1992; Ridet et al., 1992). However, some 
uncertainty remained with respect to the intensity of the 
dopamine innervation of the motoneuronal cell groups. 
The present study was undertaken to investigate in 
detail the localization of dopamine in all spinal 
segments of the rat, cat and monkey spinal cord by 
using immunocytochemistry with highly specific 
antibodies against dopamine. We found dopamine 
immunoreactivity in all laminae of the spinal cord, 
without major differences between species. Labeling 
was concentrated in the dorsal horn and the 1I\1L. In 
addition we found many lightly stained varicosities in 
the motoneuronal cell groups, confinning the existence 
of a prominent dopamine projection to spinal 
motoneurons. 
Materials and methods 
A detailed analysis was performed on material obtained 
from adult male Wistar rats, three female cats, one 
female monkey (Macaca fasicularis) and one male 
monkey (Macaca arctoides). All the animals were 
obtained through the institutional animals facility, 
housed and handled according to national guidelines, 
supervised by an institutional animal care and usage 
committee. The male monkey was bred by a 
pharmaceutical company and had not been involved in 
any previous testing. The female monkey, which had 
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been obtained from an institutional research facility, 
had been involved in behavioral experiments, without 
any known pharmacological testing. They were kept in 
our institutional facility for at least 1 year in good 
health. The other animals were obtained from approved 
breeders through the institutional experimental animals 
facility. Before perfusion, the animals were deeply 
anaesthetized with pentobarbital (70 mglkg) 
intraperitoneally. 
Immunocytochemical procedures 
The animals were perfused transcardially with 50 nal 
(rats), 150 ml (cats) or 500 nal (monkeys) of saline 
containing 10 mM Ascorbic Acid, pH 7.4, followed by 
1 1 (rats), 2.5 I (cats) or 4 1 (monkeys) of 10 mM 
Ascorbic Acid in 0.05 M Acetate Buffer, pH 4.0 
(AAAB), containing 5% glutaraldehyde. After 
perfusion the spinal cords were dissected and all the 
spinal segments were identified and cut with a razor 
blade. They were kept overnight at 4'C in AAAB, 
containing 30% sucrose. The following days, 30 fLm 
sections were obtained on a sliding freezing microtome 
from all cervical, lumbar and sacral as well as half of 
the thoracic and the rostral coccygeal spinal segments. 
The free floating sections were collected in Tris-
buffered saline, pH 7.4, containing 10 mM Ascorbic 
acid (TBSA). Some spinal cords segments were cut in 
horizontal or sagittal sections. The free floating sections 
were rinsed in TBSA and kept for several days in the 
same liquid at 4 'c. Next they were treated with TBSA, 
containing 1 % borohydrate (NaBH,) for 30 min at room 
temperature. They were then rinsed several times in 
TBSA and incubated overnight at 4'C with a polyclonal 
dopamine antibody from rabbit ("Jannes", Buijs et al., 
1984; Voorn and Buijs, 1987) diluted 1:4000 in Tris-
buffered saline, pH 7.4 (TBS), containing 0.5% Triton 
X-IOO and 10 mM Ascorbic Acid. In rat and cat several 
sections were also treated with a different dopamine 
antibody (Steinbusch and Tilders, 1987; Steinbusch et 
al., 1991) (SanBio B.V, Uden), diluted 1;2000 in Tris-
buffered saline. After the primary dopamine antibody, 
the sections were rinsed thoroughly with TBS and a 
goat-anti rabbit (GAR) antibody ("Betsy", diluted 
1 ;100, 1 hour incubation) was applied. Subsequently the 
sections were rinsed with TBS and incubated with a 
rabbit PAP complex (Nordic, 1: 1000, 1 hour), rinsed in 
TBS followed by phosphate buffer (0.1 M, pH 7.4). 
These incubations were performed at room temperature. 
Then the sections were reacted with 0.05% 3,3'-
diaminobenzidine in the presence of 0.01 % hydrogen 
peroxide in phosphate buffer (0.1 M, pH 7.4). After 
rinsing in phosphate buffer, the sections were mounted 
onto glass slides with a chromealum-gelatine solution, 
and some were subsequently counterstained with 0.05% 
thionin. Finally, all sections were dehydrated, 
coverslipped and exaruined with bright and darkfie1d 
illumination. As a control, some of the sections were 
processed after substitution of the primary antiserum 
with TBS. This resulted in no contrast staiuing. 
DSP-4 experiments 
In order to deplete noradrenaline in the spinal dorsal 
Dopamine in spinal cord 
MONKEY 
L2 
Th4 
Figure 3: Schematic representation of the dopamine innervation in selected segments of the monkey spinal cord. 
For details see text. Abbreviations: see fig. 2. 
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horn, 4 rats received an intraperitoneal injection (50 
mglkg) of N-(2-chloroethyl)-N-ethyl-2-bromobenzyl-
amine (DSP-4) (Jonsson, 1983), while 2 rats received 
an intraperitoneal saline injection. After a period of two 
weeks the rats were deeply anaesthetized and perfused 
for dopamine immunocytochemistry as described 
above. Alternate 30 ~m frozen sections were processed 
for either dopamine or dopamine-p-hydroxylase (DBH) 
immunocytochemistry. For dopamine immuno-
cytochemistry the same procedure was used as 
described above except for the GAR antibody (Vector, 
1:200, 1 hour incubation) and the rabbit-PAP complex 
(Nordic, 1 :800, 1 hour incubation), For DBH 
immunocytochemistry the sections were preincubated 
in a solution of 5% normal goat serum (NGS) in 
phosphate buffer (PB; 0.1 M, pH 7.4) containing 0.9% 
NaCl and 0.3% Triton X-IOO for 90 orinutes. Next they 
were incubated for 24-48 hours at 4 °C with rabbit-anti 
DBH (Eugene Tech; 1:750) in 0.1 M PBS (PH 7.4) 
containing 0.3% Triton-XIOO and 2% NGS. Hereafter, 
the sections were rinsed and incubated (1-2 hour) with 
biotinylated GAR (Vector; 1:200). After a few rinses, 
biotin avidin complex (Vector) was applied (1-2 hour). 
Finally, the sections were reacted with 3,3'-
diantinobenzidine in the presence of 0.01 % hydrogen 
peroxide, rinsed several times in PB, mounted on glass 
slides with chromealum, dehydrated, coverslipped and 
examined with bright and darkfield illuorination. 
Results 
The distribution of dopamine immunoreactivity was 
examined light microscopically in transverse, horizontal 
and sagittal sections from nearly all segments of the rat, 
cat and monkey spinal cord (figs. 1-11). Dopamine 
immunoreactivity was present almost exclusively in 
fibers and (presumed) terminals. Labeled neuronal cell 
bodies were found in all species only in the rostral part 
of Cl. Labeled neuronal cells (0-5 cells per section) 
were found in the ventrolateral funiculus and in the area 
immediately dorsal of the central canal. In all likelihood 
these cells represented the caudal extension of the Al 
and A2 cell group respectively as described by 
Dahlstrom and Fuxe (1964) in the lower medulla. 
Labeled neuronal cell bodies were never found in other 
areas of the spinal cord. Dopantine fibers and 
varicosities were found in all laminae of the spinal grey 
matter at all spinal levels, but with considerable 
differences in regional density. 
The following detailed descriptions were made from 
sections treated with the "Jannes" dopamine antibody 
for which the method was optiotized. An identical 
labeling pattern was obtained using the Sanbio 
dopamine antibody. The distribution of the dopamine 
immunoreactivity will be described separately for the 
dorsal horn, the ventral horn and various "specialized 
areas" in the spinal cord. In addition, the location of the 
descending fibers in the white and grey matrer will be 
described. 
Dorsal horn 
Within the dorsal horn of the rat, cat and monkey spinal 
cord, dopamine immunoreactivity was found in all 
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lantinae (figs. 1-7 and 8). As a rule, labeling was 
moderate in lantina I, sparse (rat and monkey) to 
moderate (cat) in lamina II (substantia gelatinosa) and 
strong in laminae ill-V. In laminae I ofrat and monkey 
there were many short fibers with varicosities and 
occasional patches of labeling consisting of many small 
caliber fibers and varicosities, which sometimes seemed 
to exceed the width of lamina I in dorsal or ventral 
direction. Only a few varicose fibers were traversing 
lamina II. In the cat the difference in labeling intensity 
between lamina I and II was less pronounced. In lamina 
III, IV and V, including the neuropil of the lateral 
reticular part of these laminae, thick fibers with clear 
varicosities formed a dense network. Horizontal and 
parasagittal sections (fig. 11) showed that most fibers in 
lamina ill, as well as those in laminae I and II, were 
oriented predominantly in a rostrocaudal direction, 
while in laminae V and to a lesser extent in lamina IV 
this rostro-caudal orientation of the fibers was not 
observed; instead they were oriented more randomly. 
The area around the central canal contained only a few 
rostra-caudally oriented fibers. In transverse sections it 
appeared that many dorsoventrally oriented fibers at the 
medial border of the dorsal horn terotinated in the 
central canal region or crossed to the other side, mostly 
into the dorsal grey matter. In addition to these general 
aspects of dopamine immunoreactivity in the dorsal 
horn, there were also differences between species as 
described below. 
Rat dorsal hom. In rat (figs. 1, 6, 7 and 8), labeling 
was strongest in lantina III and slightly less prominent 
in lantina IV and V. In lamina I the intensity of the 
labeling was clearly less as compared to the deeper 
laminae. The lowest amount of labeling was seen in 
lamina II where immunoreactivity was almost absent, 
apart from some traversing fibers, which ran mostly in a 
rostro-caudal direction (fig. 11). At the lower cervical 
as well as the lower lumbar levels, there was less 
labeling in the medial part of laminae ill-Vas 
compared to the lateral part (fig. 8). The overall labeling 
of the dorsal horn was less dense in the lumbo-sacral 
cord than in the cervical cord, although the general 
pattern of the labeling was the same at both levels. The 
lateral spinal nucleus (not indicated in fig. 1) was 
moderately innervated throughout the spinal cord. 
Cat dorsal hom. In cat (figs. 2 and 4), the 
differences in labeling intensity between laminae was 
much less as compared to the rat. Strongest labeling 
was found not only in lamina III-V, but also in lantina I. 
Lamina II was moderately innervated. Differences in 
labeling between the medial and lateral part of laminae 
III-Vat low cervical levels were less pronounced than 
in rat and monkey. At thoracic levels, the overall 
labeling intensity became less than at cervical levels 
and labeling in lantina II was sparse, containing mostly 
rostro-caudally oriented fibers. Going further caudally 
to lumbar levels, the labeling intensity increased again, 
being strongest at L 7. However, like in rat, labeling was 
still less intense as compared to the cervical cord. 
Monkey dorsal hom. In monkey dorsal horn (figs. 3 
and 5-top) the overall labeling intensity was somewhat 
less than in the rat and cat. In the Macacafasicularis, at 
Dopamine in spinal cord 
Figure 4: Photomicrograph with darkfield illumination of a section from the cat L6 segment showing dopamine 
immunoreactive fibers and varicosities. Note the difference in type of labeling in the dorsal and ventral horn, the 
sparse labeling in the substantia gelatinosa (lamina II, see fig. 2) and in the ventral horn intermediate zone (laminae 
VII and VIII, see fig. 2). Also note the descending fibers in the dorsolateral funiculus close to the dorsal horn (see 
also fig. 2). 1 cm: 120 ~m. 
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cervical levels, lamina I was moderately labeled with 
fine caliber fibers, while in lamina III and IV several 
thick strongly labeled fibers were present, mainly in the 
medial part of this area. Lamina II was sparsely labeled, 
containing a few rostro-caudally oriented fibers. At 
thoracic levels, overall labeling intensity was decreased, 
with very few labeled fibers in lamina II. Going further 
caudally to lumbosacral levels, the intensity of the 
labeling increased again, but lamina II remained 
sparsely innervated. The same pattern, including a 
sparsely innervated lamina II was also found at sacral 
levels. In the Macaca arctoides the labeling pattern was 
rather different from the other two monkeys, because of 
a sparse to moderate labeling of lamina III and IV, 
while lamina I was strongly labeled and labeling in 
lamina II was sparse (fig. 5-top). This typical pattern of 
dorsal horn labeling was especially apparent at cervical 
levels and was not seen in rats and cats, or in the other 
monkey. 
Ventral horn 
The dopamine llnmunoreactIvity in the ventral hom 
(figs. 1-4,6-10 and 11) had a very different appearance 
as compared to the dorsal hom. For a major part this 
difference was due to the type of innervation of the 
motoneuronal cell groups. This area (lamina IX) 
received a dense innervation of immunoreactive 
varicosities, many of which appeared to be smaller than 
in other laminae of the spinal cord. In addition, 
intervaricose segments were less pronounced, giving 
the labeling of the motoneuronal cell groups a fine 
granular (punctate) appearance, especially at lower 
magnifications (compare figs. 4, 6 and 9 with fig. 7). 
Interestingly, this type of labeling was found in 
transverse, horizontal and sagittal sections, indicating 
that the innervation pattern is organized without a 
predominant orientation, except for some "specialized 
areas" (see below). In all species a very strong labeling 
of the motoneuronal cell groups innervating the tail 
muscles was observed at the sacral (fig. 6) and 
coccygeal segments. This labeling was also of a fine 
granular appearance. In the intermediate zone (laminae 
VII and VIII) labeling was sparse with only a few 
traversing fibers. 
Rat ventral hom. In the rat ventral hom (figs. 1,6,7 
and 10) dopamine immunoreactivity generally appeared 
as indicated above. With respect to regional differences, 
there was a slightly increased labeling in the 
ventrolateral group of motoneurons mainly at the C7 
segment (Matsushita and Ueyama, 1973). Dopamine 
Dopamine in spinal cord 
immunoreactIVIty in the medial and lateral 
motoneuronal cell groups was equally strong both at 
low cervical and low lumbar spinal levels. At caudal 
thoracic and especially at lumbar levels, there was a 
slight increase in varicose fibers in the motoneuronal 
cell groups and, as a result, the fine granular appearance 
of the dopamine immunoreactivity became less 
conspicuous. 
Cat ventral horn. In cat (figs. 2 and 4), as in rat, 
dopamine immunoreactivity was much stronger in the 
motoneuronal cell groups as compared to the 
intermediate zone. However, the differences in the type 
of labeling between the two areas, as found in rat, was 
much less apparent in cat. This was due on the one hand 
to an increased number of labeled fine caliber fibers and 
varicosities in the intermediate zone, while on the other 
hand the number of labeled large varicosities and fibers 
in the motoneuronal cell groups was increased. At low 
cervical levels there was especially strong labeling in 
the ventral motor nucleus (Matsushita and Ueyama, 
1973), at the C7-8 segments. At thoracic and high 
lumbar levels the intermediate zone was almost devoid 
of labeling, while labeling of the motoneuronal cell 
groups remained strong. 
Monkey ventral hom. In the monkey ventral horn 
(figs. 3 and 9) the fine granular aspect of the dopamine 
immunoreactivity in the motoneuronal cell groups was 
in sharp contrast to the thick varicose fibers in the 
dorsal hom. Thick varicose fibers were also found in 
the intermediate zone, but here the number of fibers and 
varicosities was much less. The difference in density 
and intensity of the labeling between the intermediate 
zone and the motoneuronal cell groups became less 
apparent at the cervical and lumbar enlargements 
because of a stronger labeling in the intennediate zone. 
Also in these areas the labeling in the motoneuronal cell 
groups was somewhat stronger. 
Specialized areas 
Central cervical nucleus. This area, just dorsolateral to 
the central canal, is present mainly at high cervical 
levels, but is often difficult to delineate. It received a 
very sparse dopamine innervation, consisting mainly of 
a few fibers traversing the nucleus. 
Lateral cervical nucleus. This nucleus, which is 
located at the segments CI-C3, is most prominent in the 
cat and monkey. It received a moderate innervation 
with dopamine fibers and varicosities. 
Region around the central canal. This area, also 
referred to as lamina X, received a strong dopamine 
Figure 5: Top: photomicrograph with darkfield illumination of a section from the monkey L2 segment showing 
dopamine immunoreactive fibers and varicosities. Note only very sparse labeling in the dorsal nucleus (column of 
Clarke, see fig. 3) and very strong labeling in the IML nucleus. 1 em = 60 flm. Bottom: photomicrograph with darkfield 
illumination of a horizontal section from the rat Th6-7 segment showing dopamine immunoreactive fibers and 
varicosities. Note in the midline on the left the central canal and on the right the dorsal funiculus, indicating that the 
horizontal section is oriented slightly dorsoventrally. This makes it possible to see the strong labeling in the IML 
nucleus on the right, the labeling in the intercalatus nuclei in the middle and the central autonomic nuclei on the left. 
Also note that neurons of the dorsal nucleus (right, close to the dorsal funiculus, relatively small at this level) are 
avoided by the dopamine fibers. In the lateral funiculus (located along the entire length of the top and the bottom of 
the micrograph) some rostro-caudally oriented fibers can be seen as well as laterally running fibers, which probably 
innelVate laterally running dendrites of IML neurons. 1 em = 140 flm. 
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innervation, consisting of both thick and fine caliber 
fibers and varicosities (figs. 1-6). This innervation was 
limited to the region directly surrounding the central 
canal and a somewhat wider area extending bilaterally 
in a dorsolateral direction. This area also contained 
several crossing dopamine fibers, which were located in 
the dorsal grey commissure and appeared to run 
towards the contralateral dorsal horn rather than the 
ventral horn. 
Phrenic nucleus. In transverse sections of the C4 -
C6 segments, a characteristic group of motoneurons, 
corresponding to the nucleus of the phrenic nerve 
(Kuzuhara and Chou, 1980), was observed 
ventromedially in the ventral hom (figs. 1-3 and 10). 
Dopamine immunoreactivity in the phrenic nucleus 
showed a fine granular aspect, similar to that of 
surrounding motoneurons. In longitudinal and sagittal 
sections the phrenic motoneurons were easily 
distinguished by their longitudinally organized 
dendrites. In contrast to the findings in the transverse 
sections, dopamine immunoreactivity was stronger in 
the area containing these longitudinal dendtites than in 
the surrounding neuropil (fig. 10). It was, therefore, 
concluded that the dopamine labeling of the phrenic 
nucleus was somewhat stronger than the surrounding 
motoneurons and organized predominantly in a 
longitudinal fashion. 
Sympathetic preganglionic neurons. These neurons 
are located in the spinal segments between the caudal 
C8 and L3. The large majority of the sympathetic 
preganglionic neurons are located in the IML and a few 
neurons are present near the central canal (central 
autonomic nucleus) or the area in between (nucleus 
intercalatus) (Strack et al., 1988). All these areas, but 
especially the IML, received a very strong dopamine 
innervation (fig. 5). Cell bodies often stood out as small 
unlabeled areas in a massively irmervated region. The 
area between the IML and the central canal, which 
contains many dendrites of sympathetic neurons, also 
received a strong dopamine innervation, which 
sometimes appeared as a heavily labeled band between 
the IML and the central canal. In horizontal sections 
(fig. 5) the dopamine intrnunoreactivity was clearly 
seen to be organized in a "ladder like" pattern (Hosoya 
et al., 1991). 
Dorsal nucleus (column of Clarke). This area 
contains large cells, projecting to the cerebellum, and is 
located in segments Th1 to L3 (Grant et al., 1982). 
Dopamine innervation was nearly absent with only an 
occasional fiber and some tenninal-like structures (fig. 
5); most fibers seemed to avoid the nucleus. 
Cremaster nucleus. The cremaster nucleus, a 
sexually dimorphic motor nucleus innervating the 
cremaster muscle, is located primarily in the segments 
Ll and L2 and is most prominent in the male (Nagy and 
Senba, 1985). In the male Arctoides monkey the 
cremaster nucleus received a very strong dopamine 
innervation (fig. 9). In transverse sections the same 
strong innervation was sometimes seen in medio-
laterally oriented dendritic bundles, which are known to 
belong to cremaster motoneurons (fig. 9). In male rats 
and female cats, the cremaster nucleus also received a 
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stronger innervation in comparison with surrounding 
motoneurons, but this labeling was less prominent than 
in the male monkey. 
Lumbo-sacral motoneurons. The motoneurons 
which innervate, through fibers in the pudendal nerve, 
the anal and urethral sphincter muscles and related 
muscles form a special group of motoneurons 
(Schr¢der, 1980). They are somewhat smaller than the 
surrounding (somatic) motoneurons and they are 
sexually dimorphic (McKenna and NadeIhaft, 1986). In 
different species these motoneurons are located in 
different areas of the ventral horn. In rat two different 
groups can be distinguished, namely the nucleus 
dorsomedialis (DM) (also known as the spinal nucleus 
of the bulbocavernosus, SNB) and nucleus 
dorsolateralis (DL) (Schr¢der, 1980). In cat the DM and 
DL nuclei, as distinguished in the rat, are fused to fonn 
a ventrolaterally located nucleus, designated (like in 
man) as Onufs nucleus (Sato et aI., 1978; Ueyama et 
aI., 1984). In monkey the organization is similar to the 
cat (Nakagawa, 1980). The DM and DL nuclei in the rat 
and Onufs nuclei in the cat and monkey received a 
strong dopamine innervation, which was much stronger 
than dorsolaterally located motoneurons, which 
innervate muscles associated with the foot. Sometimes 
prominent dendritic bundles were seen radiating 
laterally and medially from Onufs and DL nuclei and 
laterally from the DM nucleus. These bundles also 
received a strong dopamine innervation. The intensity 
of the labeling in the sexually dimorphic nuclei was 
similar to that of the tail-muscle motoneurons, which 
first appear ventromedially in the ventral horn, at the SI 
segment. In addition, a ventral group of motoneurons, 
innervating the levator ani muscle, also received a 
strong dopamine innervation, similar to Onufs nucleus. 
Sacral parasympathetic area. This area, located 
mainly in the segments SI-S4 (depending on species) 
contains the parasympathetic nucleus. This area showed 
a stronger dopamine innervation than the surrounding 
intennediate zone (fig. 6), but it could not be 
detennined whether the dopantine fibers tenninated 
specifically on the preganglionic parasympathetic 
neurons. 
Location of the descending dopamine fibers 
In all animals the majority of the descending dopamine 
fibers was located in the dorsolateral funiculus (figs. 1-
6) and, to a limited extent, in the lateral and 
ventrolateral funiculi at cervical levels. An occasional 
fiber was seen in the ventromedial and dorsal funiculi. 
In sagittal and horizontal sections it was found that the 
funicular fibers showed few varicosities and appeared 
as relatively straight structures. Occasionally a fiber 
gave rise to a collateral, often at a right angle, which ran 
to the lateral part of the dorsal horn. Collateral fibers, 
which originated from stem fibers in the dorsolateral 
and lateral funiculi, were rarely seen to reach the ventral 
horn. Apart from the fibers in the funiculi there were 
also rostrocaudally oriented fibers in the dorsal horn, 
most notably in laminae I and III, but also in lantina II 
(fig. 11). In the region around the central canal there 
were a large number of fibers, including several rostro-
caudally oriented fibers. However, it appeared from 
Dopamine in spinal cord 
Figure 6: Photomicrograph with darkfield illumination of a section from the rat Sl segment showing dopamine 
immunoreactive fibers and varicosities. Note the labeling in the area of the parasympathetic preganglionic neurons 
just medial of the descending fibers in the dorsolateral funiculus (white arrowheads). Also note the strong, punctate 
labeling in the motoneuronal cell groups. 1 em = 70 flm. 
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sagittal and horizontal sections that these fibers fonn a 
minority and hence do not contribute significantly to the 
descending dopamine system. 
DSP-4 experiments 
Sections from the spinal cords of rats treated with DSP-
4, which only affects the noradrenaline fibers in the 
dorsal horn (Jonsson, 1983), were processed for DBH 
immunocytochentistry (fig. 8), while alternate sections 
from the same (DSP-4 treated) rat were processed for 
dopamine immunocytochentistry (fig. 8). In these DSP-
4 treated rats there were very few DBH-
immunoreactive fibers in the dorsal horn, while the 
ventral horn contained many DBH immunoreactive 
fibers. These results are similar to those described 
previously (Fritschy and Grzanna, 1989; Lyons et al., 
1989). In contrast, the alternate sections showed many 
dopamine immunoreactive fibers and varicosities 
throughout the spinal grey matter, including the dorsal 
horn, with the same pattern and intensity as in untreated 
rats. This demonstrated that the absence of 
(nor)adrenergic fibers, as visualized by the lack ofDBH 
immunoreactivity. did not influence the dopamine 
immunoreactivity. Alternate sections from saline 
injected control rats, treated for DBH (fig. 8) or 
dopantine immunocytochentistry as the DSP-4 treated 
rats, showed many immunoreactive fibers and 
varicosities throughout the dorsal and ventral horn in a 
similar pattern as found in the present study for 
dopantine or described elsewhere for DBH (Westlund 
et al., 1983; Fritschy and Grzanna, 1990; Rajaofetra et 
al., I 992b) 
Discussion 
The present study shows the distribution of dopamine in 
the spinal cord of the rat, cat and monkey. It provides a 
detailed study of all parts of the spinal cord, including 
the various specialized areas. Below the specificity of 
the dopamine antibodies that we used will be discussed. 
Then the topographical distribution of the labeling, as 
compared with the other monoamines, will be 
discussed, followed by some functional considerations. 
Methodological aspects 
In the present study the distribution of dopantine in the 
rat, cat and monkey spinal cord was detennined by 
using immunocytochentistry with highly specific 
antibodies directed against (glutaraldehyde-bound) 
dopantine. 
Nevertheless the possibility that the dopantine 
antibody reacted with adrenergic and/or noradrenergic 
tenninals should be considered, not because of cross-
reactivity of the antibodies (see below), which have 
been extensively tested and used, but rather because the 
dopamine antibodies may recognize dopamine, which is 
present as a precursor in (nor)adrenergic terminals. 
However, biochemical studies in areas with a high 
noradrenaline and a low dopamine innervation, like the 
cerebellum and hippocampus, have shown that the 
dopamine concentration is only 1-3% of the 
noradrenaline concentration (Commissiong et al., 1978; 
Westerink and Mulder, 1981; Verhage et aI., 1992). 
These studies further showed that destruction of the 
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locus coeruleus, and consequently the noradrenaline 
innervation of several brain areas, including the 
cerebellum and hippocampus, had no effect on 
dopamine levels in those areas rw esterink and De 
Vries, 1985). This would indicate that even in areas 
with a relatively high noradrenaline and a low 
dopamine concentration, dopamine represents the 
transmitter pool rather than the "precursor pool" of 
noradrenaline. Subsequent biochemical and/or 
anatontical studies in cerebellum (Panagopoulos et al., 
1991; Ikai et al., 1992) and hippocampus (Verney et al., 
1985; Verhage et al., 1992; Gasbarri et aI., 1994) 
confirmed the existence of a dopamine projection 
independent from the noradrenaline innervation. 
Furthermore we have found (van Dijken and Holstege, 
1995) that in the external cuneate nucleus and the area 
postrema of the lower brainstem there was a strong 
inununoreactivity for DBH, while labeling for 
dopamine was virtually absent (using the same "Jarmes" 
antibody as we have used in the present study). This 
indicated that the dopantine "precursor pool" in 
(nor)adrenergic terntinals was too low to be identified 
by the dopantine antibody, probably due to a very high 
turnover rate of dopamine in these terminals. These 
findings further showed that there is no cross-reaction 
of the dopantine antibody with noradrenaline, 
confirnting the high specificity of the antibody. On the 
other hand it should be mentioned that (nor-)adrenergic 
cell somata, like those in the locus coeruleus, show 
some immunoreactivity for dopamine, probably 
because more dopamine is present as a precursor in the 
somata than in the terntinals of (nor-)adrenergic 
neurons (see also Geffard et aI., 1984). 
Our control experiments for the spinal cord with 
DSP-4 treated rats, in which DBH labeled (nor) 
adrenergic terntinals in the dorsal hom had disappeared 
almost completely, showed that the dopantine 
immunoreactivity was still present in those rats. 
Moreover, the intensity and the pattern of the dopamine 
labeling were identical to those in untreated rats. A 
similar finding was obtained in a study (Mouchet et at., 
1992) using rats treated with 6-0HDA, which causes a 
specific degeneration of noradrenergic tenninals, 
leaving the dopantinergic terntinals largely unaffected. 
These experiments showed that in 6-0HDA treated rats, 
dopamine immunoreactive fibers were still present, 
while in other 6-0HDA treated rats the noradrenaline 
immunoreactivity had disappeared. Taken together, the 
various data demonstrated that the dopantine antibody 
did not recognize dopamine in noradrenergic terminals, 
nor did it crossreact with noradrenaline. 
It may be concluded that in the spinal cord, 
including the motoneuronal cell groups, a dopamine 
innervation is present, which is independent of the 
(nor)adrenergic innervation. Moreover, the dopamine 
labeling in the spinal cord as found in the present study 
represented exclusively dopamine fibers and terminals. 
Topographical distribution 
The results of the present study show that in rat, cat and 
monkey dopamine fibers and varicosities are present in 
all laminae of the spinal grey matter throughout the 
spinal cord, but with clear regional differences. The 
Dopanline in spinal cord 
Figure 7: Top: photomicrograph with darkfield illumination of a section from the rat C1 segment showing dopamine 
immunoreactive fibers and varicosities in the dorsal horn. Note the strong labeling in laminae III-V and the 
moderate labeling in lamina I, while labeling in lamina II (the substantia gelatinosa) is only sparse. See fig. 1 for 
laminar arrangement. 1 cm = 65 ~m. Bottom: photomicrograph with darkfield illumination of the motoneuronal cell 
groups from a section from the rat L5 segment showing dopamine immunoreactive fibers and varicosities. Note the 
abundance of small varicosities, presumably terminals, with a paucity of intervaricose fibers, although the position 
of many varicosities suggests that they are interconnected. The motoneurons appear as "black holes". The ventral 
funiculus can be seen below and left. 1 cm = 35 ~m. 
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general pattern of labeling of the dopamine fibers and 
terminals is similar in the species investigated. 
Dopamine labeled neuronal cell bodies were only found 
in the rosttal Cl segment, probably representing the 
caudal extension of the medullary Al and A2 cell 
groups. Although many neurons in the Al and A2 cell 
group contain DBH, some of them were found to be 
immunoreactive for dopamine (Maqbool el al., 1993) or 
TH (Mouchet el al., 1986) and not for DBH, indicating 
that they actually represented dopaminergic neurons. 
Labeled (neuronal) cell bodies were never identified 
below rostral C 1, which is in contrast with the finding 
(Mouchet et al., 1986) of TH immunoreactive neurons 
at the S 1 segment. If both observations were correct it 
must be assumed that these TH-Iabeled cells are not 
able to convert L-DOPA (the TH product) into 
dopamine, as has been shown to occur in the 
hypothalamus (Meister et al., 1988; Steinbusch et ai., 
1991). 
Dorsal horn. In the dorsal horn, the lack of 
innervation of the substantia gelatinosa is the most 
conspicuous finding, which is consistent throughout all 
species, but least obvious in the cat. Previous studies in 
rat, using immunocytochemistry with an antibody 
directed against dopamine (Yoshida and Tanaka, 1988; 
Mouchet el al., 1992; Ridet et al., 1992), have described 
the same pattern of innervation of the dorsal horn as in 
the present study. Similar to the distribution of 
dopamine, serotonin also showed a widespread 
innervation of the dorsal hom including a sparse 
innervation of the substantia gelatinosa, especially in its 
inner part. In rat (Marlier et al., 1991), cat (Ruda et ai., 
1982) and monkey (Kojima and Sana, 1983; LaMotte 
and Lanerolle, 1983) serotonin immunoreactive 
labeling in the dorsal horn was found to be strongest in 
lamina I and outer lamina II, whereas there was only 
sparse labeling in the inner part of lamina II. Laminae 
III-VI were only moderately innervated. The 
distribution of the dopamine labeling in laminae III-V is 
slightly different than the serotonergic innervation since 
the dopamine labeling is stronger (rat) or similar (cat 
and monkey) as compared to the labeling in lamina I. 
An extensive innervation of the dorsal hom has also 
been described for noradrenaline or DBH 
immunoreactive fibers and terminals in the rat 
(Westlund et al., 1983; Fritschy and Grzanna, 1990; 
Hagiltira et al., 1990; Rajaofetra et ai., 1992b), cat 
(Doyle and Maxwell, 1991) and monkey (Westlund el 
ai., 1984). The low innervation of lantina II, which is 
typical for dopamine and serotonin, is less obvious in 
case of noradrenaline, although a stronger innervation 
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of the outer part of lamina II versus the inner part has 
been suggested (Westlund et ai., 1983; Hagiltira et ai., 
1990; Rajaofetra et al., 1992b). Also in our study with 
DBH, the difference between dopamine and 
noradrenaline with respect to the innervation of the 
substantia gelatinosa was very clear (compare fig. 8 lop 
and bottom). In several areas the dopamine innervation 
of lamina I appeared as patches occasionally located 
outside the boundaries of tins lamina. Whether these 
patches actually exceeded the border between laminae I 
and n or whether there was a local widening of lamina 
I, cannot be determined with certainty in the present 
material. The finding in one monkey of only sparse 
labeliug in lamina II and deeper laminae, while lamina I 
was strongly labeled (fig. 5-lop), was rather surprising. 
This finding showed that regional density can vary, not 
only between, but also within species. 
The inlermedio-Ialeral cell column (IML). The IML, 
which is located from caudal C8 to L3 (Strack el al., 
1988), received a massive dopamine innervation and 
this was also true for the nuclei that may be considered 
as the medial extensions of the IML towards the central 
canal: the nucleus intercalatus and the central 
autonomic nucleus, located just dorsal and dorsolateral 
to the central canal. These findings are in agreement 
with previous reports on the dopamine innervation of 
the spinal cord (Skagerberg el al., 1982; Yoshida and 
Tanaka, 1988; Mouchet et al., 1992; Ridet el ai., 1992). 
The IML is characterized by a patchy organization with 
dendritic bundles interconnecting the sympathetic 
subnuclei, forming a "ladder-like" pattern when viewed 
in horizontal sections (Romagnano and Hamill, 1984; 
Hosoya et al., 1991). The dopamine innervation exactly 
mimics this discontinuous organization, indicating that 
the dopamine fibers are aimed at the sympathetic 
preganglionic neurons and their dendrites. A similar 
"ladder-like" pattern of innervation was found with 
many other transmitters, including noradrenaline, 
serotonin, adrenaline and various peptides like 
substance P, oxytocin, vasopressin, neurotensin, 
somatostatin, neuropeptide Y and enkephalin (Swanson 
and McKellar, 1979; Glazer and Ross, 1980; Holets and 
Elde, 1982; Westlund et al., 1983; Romagnano and 
Hantill, 1984; Krukoff, 1987; Fuxe et al., 1990; Hosoya 
et al., 1991; Rajaofetra et al., I 992b). 
The dorsal nucleus (column of Clarke). This nucleus 
is located in the same segments as the IML. It projects 
mainly to the cerebellum (Grant et ai., 1982). In 
contrast to the IML, the dorsal nucleus received very 
few, if any, dopamine immunoreactive fibers. The 
serotonergic innervation of the nucleus dorsalis is also 
Figure 8: Photomicrograph with darkfield illumination of the dorsal horn from the rat C7 segment. Top: DBH 
immunoreactive fibers and varicosities in a control (saline-injected) rat. Note that, in comparison with the dopamine 
labeling (bottom), the density of the DBH labeling is similar in all laminae of the dorsal horn (including lamina II) 
and the relatively fine caliber of the fibers. 1 cm = 90 jlm. Middle: DBH immunoreactive fibers and varicosities two 
weeks after treatment with the neurotoxin DSP-4. Note that most DBH labeling has disappeared after DSP-4 
treatment (compare with control animal in top micrograph). 1 cm = 90 jlm. Bottom: Dopamine immunoreactive 
fibers and varicosities two weeks after treatment with the neurotoxin DSP-4 (same rat as in middle micrograph). 
Note that the dopamine immunoreactivity has not changed significantly in the absence of (nor)adrenaline (see 
middle micrograph), providing direct proof that the dopamine immunoreactivity is not located in (nor)adrenergic 
fibers and varicosities. 1 cm = 90 jlm. 
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Figure 9: Photomicrograph with darkfield illumination of a section from the monkey L3 segment showing a very 
large number of dopamine immunoreactive fibers and varicosities around the mota neurons of the cremaster 
nucleus. Note that this strong innervation is also present along (presumed) dendritic bundles (white arrowheads) 
that radiate in several directions. Also note the fine granular labeling in the other (medial and lateral) motoneuronal 
cell groups, while the intermediate zone is only sparsely innervated. 1 em = 100 11m. 
low but not absent (Kojima et al., 1983a; Polistina et 
al., 1990). It is interesting to note that the central 
cervical nucleus, which also projects to the cerebellum 
(Matsushita and Hosoya, 1979), received a very sparse 
dopamine innervation as well. This might suggest that 
cerebellar-projecting neurons are avoided by the 
dopamine fibers. On the other hand, there are many 
more neurons, apart from the nucleus dorsalis and the 
central cervical nucleus, that project to the cerebellum 
(Grant et aI., 1982). Since these cells are scattered over 
different locations in the spinal cord, it will be difficult 
to detennine whether or not they receive a 
monoaminergic innervation. The reason for the 
avoidance by dopamine of spinal nuclei projecting to 
the cerebellum is still unclear. 
The ventral hom. The presence of dopamine in the 
motoneuronal cell groups of the ventral horn was 
discovered much later than in the dorsal horn (Yoshida 
and Tanaka, 1988; Shirouzu et al., 1990; Ridet et al., 
1992). The most conspicuous aspect of the dopantine 
labeling in the motoneuronal cell groups was its fine 
granular. punctate-like aspect, which was especially 
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apparent in the rat. This appearance, that is probably 
caused by a large number of small, lightly stained 
terminals, may have been the reason why initially the 
existence of dopaminergic terminals in the ventral horn 
was denied or neglected. Also in our material. after a 
less than optimal fixation or immunocytochemical 
procedure, the dopamine labeling in the ventral horn 
was the first to disappear. Thus, sensitive techniques are 
necessary for the anatomical identification of 
dopaminergic temrinaIs in the ventral hom, which is in 
line with the biochemical observation that the dopamine 
concentration in the ventral hom is significantly lower 
than in the dorsal horn (Fleetwood-Walker and Coote, 
1981; Basbaum et al., 1987). Apparently, the fine 
granular network in the motoneuronal cell groups of the 
ventral horn is derived mostly from fibers in the dorsal 
horn, which are running through the intermediate zone 
to reach the motoneuronal area. Other monoaminergic 
transmitters, like serotonin and noradrenaline, have also 
been reported to show a finer appearance in the 
motoneuronal cell groups than in the dorsal hom 
(Kojima et aI., 1983a; Fritschy et al., 1987). The 
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Figure 10: Photomicrograph with darkfield illumination of a horizontal section through the ventral horn of the 
rat C4-C5 segments. The ventrolateral funiculus is located on the left side of the micrograph and the 
ventromedial funiculus is located on the right side. Note the longitudinally oriented dopamine labeling in the 
area of the phrenic nucleus (white arrowheads), presumably alongside dendrites of phrenic motoneurons. Also 
note that the longitudinally oriented labeling appears somewhat stronger than the labeling in the surrounding 
neuropil. 1 cm = 55 ~m. 
strongest labeling in the motoneuronal cell groups was 
found in the cremaster nucleus, situated ventromedially 
at rostral lumbar levels, and in Onufs nucleus (in cat 
and monkey) and its homologue in the rat (see results) 
at the lumbo-sacral leveL These sexually dimorphic 
nuclei also receive a strong irmervation of serotonin, 
noradrenaline and various peptides (Kojima et aI., 
1983b; Kojima and Sano, 1984; Kojima ef al., 1985; 
Nagy and Senba, 1985; Uda ef al., 1986; Newton and 
Hamill, 1988; Wang ef al., 1989; Newton, 1990; Poulat 
ef aI., 1992; Rajaofetra ef aI., 1992a). We are presently 
investigating the dopamine innervation of these nuclei 
in more detail, especially with respect to possible 
differences in irmervation between males and females. 
Dopamine and glutamate. In most parts of the 
spinal cord, the distribution of the dopantine 
immunoreactivity is very similar to the distribution of 
noradrenaline and serotonin. In this respect it is 
interesting to note that immunoreactivity for glutamate 
or glutaminase (a glutamate synthesizing enzyme) was 
present in serotonergic neurons of the raphe nuclei 
(Kaneko ef aI., 1990; Nicholas ef aI., 1992; see also 
Holstege, 1996) and noradrenergic neurons in the locus 
coeruleus area (Kaneko ef aI., 1990; Fung ef al., 1994; 
Liu ef al., 1995), all of which give rise to descending 
spinal projections. These findings suggest an extensive 
colocalization of glutamate with serotonin and with 
noradrenaline. In view of the many similarities between 
the different monoamines, it may be speculated that the 
dopaminergic terminals in the spinal cord also contain 
glutamate, as was also suggested by the presence of 
glutaminase in dopaminergic neurons in the All cell 
group (Kaneko ef al., 1990) from which the spinal 
dopaminergic terminals originate. 
Functional considerations 
Dopamine fibers and terminals are located throughout 
the spinal grey matter. Consequently it is to be expected 
that dopamine will influence both sensory and motor 
systems as well as various autonomic functions. Below 
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the effects of dopamine on some major spinal cord 
functions, and the receptors involved, will be discussed. 
Dopamine effects on sensory transmission. Initially 
the effects of dopamine on sensory processing of 
peripheral sensory infonnation in the spinal cord were 
studied by measuring the latencies of several (spinal) 
reflexes, like the hot-plate and tail-flick reflexes, 
following application of dopamine and various 
dopamine agonists (Barasi et ai., 1987; see Jensen, 
1986 for review). These studies generally showed an 
increase in latency, suggesting an inhibition of sensory 
(pain) transmission. In most cases these effects could be 
reversed by dopamine Drreceptor antagonists. 
However. effects on spinal reflexes may also be 
produced by influencing the motor component of the 
reflex. This problem does not occur with direct 
recordings from spinothalamic tract neurons in the 
superficial or deep dorsal hom. These studies showed 
that in monkey (Willcockson et al., 1984) dopamine 
decreased the response of dorsal horn cells to glutamate 
and to noxious pinch. In rat and cat (Fleetwood-Walker 
et aI., 1988) dopamine or a D2-agonist, 
iontophoretically applied to dorsal hom neurons, 
selectively inhibited the responses of these neurons to 
noxious stimuli, while the responses to nonnociceptive 
stimuli were unaffected. The same results were 
obtained after stimulating the All dopamine cell group, 
from where the dopamine spinal projections originate. 
All these effects were reversed by a Drreceptor 
antagonist. More recently, evidence was found that 
spinal dopamine is involved in the antinociceptive 
effects of morphine (Weil-Fugazza and Godefroy, 
1991) and cocaine (Kiritsy-Roy et aI., 1994). These 
effects could also be antagonized by Dz-antagonists. 
However, the exact mechanisms involved are still 
unclear. 
The above studies all indicate a prominent role of 
Dz-receptors in mediating the antinociceptive effects of 
dopamine. This is in agreement with ligand binding 
studies on dopamine receptors in the spinal cord which 
all show the existence of Dz-receptors in the dorsal horn 
(for details and references see van Dijken et al., 1996). 
Furthermore, recent in situ hybridization and 
immunocytochemical studies on the localization of 
spinal Dz-receptors in our laboratory (van Dijken et al., 
1996) have also shown the existence of neurons in the 
dorsal hom, including lamina I, expressing Dr 
receptors. Taken together the various data indicate that 
dopamine exerts an inhibitory effect on nociceptive 
transmission in the spinal dorsal horn, mediated by D 2-
receptors, while the effects on non-nociceptive 
transmission and the involvement of Drreceptors may 
be less prominent. 
Dopamine effects on motor control. At present only 
a few studies have investigated the effects of dopamine 
on spinal motor output. In an early study in cat (Barasi 
and Roberts, 1977), an increase in the field potential of 
antidromically activated motoneurons was found, after 
iontophoretic application of dopamine in the 
motoneuronal cell groups. This effect was blocked by a 
(nonspecific) dopamine receptor antagonist. These 
results suggested that dopamine produced an increase in 
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motoneuron excitability. This effect may be 
accomplished by enhancing glutamate activated 
currents, as shown in cultured embryonic chick 
motoneurons (Smith et al., 1995). A similar 
mechanism, i.e. the facilitation of motoneuronal 
excitation by other transmitters, like glutamate, has also 
been proposed for serotonin and noradrenaline (White 
and Neuman, 1980; White, 1985). Other studies have 
investigated the effect of dopamine or dopamine 
receptor agonists and antagonists on various 
monosynaptic and polysynaptic spinal reflexes with 
contradictory results. In some cases facilitation was 
found (Dupe1j and Gcber, 1981), while others reported 
an inhibitory effect (Carp and Anderson, 1982; Ono and 
Fukuda, 1984; Pehek et al., 1989). In addition it was 
found in spinal rats (Maitra et al., 1993) that 
intravenously applied apomorphine, a non-selective 
dopamine receptor agonist, had an inhibitory influence 
on Renshaw cell bursts elicited by electrical stimulation 
of the ventral roots, while a similar concentration of 
apomorphine had no effect on the monosynaptic reflex 
from the dorsal root. A recent study on the 
monosynaptic reflex in acutely spinalized rats using 
various dopamine agonists and antagonists like 
apomorphine and bromocriptine (a D,-agonist) (Kamijo 
et al., 1993) showed a depression of this reflex, which 
was mediated by neither D j - nor Dz-receptors. 
In a separate line of experiments, mostly performed 
in the late sixties (see Grillner, 1975 for review) the 
effects of 3,4-dihydroxyphenylalanine (DOPA) were 
investigated. An intravenous injection of DOPA 
produced walking on a treadmill in the spinal cat and 
had powerful, but complicated, effects on various other 
reflexes (And€n et al., 1966b; Commissiong and 
Sedgwick, 1974; Grillner, 1975). Since DOPA is a 
precursor in the dopamine and noradrenaline synthesis 
and active only after decarboxylation (Anden et al., 
1966a), it was generally assumed that the synthesis of 
dopamine from DOPA and the subsequent formation 
and release of noradrenaline, were responsible for the 
effects of DOPA in the spinal cord. This assumption 
was based on pharmacological experiments (Jurna and 
Lundberg, 1968) and the supposition that dopamine was 
present only as a precursor for noradrenaline (see 
introduction). However, there are indications that 
dopamine may also playa role in mediating the effects 
of DOPA (Carp et al., 1989). A recent study (Skoog 
and Noga, 1995) in cat and guinea-pig on the effects of 
iontophoretically applied dopamine on group II afferent 
fibers showed a significant depression of the 
monosynaptic field potential of electrically stimulated 
group II fibers, while there were no effects on group I 
fibers. It was further suggested that the effects in the 
dorsal hom were mediated by D j - as well as D2-
receptors, while those in the intennediate zone were not 
mediated by dopamine receptors. This latter finding 
would fit with the low amount of dopamine that we 
have found in the intermediate zone. The strong 
innervation of the sexually dimorphic nuclei in the 
spinal cord suggests a specific function of dopamine in 
this special group of motoneurons. The finding (van 
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Figure 11: Schematic drawings of the dopamine labeling in the rat low cervical spinal cord. Top: three-dimensional 
drawing of the low cervical spinal cord. On the left the labeling as it appears in a transverse section, on the right the 
plane of section of the drawing in 8) is indicated. Bottom: labeling in a sagital section as indicated above. Note the 
rostro·caudally oriented fibers in laminae 1·111, the more random orientation in laminae IV and especially lamina V, 
the paucity of labeling in laminae VII and VIII and the punctate labeling in lamina IX. 
Dijken et ai., 1996) that D,-receptors were present in 
the (the homologue of) Onufs nucleus in the rat would 
strengthen this idea, although the specific function of 
dopamine in these cases is unclear. Taken together it 
may be concluded that the effects of dopamine on 
motor output are diverse and exerted on the 
motoneuronal as well as on the interneuronal level. It 
seems likely that different types of dopamine receptors 
are involved, while some effects may be produced by 
non-dopamine receptors. Also a presynaptic action 
should not be excluded (Maitra et al., 1993). More 
detailed analyses of the effects of dopamine on 
individual (motor) neurons, rather than on groups of 
cells or on reflexes, are needed to broaden our 
understanding of the effects of dopamine on the motor 
system, and to compare the cellular physiology of 
dopamine with the actions of noradrenaline and 
serotonin (for review see White et al., 1996). In view of 
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the presence of dopamine in the motoneuronal cell 
groups the question arises whether part of the disturbed 
motor performance in Parkinson's disease may be 
attributed to changes in dopamine neurotransmission at 
the spinal level (Lindvall et aI., 1983). However, there 
is no evidence that All dopaminergic neurons are 
affected in Parkinson's disease and in addition it was 
shown (Scatton et aI., 1986) that the dopamine 
concentration in the spinal cord of Parkinsonian patients 
was the same as compared to healthy subjects. 
Therefore, it seems at present unlikely that changes in 
spinal dopamine are involved in producing the motor 
deficits associated with Parkinson's disease. 
Dopamine effects on autonomic functions. The 
dense dopamine innervation of the preganglionic 
neurons in the IML, suggests that dopamine is strongly 
involved in regulating the sympathetic outflow. Studies 
on the effects of dopamine have focussed mainly on 
blood pressure and heart rate, which are controlled by 
the preganglionic sympathetic neurons in the upper 
thoracic area (LaWou et al., 1990). Intrathecal 
administration of Dr and Drreceptor agonists showed 
that hypotensive effects could be obtained after Dl and 
also after Drreceptor activation, while bradycardia was 
related only to Drreceptor activation (pellissier and 
Demenge, 1991). Our recent study (van Dijken et al., 
1996) using in situ hybridization and 
immunocytochemistry also showed the presence of Dz-
receptors in the IML. Iontophoretic application of 
dopamine onto a very limited number of preganglionic 
sympathetic neurons at the Th-2 segment induced an 
increase in firing rate of these neurons (Lewis and 
Coote, 1990), suggesting an increase in blood pressure 
and heart rate. However, it was shown in the same 
study that the effects of noradrenaline, which were 
investigated in much more detail than those of 
dopamine, were inhibitory in high doses and excitatory 
in low doses. If the same mechanism also applies to the 
effects of dopamine, it may explain that the effects of 
dopamine on the sympathetic preganglionic neurons 
regulating blood pressure and heart rate, are not 
straightforward. The effects of dopamine may depend 
not only on the types of receptors that are involved, but 
also on the concentration of the transmitter released and 
on the interaction with many other transmitters that are 
present in the IML. 
The dopamine innervation of the sacral cord 
suggests a specific innervation of the preganglionic 
parasympathetic neurons, although this innervation is 
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much less pronounced than the innervation of the 
sympathetic preganglionic neurons in the IML. With 
respect to the effects of dopamine on the 
parasympathetic nuclei there are no data available. The 
high degree of collateralization in the dopamine 
diencephalo-spinal projection would imply that 
dopamine is released simultaneously in many different 
areas of the spinal cord, including the sympathetic and 
parasympathetic preganglionic neurons. If the release of 
dopamine is part of a specific type of behavior, it is to 
be expected that dopamine will exert opposite effects on 
sympathetic and parasympathetic preganglionic 
neurons. Whether this is indeed the case is presently 
unclear. 
Conclusion 
The present study shows the existence of a distinct and 
extensive dopamine innervation of the sensory, motor 
and autonomic areas of the spinal cord of the rat, cat 
and monkey. Although the concentration of dopamine 
in the spinal cord is much less than that of 
noradrenaline and serotonin, evidence is now 
accumulating for specific effects of dopamine in these 
spinal cord areas, i.e. an inhibitory effect on sensory 
transmission, a mainly facilitory (but probably mixed) 
effect on motor transmission and a complicated, 
probably mainly inbibitory, effect on sympathetic 
outflow. However, more detailed studies are needed to 
detennine the effects of dopamine in specific areas of 
the spinal cord with more certainty. The distributions of 
dopamine, noradrenaline and serotonin are very similar, 
which strengthens the idea that the monoamines have a 
similar mode of operation and may have similar effects, 
although their activity may be regulated differently, 
depending on the behavioral context. 
This study emphasizes that besides noradrenaline 
and serotonin, dopamine should also be included when 
considering the monoaminergic effects on spinal 
processing. In fact, the interaction between the various 
monoamines may be of even greater importance than 
the effect of the respective transmitters alone. 
Investigations along this line may prove worthwhile. 
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Localization Of Dopamine D2 Receptor In Rat Spinal Cord 
Identified With Immunocytochemistry And In Situ 
Hybridization 
Abstract 
In the present study the distribution of dopamine D2-receptors in rat spinal cord was determined by 
means of immunocytochemistry using an anti-peptide antibody, directed against the putative 3" 
intracellular loop of the D2-receptor, and in situ hybridization using a [35SjUTP labeled anti-sense 
riboprobe. 
With the immunocytochemical technique, labeling was confined to neuronal cell bodies and their 
proximal dendrites. Strongest labeling was present in the parasympathetic area of the sacral cord 
and in two sexually dimorphic motor nuclei of the lumbosacral cord, the spinal nucleus of the 
bulbocavernosus, and the dorsolateral nucleus. Moderately labeled cells were present in the 
intermediolateral cell column, the area around the central canal and lamina I of the dorsal horn. 
Weak labeling was present in the lateral spinal nucleus and laminae VII and VIII of the ventral horn. 
Except for the two sexually dimorphic motor nuclei of the lumbosacral cord labeled motoneurons 
were not encountered. 
With the ISH technique radioactive labeling was present in many neurons, indicating that they 
contained D2-receptor mRNA. The distribution of these neurons was very similar to the distribution 
obtained with immunocytochemistry, but with ISH additional labeled cells were detected in laminae 
III and IV of the dorsal horn, which were never labeled with immunocytochemistry. 
The present study shows that the D2-receptor is expressed in specific areas of the rat spinal cord. 
This distribution provides anatomical support for the involvement of D2-receptors in modulating 
nociceptive transmission and autonomic control. Our data further indicate that D2-receptors are not 
directly involved in modulating motor functions with the exception, possibly, of some sexual motor 
functions. 
Introduction 
Biochemical studies in the seventies (Magnusson, 1973; 
Commissiong and Neff, 1979) first indicated that 
dopamine in the spinal cord acted as a neurotransmitter 
and not solely as a precursor in the synthesis of other 
catecholarnines. Anatomically, the presence of 
dopamine fibers in the spinal cord was first 
demonstrated by histofluorescence techniques 
(Bjorklund and Skagerberg, 1979; Hokfelt et al., 1979; 
Skagerberg et aI., 1982). More recently, 
immunocytochemical studies using dopamine specific 
antibodies at the light and electron nticroscopical level 
revealed that dopamine fibers and terntinals existed in 
virtually all laminae throughout the spinal cord 
(Holstege et al., 1990; Shirouzu et al., 1990; Mouchet 
et aI., 1992; Ridet et aI., 1992). Oopantine 
innnunoreactivity was most pronounced in the dorsal 
horn, in the area around the central canal, in the 
sympathetic intermediolateral cell column (IML), and 
in the motoneuronal cell groups. Retrograde tracing 
techniques combined with histofluorescence (Bjorklund 
and Skagerberg. 1979) or irnmunohistochentistry of 
catecholamine-synthesizing enzymes, like tyrosine 
hydroxylase (Hokfelt et aI., 1979; Skagerberg et al., 
1988) and aromatic L-amino decarboxylase 
(Skagerberg et aI., 1988), indicated that the spinal 
dopamine innervation originated exclusively from the 
All catecholamine cell group, which is situated in the 
periventricular posterior hypothalamus. The 
paraventricular nucleus has also been implicated as a 
minor source for the spinal dopamine innervation 
(S wanson et al., 1981). Thus, the existence of an 
extensive dopamine innervation of the spinal cord, 
mainly originating from the All group. is now well 
established. 
Over the years, biochemical, pharmacological, and 
electrophysiological studies (Barasi and Roberts, 1977; 
Coote et al., 1981; Fleetwood-Walker et aI., 1988) 
provided evidence for specific effects of dopamine 
within the spinal cord which were mediated by 
dopamine receptors. Presently, dopamine receptors are 
subdivided in two receptor families based on 
phannacological and biochemical criteria (for reviews 
see Civelli et al., 1991; Gingrich and Caron, 1993). 
These receptor families include D)-like receptors, 
which are stimulatory coupled to adenylate cyclase, and 
Dr like receptors, which are either inhibitory or not 
coupled to this enzyme. Subtypes belonging to the two 
dopamine receptor families have been cloned and 
sequenced: D)-like receptors include the Dl and D5 
dopamine receptors, whereas D2-like receptors include 
the O2, 0 3, and 0 4 dopamine receptors. By alternate 
splicing of the Dz-receptor gene two isoforrns (D2short 
and D21ong) are generated, which differ by a splice insert 
of 29 amino acids in the putative 3"' intracellular loop of 
the D2-receptor. This insert is present in the long 
isofonn, but is lacking in the short isofonn. 
The specific distribution of dopamine receptors in 
the central nervous system has been studied with 
receptor ligand binding, ISH, and more recently 
immunocytochemistry. So far, the few studies that were 
focussed on the distribution of dopamine receptors in 
the spinal cord were mainly based on receptor ligand 
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binding. Binding studies on homogenized rat spinal 
cord first suggested the presence of dopamine D 1-
receptors in the spinal cord (Bhargava and Gulati, 1990) 
especially in its ventral part (Dubois et al., 1986). In 
contrast, Dz-receptor binding sites were found mainly in 
the dorsal horn of the spinal cord (Demenge et al., 
1980; Dubois et al., 1986; Bouthenet ef al., 1987), 
especially laminae II and III, and near the central canal 
(Scatton ef aI., 1984). More recently, an extensive 
binding study on the D,-receptor with the highly 
selective compound YM-09151-2 confirmed and 
extended these findings (Yokoyama et aI., 1994) by 
showing additional binding in the IML and 
motoneuronal cell groups of the ventral horn. The 
presence of Dz-receptor mRNA in the spinal gray 
matter has also been reported, but no anatomical details 
were provided (Bouthenet et aI., 1991). However, the 
interpretation of the results obtained with the ligand 
binding technique is often difficult because the 
selectivity of the ligands and the anatomical resolution 
are limited. The immunocytochemical method provides 
a better anatomical resolution and may also be a more 
accurate tool to distinguish between different dopamine 
receptors and their subtypes than the current ligand 
binding techniques. Only after the discovery of the 
sequence of the D2-receptor (Bunzow et al., 1988) it 
became possible to prepare specific antibodies, using 
fusion proteins or synthetic peptides corresponding to a 
specific part of the D,-receptor. These peptide 
fragments have been used successfully for raising 
polyc1onal antibodies against the D,-receptor (McVittie 
ef al., 1991; Ariano et al., 1993; Boundy ef aI., 1993b; 
Boundy et al., 1993a; Chazot et al., 1993; Sesack et al., 
1994; Snti1ey ef aI., 1994) and other dopamine 
receptors, including the D j - and D 3-receptor (Ariano 
and Sibley, 1994; Smiley et aI., 1994). Some of these 
immunocytochemical studies also reported the presence 
of dopamine receptors in the spinal cord (Ariano et al., 
1993; Snti1ey ef al., 1994), however, no anatomical 
details werc provided. Taken together, the available 
data, mostly based on receptor ligand binding, suggest 
that dopamine Drreceptors are predominantly located 
in the ventral horn, while D2-receptors are mainly 
localized in the dorsal horn, but may also be found in 
motoneuronal cell groups of the ventral horn. 
In the present study we have used a polyc1onal 
antipeptide antibody (Plug ef aI., 1992) for mapping of 
the Dz-receptor in rat spinal cord. In addition we have 
applied the ISH technique to verify and extend the data 
obtained with immunocytochemistry, using an 
anti-sense [35S]UTP labeled riboprobe for detection of 
D,-receptor mRNA. 
Materials and methods 
Preparation and characterization of the Dz-receptor 
antibody 
Preparation and characterization of the antibody used in 
the present study has been described previously (Plug ef 
al., 1992). Briefly, a polyc1onal antiserum (pAb2) was 
obtained from rabbits after injecting a synthetic peptide 
coupled to keyhole limpet hemocyanin. The peptide 
was derived from an amino acid sequence (amino acids 
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301 - 315) in the 3m intracellular loop of the rat 
Dz-receptor, which is present in both the short and long 
isoform. For the purpose of the present study two 
different affinity gels were used to obtain purified 
antibodies from this antiserum: (1) Protein A-Sepharose 
6MB (pharmacia) and (2) synthetic peptide coupled 
directly to CNBr-activated Sepharose 4B. In each case 
500 fJl antiserum was incubated with 500 fll of the 
corresponding gel in a total volume of 5 ml 10 mM 
Tris-HCI (PH 7.4), 250 mM NaCI. After 16 h at 4°C the 
gel suspension was transferred to a 3 ml disposable 
column and washed extensively with Tris-HCI buffer. 
Specific antibodies were eluted with 3 column volumes 
of 0.1 M glycine-chloride (PH 2.5) and neutralized 
immediately by collecting them in 0.3 column volume 1 
M Tris-HCI (PH 8.0), followed by addition of bovine 
serum albumin solution to a final concentration of 1 
mg/ml. The collected purified antisera were stored 
frozen at -80°C until use. The antibodies obtained with 
the protein A-sepharose 6MB gel gave the most intense 
staining in all regions of the spinal cord, and antibodies 
obtained with this method were mainly used for the 
purpose of this study. 
Immunocytochemlstry 
Adult, male Wistar rats were deeply anaesthetized with 
sodium pentobarbital and perfused transcardially with 
50 ml saline, followed by 500-750 ml 4% (wt/vol) 
freshly made paraformaldehyde in 0.1 M phosphate 
buffer (pH 7.4). In some cases up to 0.05-0.2 % 
(vol/vol) glutaraldehyde was added to the fixative and 
best results were obtained with 0.1 % glutaraldehyde. 
The fixation liquid was followed by 150 ml of 10-15% 
(wt/vol) sucrose in phosphate buffer. After perfusion 
the brains and spinal cords were removed and stored 
overnight at 4 °C in phosphate buffer containing 
20-25% (wt/vol) sucrose. The next day 30 flm frozen 
sections were cut from all spinal segments and selected 
parts of the brain and collected in 0.1 M Tris buffered 
saline (PH 8.6). All subsequent procedures were 
perfonned on free-floating sections at room temperature 
except where specified otherwise. After each step 
sections were thoroughly rinsed with Tris buffered 
saline. Sections were first incubated with a solution of 
5% (vol/vol) normal goat serum (Gibco) in Tris 
buffered saline containing 0.3% (vol/vol) Triton X-100 
for 90 minutes to reduce background staining. Next, 
sections were incubated for 24A8 hours at 4 °c with 
polyc1onal D,-receptor antipeptide antibody (1 :500) 
followed by biotinylated goat-anti-rabbit (1 :200, 120 
minutes) and the ABC procedure (ABC Elite, Vector). 
The peroxidase complex was visualized with 0.05% 
(wt/vol) 3,3'-diaminobenzidine (Sigma) in 0.05 M 
Tris-HCI solution (PH 7.6) in the presence of 0.01 % 
(vol/vol) hydrogen peroxide, which yields a brown 
precipitate. In some cases 0.01 % (wt/vol) nickel 
ammonium sulphate solution was added, which resulted 
in a dark blue precipitate. After completion of the 
immunocytochemical procedure sections were mounted 
onto glass slides with gelatin-chrome alum adhesive, 
and allowed to dry at room temperature. Next, sections 
were dehydrated in graded ethanol baths, transferred to 
xylene, and coverslipped with Pennount. Some slides 
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Figure 1: Schematic representation showing the distribution of neurons immunoreactive for dopamine D2 receptor 
protein (filled dots; 1 dot = 1-3 cells) or radioactively labelled for D2 receptor mRNA (stars; 1 star = 3-5 cells), as 
revealed by immunocytochemistry and in situ hybridization. Note that no stars were drawn in the first segment (C4), 
because high cervical levels were not processed for in situ hybridization. 
were counterstained with cresyl violet. Sections were 
examined light microscopically with bright-field 
illumination. 
ImmunocytochemicaJ controls 
Controls for the immunocytochemical methods 
included: (i) substitution of the anti-peptide antiserum 
with preimmune serum, (ii) substitution of the primary 
antiserum with saline, and (iii) preadsorption of the 
antiserum with an excess of its peptide antigen (1 
mglml antiserum) prior to incubation. Omission of the 
primary antibody or substitution of preimmune serum 
for the anti-peptide antibody resulted in clean sections 
without staining. Preadsorption of the antiserum with an 
excess of its peptide antigen prior to incubation 
prevented neuronal staining, except for some white 
matter glia, which is, therefore, considered as 
background staining. Adding glutaraldehyde to the 
perfusion fixative resulted in reduction of background 
staining, including the white matter glia, while the 
labeling in the areas described remained, albeit less 
intense. 
In the brain Dz-receptor immunoreactivity was 
found in many areas, among which the cerebral cortex, 
striatum, substantia nigra pars compacta, hippocampus, 
ventral tegmental area, superficial layers of superior 
colliculus, and hypothalamus. The labeling obtained in 
brain was very similar to previous anatomical studies on 
the localization ofD,-receptor using ISH (Weiner et aI., 
1991; Brouwer ef aI., 1992), receptor ligand binding 
(Dubois et at., 1986; Bouthenet et at., 1987; Yokoyama 
et at., 1994), and immunocytochemistry (Brock et at., 
1992; Ariano ef at., 1993; Levey et at., 1993). We 
therefore concluded that the immunocytochemical 
labeling of neuronal elements obtained in the present 
study represented Dz-receptor protein. 
In situ hybridization 
Rats were decapitated and their spinal cords were 
quickly removed and frozen on dry ice. Cryostat 
sections (10 [.lm) from thoracic, lumbar and sacral 
levels of the spinal cord were made and collected on 
gelatin-coated slides, air dried at room temperature and 
fixed with 4% (wtJvol) paraformaldehyde solution in 
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Figure 2: A-F. Light micrograph of dopamine D2 receptor protein immunoreactive cells in different areas of the rat 
spinal cord as indicated schematically in each inset. (A) Lamina I; (8) Lateral spinal nucleus of the dorsal horn; (e) 
Area around the central canal. (D) Preganglionic cells of the intermediolateral cell column of the thoracic cord. (E) 
Parasympathetic area of the sacral cord; (F) Sexually dimorphic motoneurons in the dorsolateral nucleus of the 
ventral lumbosacral cord. Scale bar = 50 ~m. 
0.05 M phosphate buffered saline (PH 7.4). After three 
rinses in phosphate buffered saline, sections were 
treated with acetic arthydride, dehydrated in graded 
ethanol baths, followed by two successive chloroform 
baths for ten minutes each. Next, slides were allowed to 
air dry and were stored at -70 "C until further 
processing. 
Sections were hybridized with [35S]UTP labeled 
anti-sense rihoprobe for D2-receptor as described 
(Jongen-Re!o et ai.. 1994). After hybridization and 
stringency washing steps the sections were air dried, 
dipped into nuclear photographic emulsion (Kodak 
NTB-2) and stored in the dark (4 "C). After 12-16 
weeks exposure the sections were developed, fixed, and 
counterstained with cresylviolet. The distribution of 
labeled neurons was analyzcd light nticroscopically 
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with dark-field illumination. 
Specificity controls for the ISH included 
hybridization with "sense" probe and tissue treatment 
with RNAse prior to antisense probe hybridization. 
Both methods resulted in absence of labeling and 
confirmed the specificity of the hybridization signal 
generated by the radioactively labeled riboprobe. 
Results 
Immunocytochemistry 
In all positive-staining regions examined in the central 
nervous system the DAB reaction product, indicating 
the presence of Dz-receptor protein, was mostly 
associated with neuronal cell bodies and their proximal 
dendrites, but in some cases the dendritic processes 
could be followed for some distance within a section. 
Application of the antibody on spinal cord sections 
resulted in a distinct pattern of labeled neurons. In 
comparison with most brain areas, labeled neurons in 
the spinal cord were few, and weakly labeled. However, 
some strongly labeled neurons were also observed (see 
below). 
At all levels of the spinal cord labeling was found 
exclusively in cell bodies and their proximal dendrites. 
The immunoreactivity was virtually absent from other 
neuronal processes, like axons, small dendrites nor was 
there any indication for localization of 
immunoreactivity in terminals. The labeled neurons 
were located in specific areas throughout the spinal 
cord, including the superficial dorsal horn, the region 
surrounding the central canal, the sympathetic IML and 
the sacral parasympathetic area and, to a lesser extent, 
in the ventral hom (fig. I). 
In the dorsal horn densely labeled neurons were 
present in lamina I (fig. 2A). In every section examined, 
an average of 1-3 labeled cells were observed. They 
were found at all levels of the spinal cord and were 
distributed both medially and laterally within lamina I. 
In the lateral spinal nucleus, located in the lateral 
funiculus of the spinal cord, moderately labeled cells 
were occasionally present (fig. 2B). At high cervical 
levels no labeled cells were seen in the lateral cervical 
nucleus, although it was sometimes difficult to delineate 
its boundary with the lateral spinal nucleus. In each 
spinal cord section, from high cervical to low sacral 
levels, on average 1 or 2 cells were labeled in the lateral 
spinal nucleus. No labeled cells were observed in 
lamina II and III of the dorsal hom. In lamina IV and V 
some scattered weakly labeled cells were present, and 
occasionally a moderately labeled cell was encountered. 
In general, when going from lamina IV to laminae V 
and VI more labeled cells were observed and the 
labeling became more intense, although they were still 
not strongly labeled. In the area around the central canal 
moderately and weakly labeled cells were present at all 
levels of the spinal cord, but they were somewhat more 
intense at the lumbar level (fig. 2C). The labeled cells 
were scattered around the central canal and clusters of 
moderately labeled cells were present in the area 
immediately dorsal of the central canal. 
In the IML of the spinal cord, at thoracic and high 
lumbar levels, clusters of 5-6 moderately labeled cells 
were present (fig. 2D) in many, but not all sections. The 
labeling extended into the proximal dendrites radiating 
towards the lateral funiculus. A high proportion of the 
neurons of the IML were immunoreactive. Additional 
labeled cells were located in related areas towards the 
central canal (intercalated nuclei), but these cells were 
less intensely labeled. 
Strongest labeling within the spinal cord was found 
in celis of the parasympathetic area of the sacral cord 
(fig. 2E), and a high proportion of the neurons in this 
area were immunoreactive. The labeled cells showed a 
dense staining of their cell bodies and proximal 
dendrites. They were arranged in clusters of 4-5 celis, 
with their dendrites radiating towards the lateral 
funiculus. In addition to these strongly labeled cells also 
Dz-receptor in 5!pinal cord 
several moderately labeled cells were present in this 
area. 
In the ventral horn, a few moderately and weakly 
labeled cells were present in laminae VII and VIII. In 
general, when going more ventrally, staining of labeled 
cells became faint. Labeled motoneurons were found 
only in the lumbosacral spinal nucleus of the 
bulbocavernosus (SNB) and dorsolateral nucleus 
(DLN) (fig. 2F), which innervate different target 
muscles: the DLN innervates the external urethral 
sphincter, while the SNB innervates the external anal 
sphincter and the bulbocavernosus. Motoneurons of the 
SNB and DLN were labeled equally strong, and their 
proximal dendrites were also densely labeled. A light 
staining of the neuropil surrounding the SNB and DLN 
was observed, probably due to faint labeling of small 
dendrites, which are present in longitudinally oriented 
bundles. Labeled motoneurons were never observed at 
other levels of the spinal cord. 
In situ hybridization 
The presence of Dz-receptor mRNA was detected with 
ISH. Radioactively labeled riboprobe was hybridized to 
D,-receptor mRNA, which resulted in a distinct 
accumulation of silver grains over many cell bodies 
(fig. 3A-B). 
In general, labeling of neuronal cell bodies was 
found in the same areas of the spinal gray matter as 
described for immunocytochentistry (fig. I and fig. 
3A), but in many of these areas a larger number of 
neurons were labeled with the ISH technique. Labeled 
cells were present in lamina I of the superficial dorsal 
hom and in the lateral spinal nucleus, while no labeling 
was seen in lamina II. Some labeled cells were detected 
in lamina III and IV of the dorsal hom (fig. 3A), which 
is in contrast with the immunocytochemical findings. In 
the base of the dorsal hom labeled cells were scattered 
throughout lamina V and VI. In the area around the 
central canal labeled cells were present in clusters, 
predominantly located in the area immediately dorsal of 
the central canal. In the IML of the thoracic cord 
clusters of 5-6 labeled cells were observed, and 
additional labeled cells were present in the intercalated 
nuclei towards the central canal (fig. 3B). In the sacral 
parasympathetic area labeled cells were also present. 
Furthermore, in the ventral horn some labeled cells 
were scatrered throughout lamina VII and VIII. In the 
motoneuronal cell groups, however, no labeling was 
detected except for some labeled cells in the 
lumbosacral SNB and DLN. 
Discussion 
In the present study, for the first time the regional 
distribution of Dz-receptor protein and mRNA was 
identified in rat spinal cord using immunocytochemistry 
and ISH. The results showed a characteristic 
distribution of D,-receptors throughout the spinal cord, 
providing anatomical support for the involvement of 
Drreceptors in the effects of dopamine in the spinal 
cord. 
Technical considerations 
The observation that Drreceptor immunoreactivity was 
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located mainly within the somata and proximal 
dendrites of labeled neurons is in agreement with other 
studies using different DTreceptor antibodies (Brock et 
ai., 1992; Ariano et ai., 1993). A subsequent study 
(Fisher et aI., 1994) at the electron microscopical level 
showed that in neostriatal neurons the D 2-receptor 
immunoreactivity was uniformly present throughout the 
somatic cytoplasm and became less strong towards the 
periphery. The immunoreactivity was not associated 
with any cellular organelle. Some axon tenninals 
contained traces of immunoreactivity. but labeled 
postsynaptic densities were not described. These 
findings may suggest that the antibody ouly recognized 
Drreceptor protein before its incorporation as a 
functional receptor into the neuronal membrane or 
during its degradation. If this also holds true for the 
antibody used in the present study, it would explain that 
only cell somata and proximal dendrites were stained. 
On the other hand, if the antibody would recognize both 
functional and nonfunctional receptors, our results 
would indicate that the highest proportion of 
D2-receptor protein is located within the cell body and 
proximal dendrites while there are only minute amounts 
of functional receptors in more distal dendrites. 
The long exposure times (up to 3 months) that were 
needed to visualize the radioactively labeled riboprobe 
indicated that the hybridization signal was relatively 
low. Similarly, with immunocytochemistry it was noted 
that, compared to other parts of the central nervous 
system, the spinal cord contained relatively few cells 
that were immunoreactive for the Drreceptor and that 
most of them were not strongly labeled. Thus, it seems 
likely that in comparison with other brain areas the level 
of Drreceptors in rat spinal cord is low both at the 
protein and mRN A level. Due to these low expression 
levels the total number of cells expressing Drreceptors 
may have been underestimated. 
Distribution of Dz-receptors in spinal cord 
The results of the present study showed that the 
D 2-receptor is expressed in several areas of the rat 
spinal cord. In all spinal segments investigated with 
immunocytochemistry or ISH, the distribution obtained 
with each technique was very similar, i.e. all areas with 
neurons immunoreactive for Dz-receptor protein also 
showed neurons expressing Dz-receptor mRNA, 
although more labeled cells were detected with ISH. 
With immunocytochemistry, strongest labeling was 
present in neuronal cell bodies located in the sacral 
parasympathetic area and in the lumbosacral SNB and 
DLN. Moderately labeled cells were present in the 
IML, in the area around the central canal, and in lamina 
I of the superficial dorsal horn, while weak labeling was 
present in neuronal cell bodies located in the lateral 
spinal nucleus and lamina VII and vm of the ventral 
horn. The results obtained with ISH confirmed this 
distribution and extended the immunocytochemical 
findings by showing additional labeled cells in lamina 
III and IV of the dorsal horn, an area which was never 
labeled with immunocytochemistry. This difference 
may be explained by the fact that in this region the 
concentration of Dz-receptor protein may be very low 
and, therefore, undetectable with immunocyto-
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chemistry. As a consequence our findings indicate that 
for detection of Dz-receptor expression in the spinal 
cord the ISH technique may be a more sensitive 
technique than the immunocytochemistry technique. 
Finally, it should be noted that the identification of the 
spinal laminae and nuclei was based on cytological and 
topographical criteria. As a consequence, in the sacral 
parasympathetic area there is no direct evidence that 
neurons expressing the Dz-receptor actually represent 
parasympathetic preganglionic neurons, as strongly 
suggested by their location. This can ouly be 
ascertained by using double-labeling studies which 
combine Dz-receptor localization with the appropriate 
technique for identifying specific neurons. 
Previous studies on the regional distribution of 
Dz-receptors in spinal cord all used the receptor ligand 
binding technique. Ligand binding was reported in the 
dorsal horn (Scatton et aI., 1984; Dubois et ai., 1986; 
Bouthenet et ai., 1987; Yokoyama et aI., 1994), the area 
around the central canal (Scatton et ai., 1984; 
Yokoyama et aI., 1994), the IML and in motoneurons 
(Yokoyama et ai., 1994). Our findings are in agreement 
with these binding studies, but differed from the 
reported binding in the substantia gelatinosa and in the 
motoneuronal cell groups, areas which showed neither 
immunoreactivity nor hybridization signal. However, it 
must be kept in mind that the binding pattern may differ 
from the cellular distribution obtained with ISH or 
immunocytochemistry, because the functional 
Dz-receptors, i.e. the binding sites, may be located on 
dendrites of neurons which have their cell somata in 
another lamina of the spinal cord. With respect to the 
binding found in the substantia gelatinosa our findings 
indicate that the parent cell bodies of these D2-receptor 
binding sites are located outside the substantia 
gelatinosa of the dorsal hom (lanaina II). On the other 
hand, the ligands may also bind to other receptors of the 
D,-receptor family, due to a lack of pharmacological 
selectivity which is inherent to the receptor ligand 
binding technique. This may be true especially for the 
reported ligand binding in spinal motoneurons 
(Yokoyama et ai., 1994), because neither binding 
studies nor in situ hybridization studies have described 
the presence of Dz-receptors in motoneurons. 
Moreover, we never observed Dz-receptor labeling in 
motoneurons outside the lumbosacral SNB and DLN. 
Therefore, we consider the presence Dz-receptors in 
spinal motoneurons, except the SNB and DLN, most 
unlikely. 
Functional aspects 
The distribution of Dz-receptors in rat spinal cord, as 
demonstrated with immunocytochemistry and ISH, 
suggests that Dz-receptors may play a role in the 
transmission of sensory information and autonomic 
processing. Our results also indicate that Dz-receptors 
are not directly involved in modulation of motoneurons, 
with the exception of motoneurons in the SNB and 
DLN of the lumbosacral cord. 
Several studies indicate that spinal dopamine and, 
more specifically, Dz-receptors have an inhibitory role 
in the transmission of nociceptive stimuli. It has been 
reported that intrathecally administered Dz-receptor 
Figure 3: A-B. Oarkfield microautoradiographs of 
selected parts of the rat spinal cord showing 
accumulation of silver grains over neurons 
containing detecting dopamine 02 receptor mRNA 
hybridized to 35S-labeled riboprobe. (A) Lumbar 
cord; (B) Lateral horn of thoracic cord. Scale bar; 
200 ~m and 50 ~m, respectively. 
agonists produced a reversible reduction of thalamic 
nociceptive responses to noxious stimuli (Clatworthy 
and Barasi, 1987). Furthermore, focal electrical 
stimulation in the region of the All cell group 
selectively suppressed nociceptive responses of spinal 
multireceptive neurons (Fleetwood-Walker et al., 
1988). This in1tibition was rapidly reversed by 
ionophoresis of the D2-receptor antagonist sulpiride in 
Dz-receptor in spinal cord 
the superficial and deeper dorsal horn. Similarly, 
Dz-receptor antagonists antagonized the antinociceptive 
effects induced by intrathecally applied dopamine (Liu 
et al., 1992). In contrast, neither the D,-receptor agonist 
SKF38393 nor D,-receptor antagonist SCH23390 
showed any effect on the dopamine-induced 
antinociception (Barasi et aI., 1987; Liu et aI., 1992). 
These findings suggest that the dopamine-induced 
antinociceptive effects are mediated via spinal 
Dz-receptors located in the superficial and deeper dorsal 
hom. This is in good agreement with the regional 
distribution of Dz-receptors in the dorsal horn as 
described in the present study. 
The presence of D2-receptors in the IML of the 
thoracic and high lumbar cord is in agreement with its 
dense dopamine innervation (Yoshida and Tanaka, 
1988; Shirouzu et aI., 1990; Mouchet et al., 1992; Ridet 
et al., 1992; Holstege et aI., 1996). Apomorphine and 
other, more selective, D2-receptor agonists administered 
intrathecally down regulated autonomic functions, 
resulting in hypotension and bradycardia (petitjean et 
aI., 1984; Clatworthy and Barasi, 1987; Pellissier and 
Demenge, 1991; Lablou and Demenge, 1993). Our 
findings suggest that the in1tibition by dopamine of 
preganglionic cells of the IML is mediated by 
Dz-receptors. 
Dz-receptors were found to be most prominent in 
neurons of the sacral parasympathetic area and the 
lumbosacral SNB and DLN, which innervate 
anatomically distinct perineal muscles that are involved 
in functionally distinct copulatory reflexes. Previous 
studies have shown that dopamine agonists inhibit 
specific sexual motor functions like penile reflexes 
(Stefanick et aI., 1982; Pehek et al., 1989). Our results 
provide some anatomical support for the involvement of 
D2-receptors located in the lumbosacral cord in the 
regulation of sexual motor behavior at the spinal level. 
There is also some evidence favoring the idea that 
dopamine is involved in the control of spinal motor 
functions. Although dopamine is present in the ventral 
cord, including motoneuronal cell groups, our results 
indicate that Dz-receptors are not directly involved in 
modulating motoneuron activity. The reported effects of 
dopamine on somatic motor functions at the spinal level 
are contradictory. Dopamine receptor mediated 
depression of the spinal monosynaptic transmission has 
been reported (Carp and Anderson, 1982; Ono and 
Fukuda, 1984) and denied (Kamijo et aI., 1993). 
Recently, it has been reported that dopamine enhances 
glutamate-activated currents in cultured chick embryo 
spinal motoneurons. The enhancement was diminished 
by the D,-receptor antagonist SCH23390 and mimicked 
by the (partial) D,-receptor agonist SKF38393 (Smith et 
al., 1995). These findings suggest that in the 
motoneuronal cell groups the presence of dopamine 
and, more particularly, the absence of D2-receptor 
labeling in motoneurons may indicate that other 
dopamine receptors, like Drreceptors, are more 
important in this part of the spinal cord. 
It may be concluded that the D,-receptors are 
expressed in specific areas of the rat spinal cord. 
Although the level of D2-receptor in spinal cord may be 
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much lower than in brain, several physiological studies 
indicate that activation of spinal Dz-receptors has 
important functional consequences. Their distribution 
provides anatomical support for the involvement of 
spinal Drreceptors in the modulation of nociceptive 
transmission and autonomic control. Our data further 
indicate that spinal D2-receptors are not directly 
involved in modulating motor functions at the 
motoneuronallevel with the possible exception of some 
sexual motor functions. However, it should be 
mentioned that motor functions may be modulated 
indirectly via Dz-receptors located in the dorsal horn or 
at supraspinal levels. In order to further elucidate the 
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role of dopamine in modulating spinal cord functioning 
further investigation of various types of dopamine 
receptors in the spinal cord needs to be undertaken. 
Acknowledgments 
The authors thank Prof. Dr. Jan Voogd for reading the 
manuscript. We also thank Henri Klop and Allert Jan 
Jonker for their technical assistance with the ISH study. 
The technical advice of Erika Sabel-Goedknegt and 
Richard Hawkins is acknowledged. The assistance of 
Eddie Dalm in the preparation of the photomicrographs 
is appreciated. 
Chapter IV 
The Distribution Of Dopamine Immunoreactive Fibers And 
Presumptive Terminals In The Rat Brain Stem. A Comparison 
With The Distribution Of Dopamine-B-Hydroxylase. 
57 
Henk van Dijken and Jan C. Holstege. 
58 
The Distribution Of Dopamine Immunoreactive Fibers And 
Presumptive Terminals In The Rat Brain Stem. A Comparison 
With The Distribution Of Dopamine-B-Hydroxylase. 
Abstract 
In the present study the distribution of fibers and terminals immunoreactive for dopamine was 
identified light microscopically in rat brain stem and compared with the distribution of fibers and 
terminals immunoreactive for dopamine-B-hydroxylase (DBH), the enzyme essential for synthesizing 
noradrenaline and adrenaline. 
The dopaminergic fibers and terminals showed a characteristic distribution within the brain stem. 
They were present in many brain stem nuclei with various labeling densities. Strongest dopamine 
labeling was found in the dorsal motor nucleus of the vagus, principal nucleus of the inferior olive 
and dorsal raphe nucleus. Other areas, like the nucleus of the solitary tract, raphe pallid us and 
obscurus, lateral parabrachial nuclei, and the periaqueductal gray, were strongly labeled, whereas 
the sensory trigeminal complex, the medial parabrachial nucleus, the locus coeruleus and several 
other (nor)adrenergic cell groups were labeled moderate to strong. Furthermore, dopamine 
immunoreactive fibers and terminals were present in many other areas of the brain stem, including 
the inferior and superior colliculi, deep mesencephalic nuclei, pontine reticular nuclei, prepositus 
hypoglossal nuclei, cochlear nuclei, cuneate and gracile nuclei. In most nuclei, dopamine was not 
distributed throughout the nucleus, but aimed at specific subnuclei. DBH containing fibers and 
terminals in the brain stem were distributed more ubiquitously. In most areas there was much 
overlap with the dopaminergic innervation, but the regional innervation pattern differed. In other 
areas like area postrema, cerebellum, anterior portion of the ventral cochlear nucleus and external 
cuneate nucleus, which were all sparsely innervated by dopaminergic fibers, the (nor)adrenaline 
synthesizing enzyme was abundantly present. 
The results of the present study demonstrate a SUbstantial dopaminergic innervation of many brain 
stem nuclei, which is independent from the (nor)adrenergic innervation. So far, relatively few studies 
have focussed on the effects of dopamine in the brain stem. However, our anatomical findings 
suggest that dopamine is involved in modulating information processing in many brain stem areas 
and should be considered equally important as other monoamines like (nor)adrenaline and 
serotonin. 
Introduction 
The brain stem is a highly complex structure that 
includes numerous neuronal circuits for processing. 
controlling, and integrating a variety of sensory, 
autonomic and motor functions. In order to understand 
how the brain stem exerts all these different functions, it 
is essential that the connections within the brain stem 
are known, including the neurotransmitters therein. At 
present, the distributions of most classical 
neurotransmitters within the brain stem have been 
described, among which the biogenic amines or 
monoamines, which constitute a special group of 
transmitters. Originally, monoaminergic neurons and 
pathways in the brain stem were visualized by the 
Falck-Hillarp formaldehyde histofluorescence 
technique. Using this technique, Dahlstrom and Fuxe 
were the first to describe the distribution of 
monoaminergic neurons in the brain (Dahlstrom and 
Fuxe, 1964). In their pioneering study they reported the 
localization of catecholaminergic and serotonergic cell 
groups in the rat brain stem, which they designated A 1-
Al2 and BI-B9, respectively. Since the Falck-Hillarp 
formaldehyde histofluorescence technique and its 
subsequent modifications have only limited specificity, 
the different types of monoamines were distinguished 
mainly by means of pharmacological tools, like enzyme 
inhibitors (for review see Bjorklund and Lindvall, 
1984). Moreover, the histofluorescence method 
preferentially identified dopaminergic projection 
systems with a high dopamine content, such as the 
nigro-striatal and mesocorticolirnbic pathways. 
Therefore, in areas like the brain stern, where the 
dopaminergic innervation is less abundant and densely 
intermingled with noradrenaline- and adrenaline-
containing neuronal structures, the visualization of 
individual catecholamines within fibers and tenninals is 
not possible with this method alone. 
A great step forward was the introduction of highly 
sensitive immunocytochemical labeling techniques for 
detecting the major catecholamine synthesizing 
enzymes, like tyrosine hydroxylase (TH), dopamine-B-
hydroxylase (DBH), and phenylethanol-N-
methyltransferase (PNMT) (see Hokfelt et al., 1984). 
Since these enzymes play a key role in the 
catecholamine biosynthetic pathway, the presence of a 
particular catecholamine within a neuronal structure 
could be determined indirectly by comparing 
subsequent sections processed with antibodies against 
the respective catecholamine enzymes. TH, which is 
present in all catecholaminergic neurons, catalyses the 
conversion of tyrosine to dihydroxyphenylalanine 
(DOPA), which is subsequently converted to dopamine 
by aromatic L-amino acid decarboxylase. In 
59 
Chapter Four 
(nor)adrenergic structures, where dopamine is not the 
end product. DBH catalyses the conversion of 
dopamine to noradrenaline, which in tum is converted 
to adrenaline by PNMT in adrenergic structures. Thus, 
dopaminergic structures contain TH, noradrenergic 
structures contain TH and DBH, and adrenergic 
structures contain TH, DBH, and PNMT. Accordingly, 
the enzymatic profile of a structure will indicate which 
catecholamine is used as a neurotransmitter: adrenergic 
structures are detected by the presence of PNMT; 
noradrenergic structures contain DBH, but lack PNMT, 
while dopaminergic structures contain TH. but lack 
DBH (and PNMT). Consequently, a structure has to be 
screened for the presence of at least two enzymes in 
order to detennine whether it is dopaminergic Of 
noradrenergic. This is technically difficult especially for 
smaller structures, like fibers and terminals. 
Furthennore, in several studies the enzymatic profile 
was found to be inconsistent. For example, PNMT, 
which is generally considered as a specific marker for 
adrenergic structures, has been detected in 
hypothalamic neurons that do not contain TH (Ross et 
al., 1984; Ruggiero et al., 1985), and therefore may not 
be able to synthesize adrenaline precursors. In these 
structures, PNMT alone is not a reliable marker for 
adrenaline. Neuronal structures immunoreactive for TH 
but not for L-amino acid decarboxylase have also been 
reported. Since the latter enzyme is essential for the 
conversion of L-DOPA to dopamine, these structures 
probably may be considered as L-DOPAergic and not 
dopaminergic (Jaeger et aI., 1984). In order to avoid the 
drawbacks of the indirect labeling techniques, but to 
preserve the advantage of high sensitivity, antibodies 
against the catecholamines themselves were required. 
When antibodies directed against dopamine and 
noradrenaline became available (Geffard et al., 1984), 
they were used extensively for direct 
immunocytochemical detection of doparninergic and 
noradrenergic neuronal structures in the central nervous 
system of different species (Steinbusch, 1981; Geffard 
et al., 1984; Smiley et al., 1992). The advantage of 
direct detection with high specificity and sensitivity 
makes it the method of choice for investigating the 
dopaminergic innervation in the brain stem, especially 
in areas where the dopaminergic innervation is less 
abundant or intenningled with other catecholamines. 
Most studies on the distribution of dopaminergic 
fibers and terminals have focused on areas outside the 
brain stem, i.e. the striatum, cerebral cortex (Berger et 
aI., 1991; Smiley et al., 1992), and cerebellum 
(Panagopoulos et aI., 1991; lkai et al., 1992), while 
most studies on dopamine within the rat brain stem 
concentrated on the distribution of dopaminergic 
neurons (Armstrong et aI., 1982; Kalia et al., 1985). As 
a result, the dopaminergic innervation of the brain stem 
and its functional role may have been underestimated. 
Therefore, in the present study, a detailed mapping of 
the dopaminergic fibers and terminals in the brain stem 
was undertaken throughout medulla oblongata, pons, 
and mesencephalon caudal to the substantia nigra. A 
second objective of the present study was to compare 
the distribution of dopamine in the brain stem with that 
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of other catecholamines. For this purpose, an antibody 
raised against DBH was used to identify both 
noradrenergic and adrenergic structures. Successful 
immunocytochemical detection of dopamine requires 
that the animals are perfused with a fixative that 
contains a relatively high concentration of 
glutaraldehyde, while for detection of catecholamine 
biosynthetic enzymes, glutaraldehyde is generally 
avoided for obtaining good resuIts and 
paraformaldehyde is used (Armstrong et al., 1982; 
Kalia et al., 1985; AIdes et al., 1988; Klepper and 
Herbert, 1991; Herbert and Saper, 1992; Asan, 1993). 
However, we found that detection of DBH was feasible 
in our glutaraldehyde fixed material. This made it 
possible to compare the distributions of dopamine and 
(nor)adrenaline within adjacent sections of the same 
animal. 
Materials and methods 
Animals and tissue preparation 
Adult male Wistar rats were deeply anaesthetized with 
pentobarbital (70 mglkg) and perfused transcardially 
with 50 m1 of 0.9 % saline, 0.8 % sucrose and 0.4 % D-
glucose in 0.05 M phosphate buffer, pH 7.4, followed 
by 750-1000 m1 5% glutaraldehyde in 0.05 M acetate 
buffer, pH 4.0. Ascorbic acid (10 mM) was added to 
both perfusion liquids to prevent oxidation of the 
catecholamine ring of the dopamine molecule. 
The brain stems were removed immediately after 
fixation and left overnight at 4 DC in acetate buffer 
containing ascorbic acid and 20-25% sucrose. Next, 
serial transverse sections (30 JIm) were cut on a 
freezing microtome and collected in 0.1 M Tris 
buffered saline, pH 7.6 (TBS), containing 10 mM 
ascorbic acid. Free floating sections were rinsed and 
kept in the same liquid overnight at 4 0c. The next day, 
alternate sections were processed for either dopamine or 
DBH immunocytochemistry. 
Antisera and specificity controls 
The polyc1onal rabbit anti-dopamine antibody used in 
this study was kindly provided by Dr. RM. Buijs, 
Netherlands Institute for Brain Research, Amsterdam, 
The Netherlands. The production of the antibody and its 
characteristics have been described in detail elsewhere 
(Buijs et aI., 1984; Voorn and Buijs, 1987). A 
polyc1onal rabbit anti-DBH antibody (SanverTech) was 
used for detection of dopamine-B-hydroxylase. 
In order to test whether the dopamine antibody 
showed cross-reactivity with noradrenergic structures, 
the noradrenaline depleting neurotoxin DSP-4 was 
used, since it crosses the blood-brain barrier and 
induces the loss of a subset of noradrenergic neural 
structures as indicated by various noradrenaline markers 
without affecting dopamine structures (Fritschy and 
Grzanna, 1989; 1991). One group of rats received a 
single i.p. injection of DSP-4 (50 mglkg) dissolved in 
saline prior to use, while another group of rats received 
no treatment at all. After a period of 2-3 weeks all rats 
were sacrificed and alternate sections were processed 
for dopamine or DBH immunocytochemistry, 
respectively. 
Dopamine and DBR immunocytochemistry 
Until application of the secondary antibody, ascorbic 
acid (10 mM) was added to all solutions. Tissue 
sections were placed for 30 minutes in 0.1 M TBS, pH 
7.6, containing 1 % sodium borohydride. Sections were 
thoroughly rinsed in TBS. Alternate brain stem 
sections, obtained from the same animal, were 
incubated for 24~72 hours at 4 °C with, either anti~ 
dopamine (1:4000), or anti-DBH (1:1000) in TBS 
contaiaing 0.5 % Triton-XIOO. Dopamine sections were 
processed for peroxidase-antiperoxidase (PAP) 
immunocytochemistry and DBH sections were 
processed for ABC immunocytochemistry. After 
application of the dopamine antibody, the dopamine 
sections were incubated for 90 minutes in goat-anti-
rabbit antibody ("Betsy", diluted I :200) and then placed 
in rabbit PAP complex (1:800, Nordic) for 60 minutes. 
Between steps the sections were thoroughly rinsed with 
TBS. After application of the DBH antibody, the DBH 
sections were incubated for 90 minutes in biotinylated 
goat-anti-rabbit antibody (Vector, diluted 1:200) and 
then placed for 60 minutes in freshly prepared ABC 
Elite solution (Vector), In between steps the sections 
were thoroughly rinsed with TBS. 
In both cases, the immunocytochemical reaction 
product was revealed with 0.05% diaminobenzidine in 
the presence of 0.01 % hydrogen peroxide in 0.05 M 
Tris-HCI, pH 7.6, under visual control. Upon 
completion of the immunocytochemical staImng 
procedure the sections were mounted onto glass slides 
with gelatin-chrome alum adhesive, dehydrated in 
graded alcohol baths, transferred to xylene, and cover 
slipped with Permount. The distribution of dopamine 
and DBH immunoreactive structures were examined 
light nticroscopically under darkfield and brightfield 
illumination. 
Results 
The objective of the present immunocytochemical study 
was to identify the anatomical localization of dopamine 
and DBH immunoreactive fibers and presumptive 
terminals (appearing as punctuate profiles) within the 
rat brain stem. Neuronal cell bodies in the brain stem 
immunoreactive for either dopamine or DBH were 
mostly located in catecholaminergic cell groups. Since 
their location has already been described extensively in 
previous studies (Dahlstrom and Fuxe, 1964; 
Annstrong et al., 1982; Kalia et al., 1985), they were 
not included in the present investigation. 
DSP-4 experiments 
DSP-4 is a noradrenaline-depleting neurotoxin whose 
reported effects are restricted to areas in the central 
nervous system receiving their noradrenergic afferents 
from the locus coeruleus proper (LC), i.e. the 
cerebellum, the inferior and superior colliculi, the 
cochlear nuclei, the vestibular nuclei, the dorsal column 
nuclei, the sensory spinal trigeminal nucleus, and the 
spinal dorsal hom (Fritschy and Grzanna, 1989; 1991). 
Following systentic administration of DSP-4, there was 
a nearly complete loss of DBH staiaing in the above 
areas, whereas in the same areas of the alternate 
sections there was no change in dopamine staining. 
Dopamine and DBH in brain stem 
General appearance and morphology of dopamine 
and DBH immunoreactive structures 
The morphology of dopamine immunoreactive fibers 
was relatively uniform. Generally they were thin and 
possessed relatively large, regularly spaced, 
varicosities. Some morphological differences were 
present between dopamine immunoreactive structures 
located in different regions. Most notably in the motor 
nuclei the intervaricose fibers were only lightly stained, 
giving them a dot-like, granular appearance at low 
magnifications. In the DBH preparations, the 
morphology of DBH immunoreactive fibers was not as 
uniform as the dopamine immunoreactive ones. 
Different morphological types of DBH immunoreactive 
fibers could be distinguished. Generally they formed an 
intermingling network consisting of relatively "coarse" 
fibers with large varicosities and relatively "smooth" 
fibers with small intervaricose segments and a large 
number of small varicosities. The morphology of the 
"coarse" fibers was similar to the morphology found in 
the dopamine preparations. However, the "smooth" 
fibers were typically present in DBH preparations and 
were never found in dopamine preparations. Similar to 
the dopamine preparations, in some of the brain stem 
motor nuclei the intervaricose DBH fibers were lightly 
stained, leading to a granular appearance. 
Distribution of dopamine and DBH immunoreactive 
structure 
Dopamine and DBH immunoreactive fibers and 
tenninals were present in many brain stem nuclei with 
varying staining densities. In order to compare the 
staining densities for different brain stern areas, 7 
density levels were distinguished defrned as nearly or 
completely absent (level 0), weak (level 1), weak to 
moderate (level 2), moderate (level 3), moderate to 
strong (level 4), strong (levelS) and very strong (level 
6). The results are represented schematically in fig. 1. 
Strongest dopamine labeling (level 6) was found in the 
nucleus of the solitary tract, dorsal motor nucleus of the 
vagus, and lateral parabrachial nucleus. Other areas like 
the medial parabrachial nucleus, locus coeruleus, 
periaqueductal gray and all raphe nuclei were strongly 
labeled (levelS). The principal nucleus of the inferior 
olive was also strongly labeled. Less dense staining 
(level 1-4) was observed in many other areas of the 
brain stem, like the inferior and superior colliculi, deep 
mesencephalic nuclei, pontine reticular nuclei, both 
sensory and motor trigeminal nuclei, prepositus 
hypoglossal nucleus, cochlear nuclei, cuneate and 
gracile nuclei, and spinal trigeminal complex. A limited 
number of dopamine fibers were always present in the 
reticular formation throughout the brain stem. Other 
brain stern regions like area postrema, cerebellum, 
anterior portion of the ventral cochlear nucleus and 
external cuneate nucleus, were virtually devoid of 
dopaminergic fibers with only an occasional traversing 
fiber (level 0). 
In contrast to the more restricted organization of the 
dopamine immunoreactive fibers and terminals, DBH 
immunoreactive fibers and terminals were distributed 
more ubiquitously throughout the brain stem. Thus, 
most areas with a significant dopamine innervation also 
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Figure 1: Schematic representation of the dopamine innervation - consisting of dopamine immunoreactive fibers 
and (presumptive) terminals - in the rat brain stem, including the medulla oblongata, the pons, and the 
mesencephalon caudal to the substantia nigra. Note that neuronal cell bodies immunoreactive for dopamine are 
not included in this schematic representation. For details see text; for abbreviations see list of abbreviations. 
Dopamine and DBH in brain stem 
Figure 1: (Continued) 
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Figure 2: Photomicrographs with darkfield illumination of a section from the caudal medulla after processing for 
dopamine immunoreactivity, showing the ventral part of the spinal trigeminal nucleus, caudal division. Note that the 
labeling in lamina II (substantia gelatinosa) is less than the other laminae. Scale bar = 100 ~m. 
received a DBH innervation, but the reverse was not 
always the case. 
Below, the distribution of fibers and terminals in the 
rat brain stem inununoreactive for dopamine (fig. 1) 
and DBH will be described in detail. The description 
has been subdivided as follows: I) trigeminal complex, 
2) medulla oblongata (remaining nuclei), 3) pons and 
mesencephalon, and 4) motor nuclei of the cranial 
nerves. 
Trigeminal complex 
The tcigeminal sensory nuclei are located dorsolaterally 
in the brain stem and extend from the cervical spinal 
cord to the midbrain. They are divided into (1) the 
spinal trigeminal nucleus (SpS), which can be 
subdivided into caudal (SpSC), interpolar (SpSI), and 
oral (SpSO) subnuclei; (2) the main or principal 
trigeminal nucleus (PrS), and (3) the mesencephalic 
trigeminal nucleus (MeS). The trigeminal complex also 
contains the trigeminal motor nucleus (MoS), which is 
located in the pons next to the PrS (see below). Some 
small nuclei, like the paratrigeminal nucleus (Pa5), are 
also considered part of the trigeminal complex (Waite 
and Tracey, 1995). 
The spinal trigeminal nucleus (Sp5) 
Dopamine labeled fibers were distributed throughout 
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the SpS (fig. 1). The distribution pattern showed 
rostrocaudal, dorsoventral, and mediolateral gradients, 
which were observed throughout the SpS. Dopamine 
labeling was strongest in the caudal part of the SpS, 
except for the transition zone with the spinal cord, and 
diminished in a rostral direction. The ventral and lateral 
parts of the SpS generally displayed the strongest 
dopamine labeling. The weak labeling in the dorsal part 
of the SpS disappeared completely at more rostral 
levels. 
In the alternate sections there was a widespread 
DBH staining in all parts of the SpS. Compared to 
dopamine, the DBH staining was distributed more 
uniformly throughout the Sp5. As a result, there were 
no obvious gradients in the distribution ofDBH. 
The caudal subnucleus (Sp5C) 
The SpSC is the most caudal part of the SpS. SpSC is 
located at levels between the upper cervical cord and 
the obex. As in the dorsal hom of the spinal cord, SpSC 
has a laminar arrangement with a marginal layer 
(lamina I), a substantia gelatinosa (lamina II), and a 
magnocellular layer, with an organization analogous to 
the spinal laminae III to V. The distribution of 
dopamine in the SpSC was very similar to the 
distribution that we have observed in the cervical dorsal 
hom (Holstege et ai., 1996) (fig. 2). The marginal layer 
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Dopamine and DBH in brain stem 
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Figure 3: Schematic representation of dopamine and DBH immunoreactive fibers and terminals in the rat nucleus 
of the solitary tract at different levels of the brain stem. Note that the external cuneate nucleus and area postrema 
are both sparsely innervated by dopamine, whereas the (nor)adrenaline synthesizing enzyme DBH is abundantly 
present. For details see text; for abbreviations see enclosed list of abbreviations. 
of Sp5C was sparsely to moderately labeled with 
dopamine fibers. The lowest amount of dopamine 
immunoreactivity was found in the substantia 
gelatinosa of the Sp5C, which only contained some 
traversing fibers. Moderate dopamine labeling was 
present in the peripheral part of the magnocellular layer, 
in agreement with the findings in lamina III of the 
spinal cord. Similarly, the medial part of the 
magnocellular layer - the analogue of lamina IV and V 
of the spinal dorsal horn - was moderately labeled with 
more radially oriented dopamine fibers. At levels of the 
caudal pole of the inferior olive dopamine labeling 
became moderate to strong in the periphery of SpSC 
and slightly more rostraliy, at the level where the 
substantia gelatinosa had disappeared completely, 
dopamine fibers were running dorsoventrally along the 
outer border of the magnocellular layer. In the medial 
part of SpSC, dopamine fibers were sparse and oriented 
more or less randomly. The paratrigeminal nucleus 
(paS), located at the dorsolateral medullary surface 
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within the spinal trigeminal tract, was sparsely to 
moderately labeled with dopamine fibers. 
The distribution of DBH fibers in SpSC was also 
very similar to the distribution of DBH fibers in the 
spinal dorsal horn. In the marginal layer and substantia 
gelatinosa of SpSC the DBH labeling was moderate to 
strong. The inner part of the substantia ge1atinosa was 
stained somewhat lighter than its outer part. The 
maguocellular layer was moderately labeled with DBH 
fibers. 
The inlerpolar subnucleus (Sp5J) 
The SpSI is the rostral continuation of the SpSC. It is 
located rostral to the obex. In comparison with the 
SpSC, the SpSI was slightly stronger labeled with 
dopantine fibers. The rostrocaudal gradient of dopamine 
staining in SpSI was especially pronounced in the 
medial part. The dopamine labeling had almost 
completely disappeared at the level of the caudal pole 
of the facial nucleus (n7), except for some traversing 
fibers in the outer surface of SpSI. 
Similar to the dopamine pattern, the moderate DBH 
labeling in the SpSI also showed a rostrocaudal 
gradient, such that more rostrally DBH labeling became 
less strong. A preferential otientation of the DBH fibers 
was not observed. 
The oral subnucleus (Sp5 0) 
The SpSO, which is the most rostral subnucleus of the 
SpS, is located at the level of the facial nucleus. The 
SpSO was sparsely labeled with dopamine fibers. The 
distribution of dopamine fibers was the same as in the 
caudal SpSI, though the staining became less dense. 
The SpSO was moderately to strongly labeled with 
DBH fibers. The DBH fibers appeared continuous with 
the adjacent lateral reticular formation. 
The principal trigeminal nucleus (Pr5) 
The PrS extends caudally to the level of the rostral pole 
of the facial nucleus next to the SpSO. Rostrally it ends 
at the same level as the rostral pole of the trigeminal 
motor nucleus (MoS). In PrS the dopantine staining 
showed a dorsoventral gradient. The ventrolateral part 
of the PrS (prSVL) was sparsely labeled with dopamine 
fibers, while dopamine labeling was nearly absent in the 
dorsomedial part (PrSDM). 
In the alternate sections, PrS was moderately labeled 
with DBH fibers. Its distribution showed no 
dorsoventral gradient, both PrSVL and PrSDM were 
labeled equally strong with DBH. 
The mesencephalic trigeminal nucleus (Me5) 
The area that contains the large ganglion cells that form 
the mesencephalic trigeminal nucleus was moderately 
to strongly labeled with dopantine fibers and strongly 
labeled with DBH fibers. 
Medulla oblongata 
In addition to the trigeminal nucleus, dopantine 
irmnunoreactive fibers were present in many additional 
areas of medulla oblongata, like the nucleus of the 
solitary tract, the dorsal motor nucleus of the vagus, the 
hypoglossal nucleus, the nucleus prepositus 
hypoglossus, the inferior olive, the cochlear nuclei, and 
the cuneate and gracile nuclei and throughout the 
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The medial part of the dorsal medulla oblongata 
contains three important nuclei: the nucleus tractus 
solitarii (NTS), the dorsal motor nucleus of the vagus 
(DMNV) and the hypoglossal nucleus (nI2), which is 
located just ventrally to the DMNV. The distribution of 
fibers and terminals immunoreactive for dopamine or 
DBH in these areas are shown in detail in figs. 3 and 
4A. Dorsomedially within the nucleus tractus solitarius 
and DMNV, the medullary catecholamine group A2 is 
located. Densely stained dopaminergic or 
(nor)adrenergic neurons and dendrites (Armstrong el 
aI., 1982; Kalia el aI., 1985), belonging to the caudal 
A2 group, often appeared intermingled with the labeled 
fibers and terminals of the DMNV and nucleus tractus 
solitarius (NTS). Therefore, it was difficult to precisely 
identify the labeling as well as the underlying 
cytoarchitecture of these nuclei. 
Hypoglossal area 
The caudal hypoglossal nucleus (nI2) showed moderate 
to strong dopamine staining in its ventromedial 
quadrant, while the remaining areas were sparsely to 
moderately labeled with dopamine fibers (fig. 3). At 
more rostral levels dopamine labeling became sparse 
both in the dorsal and ventral parts of n 12. In the 
alternate sections, nI2 was moderately labeled with 
DBH fibers (fig. 3). As with dopamine, the most intense 
DBH labeling also was found at the ventromedial part 
of the caudal nI2. At its rostral pole, the DBH labeling 
appeared slightly stronger in the dorsal part. 
The dopamine labeling of the nucleus prepositus 
hypoglossus (PrH), located rostrally to the n12, was 
sparse to moderate. The supragenual nucleus (SGe), 
located at the genu of the facial nerve (g7), showed no 
dopamine staining. Some dopamine fibers immediately 
surrounded the central canal (CC).The distribution of 
DBH fibers in the PrH was similar to that of dopamine, 
albeit slightly stronger. 
The dorsal molor nucleus oflhe vagus (DMNV) 
The caudal part of the DMNV was strongly stained 
with dopamine, resulting in a sharp and conspicuous 
transition between nI2 and DMNV. Rostrally in the 
DMNV, at the level of the area postrema (AP), the 
dopamine labeling became even stronger. 
Similar to the distribution of dopamine, the 
strongest DBH staining within the dorsomedial medulla 
also was present in the DMNV. Due to the massive 
DBH staining in its caudal part it was not possible to 
distinguish individual fibers or terminals. 
The nucleus tractus solitarii (NTS) 
At levels caudal to the obex, moderate dopamine 
staining was present in the commissural nucleus tractus 
solitarius (fig. 3). At the level of the obex the labeling 
became very strong and diminished again more 
rostrally. Strongest dopantine labeling was present in 
the medial nucleus tractus solitarius, especially in the 
region lining the dorsal motor nucleus of the vagus (fig. 
3). Rostral to the obex (fig. 4), in the ventrolateral part 
of the medial subdivision, the central subnucleus was 
sparsely labeled. The ventrolateral nucleus tractus 
solitarius, which mainly constitutes the lateral 
Dopamine and DBH in brain stem 
Dopamine 
Figure 4: Photomicrographs with darkfield illumination of sections from the rat dorsomedial medulla oblongata (A) 
and the area of the periaqueductal gray (B) after processing for dopamine (left) or DBH (right) 
immunocytochemistry. The asterisk (A) indicates the external cuneate nucleus, which is labeled for dopamine, but 
not for DBH. See figs. 1, 3 and 8 for the underlying cytoarchitecture and additional notes. For details see text. Scale 
bars in A and B = 200 ~m. 
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Figure 5: Photomicrograph with darkfield illumination of sections from the parabrachial nuclei after processing for 
dopamine (A) or DSH (S) immunocytochemistry. See figs. 1 and 7 for the underlying cytoarchitecture and additonal 
notes. For details see text. Scale bar = 200 ~m. 
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Figure 6: Schematic representation of the dopamine and DBH immunoreactive fibers and terminals in the rat 
inferior olive at different levels of the brain stem. Note that the strong labeling with coarse dopamine fibers of the 
ventral lamella of the principle olivary nudeus and the medially adjacent ventrolateral outgrowth is not matched by 
OBH, whereas OBH labeling present in all other olivary (sub)nudei is not matched by dopamine. For details see 
text; for abbreviations see enclosed list of abbreviations. 
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subdivision of the nucleus tractus solitarius, was 
moderately labeled. The dopamine labeling became 
sparse at the most rostral levels. The interstitial nucleus, 
which is surrounded by solitary tract fibers, was also 
sparsely labeled with dopamine. The solitary tract itself 
was devoid oflabeling. 
The DBH pattern within the nucleus tractus 
solitarius was similar to the distribution of dopamine. 
but the staining densities were slightly stronger (Fig. 3). 
The area postrema (AP), which is usually not 
considered as a portion of the nucleus tractus solitarius, 
was sparsely labeled with dopamine fibers. The 
periventricular gray (Pe), which is located rostrally to 
the area postrema just below the floor of the 4ili 
ventricle, contained strong to very strong dopamine 
labeling. The labeling became very strong at the level of 
the adrenergic C2 group. DBH immunoreactive was 
strong in the AP and the Pe. 
The inferior olivary complex 
The inferior olive (10) is located in the ventral part of 
the medulla oblongata and is composed of three main 
subdivisions, i.e. the principal olive and two accessory 
olives (Ruigrok and Cella, 1995). The principal olive 
(PO) consists of a folded sheet of gray matter. Rostrally 
a dorsal and a ventral lamella can be distinguished. 
Caudally the PO is continuous with the ventrolateral 
outgrowth (VLO). The medial accessory olive (MAO) 
is located medial from the PO and includes several 
subnuclei. The dorsal accessory olive (DAO) is located 
dorsal to the PO. 
Dopamine immunoreactive fibers and presumptive 
terminals were primarily located in the principal olive 
(fig. 6). The labeling was not uniform but consisted of 
two very different types. The dorsal lamella and, more 
rostrally, also the dorsomedial parts of the ventral 
lamella of the principal olivary nucleus contained dense 
but extremely fine granular labeling. Coarse varicose 
fibers were occasionally observed. The labeling was 
already present at the most caudal part of the principal 
olivary nucleus, where it was almost continuous with 
the medial accessory olive. The medial accessory olive 
in turn was avoided by the dopamine labeling, thus 
clearly demarcating the borderline between the two 
nuclei (fig. 6B). In contrast to the very fine granular 
labeling of the dorsal lamella, the ventral lamella 
received coarse varicose fibers especially in its 
ventrolateral part at the middle level of the inferior 
olive, where it was very strongly labeled (figs. 6C and 
6D). In a few sections these fibers were observed to 
fonn a narrow band, which spreads out dorsomedially 
to label the ventrolateral outgrowth (lOVL). The 
labeling of the medial and dorsal accessory olivary 
nuclei (and associated nuclei) was virtually absent. 
The DBH labeling of the inferior olivary complex 
was also primarily aimed at the principal nucleus and at 
the same area as the fine grain dopamine labeling, i.e. 
mainly the dorsal lamella (fig. 6G-L). There were two 
major differences between the dopamine and the DBH 
labeling. In the first place there was a sparse to 
moderate labeling of all the other olivary (sub)nuclei 
with DBH, which were devoid of dopamine labeling. In 
the second place, the strong labeling with coarse 
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dopamine fibers of the ventral lamella of the principle 
olivary nucleus and the medially adjacent ventrolateral 
outgrowth was not matched by DBH, although there 
were some DBH fibers in these nuclei, similar to all 
other subnuclei. 
The vestibular complex 
The vestibular complex consist of the supetior (SuVe), 
lateral (LVe), medial (MVe), and spinal (SpVe) 
vestibular nuclei and some smaller cell groups. Only an 
occasional fiber was present in the L Ve and Su Ve. The 
MVe and SpVe were sparsely labeled. In the alternate 
sections, the vestibular complex showed a few 
prominent DBH fibers. The SuVe showed sparse to 
moderate DBH staining. 
The dorsal column nuclei 
The gracile nucleus (Gr) and cuneate nucleus (Cu) were 
moderately labeled with dopamine. At caudal levels the 
peripheral part of the Cu was labeled stronger than its 
central part, while more rostrally, at the level where the 
Gr had disappeared, dopamine staining in Cu was 
moderate to strong. The external cuneate nucleus (ECu) 
was virtually devoid of dopamine. The dorsal column 
nuclei, including the BCu, were moderately labeled 
withDBH. 
The cochlear nuclei (CN) 
The cochlear nuclei consist of a ventral and dorsal CN. 
Within the dorsal CN the layers containing giant cells 
received a sparse to moderate dopamine staining, 
whereas the outer layers contained sparse dopamine 
labeling. The ventral CN was sparsely labeled, except 
for a dopamine fiber plexus in the granule cell layers, 
especially more rostrally. The CN also received a 
prominent DBH staining. DBH fibers were present in 
both dorsal and ventral CN, with strong DBH staining 
within the anterior portion of the ventral CN. 
Pons and mesencephalon 
In the pons the most prominent labeling was found in 
the locus coeruleus, parabrachial nuclei, and pontine 
reticular nuclei (figs. 1,5 and 7). 
The locus coeruleus (LC) 
Dopamine immunoreactive fibers and terminals were 
observed throughout the LC (figs. 1,5 and 7). At caudal 
levels, the LC was moderately labeled with dopamine 
immunoreactive fibers and tenninals. More rostrally, 
the LC proper (cell body area) was strongly labeled 
with dopamine immunoreactive fibers and terminals, 
especially its ventral part. In comparison with the LC 
proper, the dendritic area of the LC located more 
ventromedially, appeared to be stained somewhat 
stronger than the cell body area. In the area of 
Banington's nucleus dopamine staining was sparse. In 
the alternate sections, DBH staining was very strong 
throughout the LC and in Barrington's nucleus. 
The parabrachial complex (P B) 
The parabrachial complex (PB) is made up of 
cytoarchitectonically distinct subnuclei surrounding the 
superior cerebellar peduncle in the rostral pons. It is 
divided into a lateral (LPB) and medial parabrachial 
nucleus (MPB). The LPB is located primarily dorsal to 
Dopanline and DBH in brain stem 
DA DBH 
Figure 7: Schematic representation of the dopamine and DBH immunoreactive fibers and terminals in the rat 
parabrachial nucleus at different levels of the brain stem. Note that dopamine sparsely innervates the region of the 
external lateral parabrachial nucleus, whereas DBH is abundantly present. For details see text; for abbreviations 
see enclosed list of abbreviations. 
the superior cerebellar peduncle and the MPB is located 
primarily ventral to the superior cerebellar peduncle. 
The MPB cormects with the LPB via the so-called waist 
area. About 13 parabrachial subnuclei and regions have 
been identified (c.f. Herbert et al., 1990; Saper, 1995). 
These include the central lateral, dorsal lateral, external 
lateral, extreme lateral, external medial, internal lateral, 
K611iker-Fuse nucleus, superior lateral, and ventro-
lateral subnuclei. The distributions of fibers and 
tenninals immunoreactive for dopamine or DBH are 
given in figs. 5 and 7. 
Both the LPB and the MPB received a very strong 
dopamine projection to specific subnuclei. Caudally. the 
MPB received a very strong innervation, which 
extended into the waist area where it connects with the 
central nucleus of the LPB. The labeling was confined 
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to the medial part of the MPB, while the lateral part was 
sparsely innervated (fig. 7 A). At the level where the 
superior cerebellar peduncle traverses the 
mesencephalic tract, labeling in the MPB, including the 
external nucleus of the MPB and ventrolateral 
parabrachial nucleus, became sparse (fig. 7B). Very 
strong punctuate labeling was present in the ventral 
nucleus of the LPB at caudal levels, where it is 
continuous with the waist area (fig. 7A). More rostrally, 
labeling was confined to the central nucleus of the LPB, 
while the external and lateral nuclei of the LPB were 
labeled sparse to moderate (fig. 7B). This pattern 
continued in the rostral part of the LPB with strong 
labeling in the central and dorsal nucleus and sparse 
labeling in the internal and external nuclei of the LPB 
(fig. 7C). DBH staining in the parabrachial nuclei was 
moderate to strong (figs. 7D-F and 5). 
The cerebellar nuclei and cerebellar cortex 
The cerebellar nuclei are located within the base of the 
cerebellum. They are usually subdivided into a caudal 
medial cerebellar (Med) or fastigial nucleus, an 
interposed (Int) nucleus, and a lateral cerebellar (Lat) or 
dentate nucleus. The ventral part of the caudal Lat 
showed some dopamine labeled fibers, while the other 
cerebellar nuclei showed sparse dopamine staining. 
Although an extensive examination was not attempted, 
it was observed that the cerebellar cortex was almost 
devoid of dopamine staining, except for some 
occasional dopamine fibers distinctly present in the 
medial extension of the ventral paraflocculus. The 
cerebellar nuclei were all sparsely to moderately labeled 
with DBH. In the cerebellar cortex DBH fibers were 
widely distributed. 
In the mesencephalon. at levels caudal to the substantia 
nigra, dopamine immunoreactive fibers and terminals 
were present in the periaqueductal gray, the superior 
and inferior colliculi, and deep mesencephalic nuclei 
(fig. 1). 
The periaqueductal gray (PAG) 
The PAG corresponds to the region of the midbrain that 
surrounds the cerebral aqueduct of Sylvius. The most 
caudal part of the P AG is located at the level of the 
dorsal tegmental nucleus (DTg), while the most rostral 
part of the PAG is at the level of the posterior 
commisure and the most rostral level of the oculomotor 
nucleus (n3). The PAG can be subdivided in several 
distinct regions based on cytoarchitectonic features 
(Beitz, 1985). Generally, the PAG is subdivided in 
dorsal, lateral, ventrolateral, and medial regions. 
Caudally, the ventral PAG contains the dorsal and 
dorsolateral tegmental nuclei. Rostrally, the 
ventrolateral subdivision is bordered ventrally by the 
supraoculomotor nucleus. At midlevels, the 
ventromedial part of the P AG is occupied by the dorsal 
raphe nucleus. The distributions of fibers and terminals 
immunoreactive for dopamine or DBH are given in fig. 
4 and 8. 
Strongest dopamine staining was present in the 
region of the dorsal raphe nucleus. The dopamine 
staining extended from the aqueduct towards the dorsal 
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tegmental nucleus. Laterally, in the region medial to 
Me5, the staining in the ventrolateral P AG was sparse 
to moderate. The lateral PAG was less strongly labeled, 
with strongest labeling in its dorsal part. At the dorsal 
border of lateral PAG there was a small region that 
received less dopamine labeling than the surrounding 
region, especially at more rostral levels. Prominent 
dopamine staining was present in the dorsal PAG. In 
the medial parts of the P AG moderate dopamine 
staining was present in the region lining the aqueduct. 
A dense DBH staining was present in the PAG. The 
distribution of DBH showed some similarities with the 
distribution of dopamine, but the regional DBH staining 
pattern differed (figs. 4 and 8E-F). Most striking was 
the rather sparse labeling of the dorsal subdivisions of 
thePAG. 
The inferior eollieulus 
Dopamine immunoreactivity in the inferior colliculus 
showed a characteristic distribution, which may be best 
described as medial, middle and lateral areas (fig. 9). 
These areas do not seem to follow the 
cytoarchitectonical subdivisions that have been 
described previously for the inferior colliculus (Faye-
Lund and Osen, 1985; Klepper and Herbert, 1985). The 
lateral area largely consists of the external cortex, while 
the middle area appears to include parts of the central 
nucleus as well as the dorsal and external cortex. The 
same holds true for the medial area. The middle area 
was sparsely labeled. Laterally there was a relatively 
abrupt transition to the lateral area, which showed 
sparse to moderate labeling. In the medial direction, 
there was a gradual transition from sparse to moderate 
dopamine labeling when going from the middle area to 
the medial area. Ventromedially, the strongest labeling 
was observed in a narrow strip at the most ventromedial 
part of the inferior colliculus. This area was not present 
at the most rostral and caudal parts. 
DBH labeling, ranging from sparse to moderate, 
was distributed much more unifonnly throughout the 
inferior colliculus. There was no indication of different 
areas as observed with the dopamine labeling. 
The superior eollieulus 
In the typical layered cytoarchitecture of the superior 
colliculus (see e.g. Kanaseki and Sprague, 1974), the 
dopamine immunoreactivity showed a characteristic 
distribution (fig. lOA). In the most superficial layer, the 
stratum zonale, dopamine labeling was absent. In the 
second layer, the stratum griseum superficiale. labeling 
was sparse but increases ventrally at the transition with 
layer In, the stratum opticum. where it became sparse 
to moderate. This labeling was seen throughout layer ill 
and also the dorsal part of layer IV, the stratum gtiseum 
intermedium. In the remainder of layer IV and in Layer 
V, the stratum album intermedium, labeling was sparse, 
with some traversing fibers. The area below layer V up 
to the border with the aqueduct and containing layers 
VI and VII, the stratum gtiseum profundum and the 
stratum album profundum respectively, showed 
moderate dopamine labeling, especially medially where 
the labeling blends in with that of the dorsal PAG. 
The DBH labeling (fig. lOB) in the superior 
colliculus was different from the dopamine labeling. It 
was strongest in the superficial layers and was still 
clearly present in layers ill-V, where dopamine labeling 
was sparse. In layers VI and VII, up to the border with 
the PAG, DBH labeling was only sparse, whereas 
dopamine labeling is much stronger in these areas. 
Motor nuclei of the cranial nerves 
Moderate to strong dopamine staining was observed in 
somatomotor nuclei of the cranial nerves III, V (fig. 
11), VII, and XII, whereas motor nuclei of the crarrial 
nerve IV, VI and the ambiguus nucleus were only 
sparsely labeled. The dopamine staining in the motor 
nuclei had a very different appearance as compared to 
other areas of the brain stem. The large number of 
lightly labeled dopamine immunoreactive varicosities, 
with even less stained intervaricose segments, gave the 
labeling a fine granular (punctuate) appearance, 
especially at lower magnifications (fig. 11). 
Interestingly, the DBH labeling had a similar 
appearance. 
Monoaminergic cell groups 
Dopaminergic fibers and tenninals were observed 
around cell bodies and dendrites of all the 
monoaminergic cell groups. The serotonergic raphe 
nuclei all received dopamine immunoreactive fibers and 
temtinals, with very strong labeling in the dorsal raphe 
nucleus. The raphe pallidus (RPa) was strongly and the 
raphe obscurus (ROb) was moderately to strongly 
labeled with dopamine immunoreactive fibers, mostly 
showing a dorsoventral orientation. The labeling 
increased at more rostral levels. RPa appeared 
somewhat stronger labeled than ROb. The nucleus 
raphe magnus (RMg) was moderately labeled. The area 
between RMg and the noradrenergic A5 cell group 
received a moderate to strong dopamine labeling. The 
noradrenergic cell groups, most notably the locus 
coeruleus and subcoeruleus and the AS group, but also 
the AI, A2 and the A 7 noradrenergic cell groups of 
Dahlstrom and Fuxe (1964), all received a moderate to 
strong dopaminergic innervation. Similar dopamine 
labeling was observed in the adrenergic cell groups of 
the medulla. 
DBH labeling in the monoaminergic cell groups 
was moderate to strong. 
Discussion 
Methodological considerations 
In the present study dopamine fibers and tenninals were 
identified in rat brain stem using an antiserum raised in 
rabbit against glutaraldehyde-conjugated dopamine. As 
a consequence, a relatively high concentration of 
glutaraldehyde is reqnired for fixation, which is 
generally believed to be incompatible with the 
immunocytochemical detection of many other 
substances, including the catecholamine enzymes like 
DBH. However, the current fixation protocol appeared 
suitable not only for the detection of dopamine, but also 
for immunocytochemical detection of the noradrenaline 
biosynthetic enzyme DBH, which made it possible to 
use subsequent brain stem sections for comparing the 
distribution of dopamine with that of (nor)adrenaline. 
Dopamine and DBH in bnlln stem 
The present immunocytochemical method for 
identifying doparninergic structures, i.e. with the aid of 
an antibody raised against the neurotransmitter itself, 
has the distinct advantage that it offers a relatively 
simple and direct procedure for demonstrating 
dopaminergic fibers as well as temtinals with a high 
specificity. No additional marripulations or 
pharmacological tools are required to distinguish the 
dopaminergic fibers and terminals in the brain stem 
from the (nor)adrenergic ones, which are also 
abundantly present. 
Dopamine is present in the brain not only as a 
neurotransmitter, but also as a precursor in the 
biosynthesis of the catecholamines noradrenaline and 
adrenaline. Theoretically, the possibility exists that 
noradrenergic and adrenergic fibers and tenninals 
contain levels of precursor dopamine that are detected 
by dopamine immunocytochemistry. As a consequence, 
these fibers would be falsely identified as 
dopaminergic, i.e. using dopamine as a transmitter. 
However, several lines of evidence suggest that the 
majority of dopamine immunoreactive fibers and 
terminals in the brain stem are indeed dopaminergic. 
Firstly, our control experiments with the neurotoxin 
DSP-4, that affects a specific subset of noradrenergic 
fibers and terminals (Fritschy and Grzanna, 1989), 
showed a selective loss of DBH staining. In the 
alternate sections the dopamine immunoreactivity 
remained unaffected by the drug (see also Holstege et 
al., 1996). These results strongly suggest that in the 
affected areas the precursor dopamine in noradrenergic 
fibers and temtinals does not reach detectable levels. 
Therefore, in the affected areas, which receive the 
noradrenergic input from the locus coeruleus, the 
present immunocytochemical method appears to 
visualize exclusively genuine dopaminergic fibers and 
tenninals. The possibility exists, however, that in some 
of the areas which remained unaffected by DSP-4, 
precursor dopamine may have reached detectable levels 
as suggested by Alonso et al. (1995). They reported that 
metabolic dopamine could be detected, especially in 
areas receiving an extremely dense catecholaminergic 
innervation like the locus coeruleus, the dorsal motor 
nucleus of the vagus, the area postrema, the nucleus of 
the solitary tract and the hypoglossal nucleus. On the 
other hand, they found that dopamine immunoreactivity 
was not associated with the large majority of the 
noradrenaline immunoreactive fibers detected in several 
other regions of the brain stem, including vestibular, 
dorsal column and spinal trigenrinal nuclei. Thus, only 
in areas receiving a very strong catecholaminergic 
innervation dopamine may reach detectable levels, 
whereas in the large majority of the brainstem nuclei 
precursor dopamine remains undetectable by 
immunocytochemistry. In accordance, biochemical 
studies (Westerink and de Vries, 1985; Verhage et al., 
1992) have shown that in areas with a rich 
noradrenergic innervation and very low dopamine 
levels, such as the cerebellum and lateral hippocampus, 
even these very low dopamine levels were not present 
as precursor dopamine in noracirenergic tenninals, in 
agreement with the results of the present study. In some 
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areas of the brain stem, like the cerebellum, the area 
postrema, the anterior portion of the ventral cochlear 
nucleus, and the external cuneate nucleus, a relatively 
dense staining for DBH immunoreactive structures was 
present, whereas in the alternate sections, virtually no 
dopamine immunoreactive fibers and tenninals were 
observed. This further emphasized that the dopamine 
antibody did not label (nor)adrenergic structures, 
identified by the presence of DBH staining. The few 
labeled fibers in these areas probably were true 
dopaminergic fibers, since some of these areas do 
contain a minor doparninergic innervation. On the other 
hand, it should be mentioned that some of the presumed 
noradrenergic somata of locus coeruleus neurons 
showed a faint staining for dopamine, probably because 
more precursor dopamine is present in somata than in 
the fibers and terminals of (nor)adrenergic neurons. 
It is concluded that the dopamine immunoreactive 
fibers and terminals, detected in the present study, 
virtually all contained dopamine. not as a precursor, but 
rather as a transmitter. Therefore. in the remainder of 
the discussion, we will consider the dopamine 
immunoreactive fibers and tenninals as dopaminergic. 
Since noradrenaline and adrenaline can not be 
distinguished individually with the catecholamine 
biosynthetic enzyme DBH as a marker, they will be 
collectively termed (nor)adrenergic. 
Anatomical distribution of dopaminergic and 
(nor)adrenergic fibers and presumptive tenninals 
The results of the present study show a characteristic 
distribution of dopaminergic fibers and terminals in 
various regions of the rat brain stem. (Nor)adrenergic 
fibers clearly outnumbered the dopaminergic ones and 
were observed in areas that were not or only scarcely 
innervated by dopamine. Dopaminergic and 
(nor)adrenergic fibers formed an complex pattern of 
fine varicose fibers and punctate labeling, the latter 
often appearing as terminals, although this can only be 
ascertained by electron microscopy. The distribution of 
dopaminergic and (nor)adrenergic fibers and terminals 
showed a considerable overlap in many brain stern 
regions indicating similarities in the innervation of the 
rat brain stem by different catecholamines. However, 
despite the overlap, the dopaminergic and the 
(nor)adrenergic fibers and tenninals were not 
distributed identically in all brain stem regions. 
Sensory trigeminal complex 
The distribution pattern of dopamine immunoreactive 
fibers in the trigeminal complex showed a rostrocaudal, 
dorsoventral, and mediolateral gradient. Within the 
rostrocaudal gradient of the trigeminal complex the 
most prominent labeling was observed in its most 
caudal nucleus, the spinal trigeminal nucleus (Sp5), 
especially its caudal and ventral parts. The presence of 
dopamine fibers in Sp5 is in agreement with a previous 
immunocytochemical study on dopamine in the feline 
medulla (Maqbool et aI., 1993). The dorsoventral 
distribution in Sp5 implied that the ventrally situated 
ophthalmic division of the trigeminal nucleus (VI) 
received strongest dopamine innervation, followed by 
the maxillary (V2) and the mandibulary (V3) divisions. 
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The functional meaning of these gradients is unclear, 
but the predominance of the dopaminergic input on the 
caudal Sp5 is of particular interest, since this area is 
specifically involved in pain transmission of the head 
and neck. In accordance, a dopamine distribution 
similar to that of the caudal Sp5 is also present in the 
cervical dorsal hom (for details see Holstege et al., 
1996). More detailed investigations on the effects of 
dopamine in the spinal cord have shown that D2-
receptors are present in the superficial and deep dorsal 
hom (van Dijken et al., 1996) and exert an inhibitory 
role in the transmission of nociceptive stimuli 
(Clatworthy and Barasi, 1987; Fleetwood-Walker et aI., 
1988; Liu et aI., 1992), whereas D1-receptors are 
without effect (Barasi et al., 1987; Liu et al., 1992). 
These findings suggest that dopamine induces 
antinociceptive effects, which are mediated via spinal 
Drreceptors located in the superficial and deeper dorsal 
horn (van Dijken et al., 1996). The similarity in the 
distribution of dopantine in Sp5C and the spinal cord 
suggests that dopamine has a similar mode of action in 
these areas, an idea which is strengthened by the 
reported binding of D2-receptor ligands in the Sp5 
(Bouthenet et al., 1987; Yokoyama et al., 1994; 
Lawrence et aI., 1995). 
In contrast to the distribution of dopamine, the 
(nor)adrenergic innervation pattern of Sp5 showed no 
obvious gradients. The DBH immunoreactive fibers in 
Sp5 represent largely, if not exclusively, noradrenergic 
fibers originating in the locus coeruleus proper 
(Grzanna and Fritschy, 1991). The Sp5 also receives 
serotonergic input from all levels of the brain stem 
(Dahlstrom and Fuxe, 1964; Steinbusch, 1981; Beitz, 
1982; Pearson and Jennes, 1988; Tallaksen-Greene et 
aI., 1993). 
Taken together, the findings suggest that dopantine, 
together with other monoamines like serotonin and 
(nor)adrenaline, plays an important role in the 
processing of sensory information, including 
nociception, from the head and neck region. 
Dopaminergic, (nor)adrenergic (Copray et aI., 
1990a; Copray et aI., 1990b), and serotonergic (Kolta et 
aI., 1993; Liem et aI., 1993; Lazarov and Chouchkov, 
1995) fibers in the mesencephalic trigeminal nucleus 
(Me5) have been reported to closely surround the large 
ganglion cells that form the Me5. Low levels of D1-
receptors and high levels of Dz-receptors were seen in 
Me5 neurons (Lazarov and Pilgrim, 1997). This 
suggests that the monoamines, and more particularly 
dopamine, are also involved in modulating 
proprioceptive infonnation from the oro-facial region. 
Solitary complex 
The existence of a dopaminergic innervation of the 
nucleus tractus solitarius and the dorsal motor nucleus 
of the vagus is well established (Hokfelt et aI., 1984; 
Kalia et al., 1985; Ruggiero et al., 1994) and is in 
agreement with high densities of D2 binding (Bouthenet 
et al., 1987; Yokoyama et aI., 1994) and D2 mRNA 
(Bouthenet et al., 1991). The present study confinns 
this strong innervation by dopaminergic as well as 
(nor)adrenergic fibers and presumptive terminals. Since 
the synthesizing enzyme of adrenaline (PNMT) is 
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Figure 8: Schematic representation of the dopamine and DBH immunoreactive fibers and terminals in the rat 
periaqueductal gray (PAG) at different levels of the brain stem, Note the rather sparse DBH labeling in the dorsal 
subdivisions of the PAG, whereas dopamine labeling is abundantly present. For details see text; for abbreviations 
see enclosed list of abbreviations. 
present in specific parts of the nucleus tractus solitarius 
(Ruggiero et al., 1994), the adrenergic innervation 
appears to represent a specific input, separate from the 
noradrenergic one. The nucleus tractus solitarius also 
receives a very dense serotonergic innervation, 
especially in its caudal parts (Steinbusch, 1981), as well 
as many serotonin receptor binding sites (Thor et at., 
1992). 
The nucleus tractus solitarius serves primarily as a 
sensory relay center for visceral, gustatory, respiratory, 
and cardiovascular afferent neural pathways (van 
Giersbergen et al., 1992; Norgren, 1995). Several 
studies have focussed on the effects of dopamine on 
nucleus tractus solitarius functions. Application of 
dopamine, but also noradrenaline, into the lateral 
nucleus tractus solitarius resulted in inhibition of the 
swallowing reflex (Kessler and Jean, 1986). With 
respect to cardiovascular functions, microinjection of 
low doses of dopamine into the nucleus tractus 
solitarius elicited a dose dependent decrease in blood 
pressure and heart rate (Zandberg et al., 1979), albeit 
less potent than noradrenaline or adrenaline. The 
depressor response of dopamine was mediated via (J.-
adrenoceptors. Apparently, dopamine acted directly and 
not after conversion into noradrenaline (van 
Giersbergen et al., 1992). In contrast, recent studies 
reported that microinjection of higher doses of 
dopamine (Granata and Woodroff, 1982) or a D,-
receptor agonist (quinpirole) (Yang et al., 1990) into the 
posterior region of nucleus tractus solitarius caused a 
consistent increase in mean arterial pressure, suggesting 
that dopamine may produce an increase in blood 
pressure via its DTreceptors. These dose dependent 
opposite hemodynamic effects were also found after 
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application of noradrenaline into the nucleus tractus 
solitarius (see De Jong, 1974; van Giersbergen et ai" 
1992). Low doses of noradrenaline caused a fall in 
blood pressure and heart rate probably via B-
adrenoceptors, whereas relatively high doses caused an 
increase in arterial blood pressure probably via cxr 
adrenoceptors (van Giersbergen et al., 1992). In the 
case of serotonin, microinjection into the nucleus 
tractus solitarius evoked inhibitory effects (Feldman 
and Galiano, 1995), whereas 5HT,-receptor activation 
in the nucleus tractus solitarius increased mean arterial 
pressure (Nosjean et al., 1995). Taken together, these 
findings may suggest that the monoamines, including 
dopamine, have a similar mode of action in the nucleus 
tractus solitarius such that the concentration of the 
monoamine will detennine which receptors are 
activated and which hemodynamic effect are 
manifested. 
Inferior olive 
Dopaminergic and (nor)adrenergic fibers were observed 
to be densely distributed in the principal nucleus of the 
inferior olive and its ventrolateral outgrowth, which is 
in agreement with the original description of the 
catecholaminergic innervation the inferior olive by 
Dahlstrom and Fuxe (1964). The dopaminergic 
innervation of the dorsal lamella of the principle 
nucleus of the inferior olive appears to be characteristic 
for rat. In cat and monkey the catecholaminergic 
innervation, and more particularly the doparninergic 
innervation, is distributed to other subnuclei of the 
inferior olive than in rat. In the cat, dopaminergic nerve 
terminals were reported to be most prominent in the 
dorsal accessory nucleus (Maqbool et al., 1993), while 
in monkey the catecholaminergic fibers and terminals 
were detected either in the medial accessory nucleus 
(Kamei et al., 1981) or in the lateral lamella of the 
principal nucleus (Sladek and Bowman, 1975). 
The presence of a dopaminergic innervation of the 
inferior olive in rat is consistent with the existence of a 
dopaminergic projection from the subparafascicular 
thalamic nucleus, whose dopaminergic neurons might 
belong to the diencephalic All group (Takada, 1993). 
The distribution pattern of (nor)adrenaline is similar to 
that of dopamine, although DBH staining was not 
evident within the ventrolateral outgrowth. The 
(nor)adrenergic projection to the principal olive consists 
largely, if not exclusively, of noradrenergic fibers and 
terminals, which originate predominantly in the locus 
coeruleus proper (Grzanna and Fritschy, 1991). The 
presence of serotonergic fibers and tenninals in the 
inferior olive has also been reported (Steinbusch, 1981), 
but the distribution of serotonergic fibers differs from 
the catecholaminergic innervation patterns (Pare et aI., 
1987). The subnucleus most densely inuervated by 
serotonergic fibers is the dorsal accessory olive, 
whereas only few punctuate serotonin profiles were 
present in the principal olive and ventrolateral 
outgrowth. These findings demonstrate that the 
innervation of the inferior olive is heterogeneous with 
respect to the different monoamines within a particular 
species, but also between different species for a 
particular monoamine like dopamine. 
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Weak D,-receptor binding was reported for the 
inferior olivary nucleus of rat (Yokoyama et al., 1994), 
especially in its central and medial part (Lawrence et 
al., 1995). Since no further details were given, the exact 
distribution and the involvement of Drreceptors in the 
inferior olivary nucleus presently remains unclear. 
The dopamine innervation of the inferior olive in 
the rat is aimed exclusively at the principal inferior 
olivary nucleus, avoiding the medial and dorsal 
accessory olivary nuclei. The main differences between 
these nuclei may be that the medial and dorsal 
accessory nuclei receive direct sensory information 
from spinal cord, the trigeminal nucleus, the dorsal 
coluITU1 nuclei and the vestibular nuclei, while the 
principal nucleus does not receive this type of direct 
sensory information, but rather receives integrated 
information from the cerebral cortex (Ruigrok and 
Celia, 1995). This indicates that the dopantinergic 
projection to the inferior olive is primarily involved in 
modulating integrative input from higher centers and is 
not involved in modulating direct sensory input to the 
inferior olive. This is, to some extent, in line with the 
avoidance by dopamine projections of spinal neurons 
projecting to the cerebelium (Holstege et al., 1996). The 
lack of innervation of the cerebellar and vestibular 
nuclei and the limited innervation of the cerebellar 
cortex further suggest that the dopaminergic projection 
is aimed at modulating specific input to the inferior 
olive rather than the processing of this information in 
the projection area of the inferior olive in the 
cerebellum. The above may also hold true for the 
(nor)adrenergic innervation, which is similar to the 
dopantinergic one, except that the medial and dorsal 
accessory olivary nuclei also receive a limited 
projection. Surprisingly, the serotonergic projection in 
the rat appears to avoid the principal olive and mainly 
projects to the dorsal and medial accessory nuclei 
(Kojima et al., 1983; Bishop and Ho, 1984; Compoint 
and Buisseret-Delmas, 1988). The heterogeneous 
distribution between species further complicates the 
issue. Therefore, functional aspects of the 
monoaminergic, and more particular dopaminergic. 
innervation of the inferior olive remain to be resolved. 
Cerebellar nuclei and cerebellum 
The cerebellar nuclei received few dopamine 
immunoreactive fibers and the same holds true for the 
cerebellar cortex (panagopoulos et al., 1991; !kai et al., 
1992). In the present study, an extensive investigation 
of the cerebellum was not attempted. Nevertheless, it 
was noticed that the paraflocculus of the cerebellum 
received a small, but distinct dopaminergic innervation. 
A finding which is in good accord with previous studies 
(Panagopoulos et al., 1991; !kai et al., 1992). 
Dopaminergic fibers in the cerebellar cortex were 
reported to be predominantly distributed to the lateral 
portions of the cerebellar hemisphere, like the crus I 
ansiform lobule and paraflocculus, and to a lesser extent 
in the crus II ansiform lobule (Ikai et al., 1992). 
Retrograde tracing indicated that the dopantinergic 
innervation of the paraflocculus was derived from cell 
bodies in the ventral tegmental area (AlO) (Ikai et al., 
1992). 
Dopamine and DBH in brain stem 
Figure 9: Photomicrograph with darkfield illumination of a section processed for dopamine immunocytochemistry, 
showing the inferior colliculus, Note that the dopamine immunoreactive fibers and terminals are not evenly 
distributed over the different parts of the inferior colliculus, See fig, 1 for the underlying cytoarchitecture, For details 
see text, Scale bar = 200 ~m, 
The cerebellar nuclei and cerebellar cortex received 
a prominent noradrenergic irmervation~ which, in the 
cat, originated in the locus coeruleus (Grzanna and 
Fritschy, 1991), In monkey, the noradrenergic 
innervation of the flocculus and paraflocculus of the 
cerebellum was found to originate in the noradrenergic 
A4 cell group (DerniJjian et ai" 1976), Many cerebellar 
structures also receive a dense serotonergic projection, 
although the exact location of the cells of origin is 
uncertain (for review see Halliday et ai., 1995), Thus, 
the paucity of dopamine fibers in large parts of the 
cerebellar nuclei and cerebellum may suggest that 
monoamines, like noradrenaline and serotonin, play a 
more important role than dopamine. 
Vestibular complex 
A number of studies have indicated a possible 
interaction between dopamine and the vestibular system 
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(see e.g. Hozawa and Takasaka, 1993). In the present 
study, only weak dopamine staining was observed in 
the vestibular complex, mainly represented by a few 
doparninergic fibers in the medial and spinal vestibular 
nuclei. The presence of dopaminergic fibers in the 
medial vestibular nucleus is in accordance with a study 
in guinea-pig brain slices (Vibert et aI., 1995) showing 
that medial vestibular nucleus neurons depolarized after 
application of dopamine as well as after application of 
selective Dz-agonists, while application of selective DI 
agonists had no effects on MV e neurons. The 
depolarizing responses to dopamine appeared to be 
dependent on the GABAA receptor, indicating that 
dopamine might exert a modulatory action on the 
vestibular system, either by a direct action on the 
vestibular neurons or by modulation of GABAergic 
transmission. 
The vestibular system also receives noradrenergic 
(Steinbusch, 1991; Schuerger and Balaban, 1993) and 
serotonergic (Steinbusch, 1981; Steinbusch, 1991) 
input. The most prominent innervation arises from the 
serotonergic system, especially in the caudal part of the 
medial vestibular nucleus. The noradrenergic 
innervation of the vestibular complex is less prominent. 
Parabrachial complex and area pastrerna 
The parabrachial nucleus (PB) is the main relay for 
ascending visceral sensory information from the 
nucleus of the solitary tract (NTS) to the forebrain (see 
Herbert et al., 1990). It has been proposed that part of 
the catecholaminergic innervation of the lateral 
parabrachial nucleus is dopaminergic (Hedreen, 1980). 
This idea has been further substantiated by findings 
with retrograde tracers combined with tyrosine 
hydroxylase immunocytochemistry (Sawchenko and 
Swanson, 1982). However, so far the detailed 
localization of dopaminergic fibers, separate from the 
other catecholamines, has not been investigated in the 
parabrachial nuclei. We found that the dopantinergic 
input is strongest in the lateral parabrachial nuclei, 
including the waist area. These parts receive a strong 
projection from the caudal part of the nucleus tractus 
solitarius, which also receives a strong dopamine input. 
With respect to the physiological effects of dopamine in 
the parabrachial nuclei, no data are available. The 
presence of dopaminergic fibers in the lateral 
parabrachial nucleus was suggested by the presence of 
scattered, presumed dopaminergic, cells in the ventral 
tegmental area after injection into the parabrachial area. 
Serotonergic fibers have also been reported in the 
parabrachial nucleus (Steinbusch, 1981; Halliday et al., 
1995; Zardetto-Smith and Johnson, 1995). 
Periaqueductal gray 
The periaqueductal gray (P AG) in the rat contained a 
dense network of dopanninergic and (nor)adrenergic 
fibers. Since DBH and PNMT are both present in the 
PAG, the catecholaminergic innervation of the PAG is 
generally considered to be largely noradrenergic and 
adrenergic. The results of the present study, however, 
indicate that a significant part of the catecholantinergic 
innervation consist of dopaminergic fibers, a finding 
which is in accord with the reported binding of D,-
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receptor ligands in the PAG (Bouthenet et al., 1987; 
Yokoyama et aI., 1994). 
The observed distribution of (nor)adrenergic fibers 
in the PAG is in general agreement with the report of 
Herbert and Saper (1992). In the present study, 
however, DBH staining was also observed in more 
dorsal subdivisions of the PAG, an area that they 
reported to be nearly devoid of DBH stained axons. A 
somewhat higher sensitivity of the DBH antibody or the 
different type of fixation used in the present study 
probably may explain this discrepancy in staining 
pattern. Interestingly, the dorsal subdivisions of the 
PAG were prontinentiy innervated by dopannine fibers, 
indicating a clear difference between the dopaminergic 
and the (nor)adrenergic innervation. 
The (nor)adrenergic innervation in the PAG largely 
represents projections from the noradrenergic cell 
groups (AI and A2) and the adrenergic cell groups (C1 
and C3) in the medulla oblongata (Herbert and Saper, 
1992), with only a limited noradrenergic projection 
from the locus coeruleus (Fritschy et al., 1990). The 
area most densely innervated with (nor)adrenergic 
fibers and terminals is the ventrolateral PAG. Injections 
into the ventrolateral subdivision reportedly result in 
retrogradely labeled neurons in medullary cell groups 
that contain catecholaminergic neurons, including the 
nucleus tractus solitarius, the dorsomedial medulla, and 
the ventrolateral medulla (Herbert and Saper, 1992). 
The dense noradrenergic fiber plexus in the ventral part 
of the ventrolateral PAG originates in the noradrenergic 
A2 neurons in the nucleus tractus solitarius, whereas the 
dorsal part of the ventrolateral PAG, bordering on the 
dorsolateral PAG, is more heavily innervated by the 
noradrenergic At neurons in the ventrolateral medulla. 
The origin of the dopannine projection to the PAG is at 
present unknown. 
The involvement of the PAG in defensive reactions, 
analgesia and autonomic regulation, has been 
extensively reviewed (Carrive, 1993; Bandler and 
Shipley, 1994; Behbeharti, 1995). Based on connections 
and anatomical representation of reactions evoked by 
electrical stimulation widtin the PAG in freely moving 
animals, it was suggested that the different functions of 
the P AG are integrated by longitudinal columns of 
neurons located dorsomedial, dorsolateral, lateral, and 
ventrolateral of the aqueduct. Attention has focused on 
the lateral and ventrolateral columns, activation of 
which results in different forms of defensive or 
protective reactions. Reactions evoked from the lateral 
P AG column are associated with somatomotor and 
autonomic activation, leading to active fight and flight 
reactions, and are related to superficial or cutaneous 
noxious stimuli. In contrast, reactions evoked from the 
ventrolateral PAG are associated with somatomotor and 
autonomic inhibition, leading to a quiescent reaction, 
and are related to deep and visceral noxious stimuli 
(Carrive, 1993). In the caudal ventrolateral PAG, 
stimulation produces inunobility (Bandler et al., 1991). 
Interestingly, the ventrolateral PAG receives the densest 
dopantinergic and (nor)adrenergic innervation widtin 
the PAG, suggesting that these catecholannines are 
especially involved in PAG functions related to a 
Dopamine and DBH in brain stem 
Figure 10: Photomicrograph with darkfield illumination of sections with the superior colliculus after processing for 
dopamine (A) or DBH (B) immunocytochemistry. Note the different distribution of the dopamine and DBH 
immunoreactive terminals over the different layers of the superior colliculus. See fig. 1 for the underlying 
cytoarchitecture. For details see text. Scale bar = 200 ~m. 
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Figure 11: Photomicrograph with darkfield 
illumination of motor trigeminal nucleus after 
processing for dopamine immunocytochemistry. 
Note the very fine labeling in the motor nucleus 
but not in the surrounding area. Scale bar = 200 
~m. 
quiescent reaction to deep visceral and muscular pain 
stimuli. The dorsal PAG is a major site for processing 
of fear and anxiety. In both cats and rats, stimulation of 
rostral dorsolateral PAG produced threat display 
associated with vocalization and strong flight responses 
(Behbehani, 1995). The predominant dopaminergic 
innervation of the dorsal PAG would suggest the 
involvement of dopamine in these functions. However, 
application of agonists or antagonists of dopaminergic, 
as well as adrenergic and serotonergic receptors had no 
effect on vocalization (Lu ef al., 1993). 
The results of the present study show that 
dopamine, as well as (nor)adrenaline may playa role in 
some of the behaviors evoked from the PAG. 
Comparison of the distributions of dopaminergic fibers 
and terminals with the (nor)adrenergic ones, indicates 
that the dorsal PAG is predominantly innervated hy 
dopamine fibers, whereas (nor)adrenergic fibers are less 
abundant in the dorsal part of the PAG. The role of 
serotonin in PAG function is complex, mainly because 
PAG contains several subtypes of serotonin receptors 
and activation of different types of receptors have 
different, sometimes opposite, effects (Behbehani, 
1995). 
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Inferior Collieulus 
In the inferior colliculus, the dopamine labeling showed 
a characteristic pattern in areas, which did not follow 
the cytoarchitectonical boundaries described previously 
(Faye-Lund and Gsen, 1985; Klepper and Herbert, 
1985), although it should be noted that these boundaries 
are difficult to identify in our material, which was not 
counterstained. The DBH labeling that we found was 
very similar to the DBH labeling described previously 
(Klepper and Herbert, 1991) and showed a much more 
homogeneous distribution than the dopamine labeling. 
The serotonergic input also showed a specific pattern 
(Klepper and Herbert, 1991) and is especially strong in 
the outer layers of the inferior colliculus. Although the 
distribution of dopamine in the inferior colliculus has 
not been described previously, the existence of a 
dopamine projection was suggested by the finding 
(Olazabel and Moore, 1989) that cells in the lateral part 
of the substantia nigra, that were retrogradely labeled 
from the inferior colliculus, showed a similar 
morphology as tyrosine hydroxylase immunoreactive 
cells observed in a separate experiment in the same 
area. The presence of Dz-receptors in the periphery of 
the inferior colliculus further suggests a role for 
dopamine. Studies on the effects of dopamine in the 
inferior colliculus have not been perfonned. 
Superior Collieulus 
The dopamine innervation of the superior colliculus 
showed a characteristic labeling pattern over the various 
layers, which is different from the DBH innervation. 
Strongest dopamine labeling is found in layer III and 
the immediate adjacent parts of layers II and IV and in 
layers VI and VII, while DBH labeling is present in all 
laminae, with an overall decreasing intensity when 
passing from layer I towards layer VII. The present 
study is the first to describe the localization of 
dopamine in the superior colliculus, but the DBH 
innervation has been described previously (Mooney et 
aI., 1990), in general agreement with our results. The 
serotonergic innervation is also present in all layers of 
the superior colliculus, showing the highest density in 
layers II and IV (Veda et aI., 1985). Thus, dopamine, 
serotonin and (nor)adrenaline are all present in the 
superior colliculus. As in other parts of the brain, the 
numbers of serotonin as well as DBH immunoreactive 
fibers appear larger than the number of dopaminergic 
fibers, but the relative density of the monoamines over 
the various layers is very different. 
With respect to the effects of dopamine in the 
superior colliculus no general data are available, but the 
presence of dopamine Dz-receptors in layers II and III 
suggests that dopamine does playa role in infonnation 
processing in the superior colliculus. The effects of 
noradrenaline have been investigated: iontophoretic 
application of noradrenaline generally showed an 
inhibitory effect, reducing both spontaneous and 
stimulus evoked activity (Mooney ef al., 1990; Sato and 
Kayama, 1983). In addition it was found (Wichmann 
and Starke, 1988) in a slice preparation that the release 
of noradrenaline was inhibited by dopamine through 
presynaptic Drreceptors, further under1ining the 
complicated interplay that occurs between the different 
monoamines throughout the brainstem. 
Noradrenergic and serotonergic cell groups in the 
brain stem. Dopaminergic fibers and terminals were 
observed around cell bodies in many monoaminergic 
cell groups, including the serotonergic raphe nuclei 
(raphe pallidus, raphe obscurus, raphe magnus, raphe 
centralis and raphe dorsalis) and the noradrenergic 
locus coeruleus, a finding which confirmed previous 
reports (Geffard et aI., 1984; McRae-Deguerce et al., 
1988; Maqbool et aI., 1993; Maeda et al., 1994). These 
monoaminergic cell groups have also been reported to 
contain Dz-receptors, as indicated by the presence of D2 
binding (Bouthenet et aI., 1987; Yokoyama et al., 1994) 
and D2 mRNA (Bouthenet et al .• 1991). Dopaminergic 
afferents to the LC originate predominantly from the 
AI3 cell group and partly from the rostral portion of the 
All group (Maeda et al., 1994). The ventral tegmental 
area also projects to the locus coeruleus, but this 
projection is largely non-dopaminergic (Sawchenko and 
Swanson, 1982). 
The existence of a dopaminergic innervation of 
monoaminergic cell groups located in the brain stem 
suggest that dopamine interacts with other 
monoaminergic cell groups, not only at the level of the 
terminal fields in the target areas, but also by directly 
affecting the activity of the parent cell bodies of the 
monoaminergic fibers. This strengthens the idea of a 
strong interaction between the different monoaminergic 
cell groups. 
Functional considerations 
The anatomical distribution of dopamine in the 
brainstem shows that the functions of dopamine are not 
limited to one system. In fact, dopamine is involved in 
sensory processing, which includes nociceptive and 
non-nociceptive sensory input, like proprioception 
(Me5 and the dorsal column nuclei), as well as in the 
processing of visceral afferent infonnation (NTS and 
parabrachial), while dopantine is also involved in 
processing motor output, both somatic (hypoglossal) 
and branchiomotor (facial and trigeminal) as well as 
parasympathetic (DMNV) and, indirectly, sympathetic 
(e.g. RVL). In addition dopantine is present in a more 
integrative system like the PAG and in various 
monoaminergic cell groups (LC, raphe nuclei). In the 
spinal cord, a similar distribution, comprising motor, 
sensory and autonomic areas, is seen (Holstege et al., 
1996). It has been suggested that in the spinal cord, the 
dopantinergic system is specifically activated in fight 
and flight situations with inhibition of pain transmission 
and facilitation of motor neuron activity. In the 
brainstem, a similar situation may be applicable, in 
which blood pressure, heart rate and respiration are 
increased, while the activity in other, non-vital systems 
is diminished. At the same time it should be realized 
that there is a considerable degree of overlap in the 
distributions of the monoamines within the brain stem, 
suggesting that they are all involved in modulating the 
same brain stem functions. This notion strengthens the 
idea that the integrative effects of the monoamines 
together may determine the final effect at the level of a 
particular innervation area. The presence of a 
dopaminergic innervation in the noradrenergic and 
Dopamine and DBH in brain stem 
serotonergic cell groups further emphasizes the intricate 
relationship between the different monoamines. 
Motor nuclei of the cranial nerves 
The present study revealed the presence of dopantine 
immunoreactive processes in the motor nuclei of cranial 
nerves Ill, V, VII, and XII, whereas motor nuclei of the 
cranial nerve IV, VI and the ambiguus nucleus were 
only sparsely labeled. The presence of a dopantinergic 
innervation is in accordance with the reported Dr 
receptor ligand binding in motoneuronal cell groups of 
the brain stem and spinal cord (Bouthenet et aI., 1987; 
Yokoyama et al., 1994). In spinal cord, the presence of 
dopamine in the motoneuronal cell groups was 
discovered much later than in other parts of the spinal 
cord (Yoshida and Tanaka, 1988; Shirouzu et al., 1990; 
Ridet et al., 1992). Under less optimal conditions 
dopantine labeling in the motoneuronal cell groups in 
the spinal cord is the first to disappear (Holstege et aI., 
1996), which is in line with its lower dopantine content 
as compared to other areas of the spinal cord. 
Therefore, more sensitive detection methods are 
required to visualize dopaminergic fibers and terminals 
in the motoneuronal cell groups as compared to other 
parts of the brain stem and spinal cord. 
Probably the most prominent feature of the 
dopaminergic, as well as noradrenergic, fibers located 
in motoneuronal cell groups was their fine granular 
aspect, which is probably caused by a large number of 
fibers with small varicosities and thin, or lightly stained, 
intervaricose segments. This dot-like innervation 
pattern of both catecholarnines is also observed in the 
motoneuronal cell groups of the spinal cord (Grzanna et 
aI., 1987; Fritschy and Grzanna, 1989; Holstege et aI., 
1996). Thus, it appears that, throughout the neuraxis, 
there is a consistent dopaminergic and noradrenergic 
innervation of motor nuclei by fibers with a similar 
morphology in immunocytochemical preparations. 
Interestingly, Fritschy and Grzanna (1989) reported 
that predominantly noradrenaline axons of the dot-like 
type were spared after DSP-4 treatment, which was 
confirmed by our DSP-4 experiments. Indeed, the drug 
spared noradrenergic fibers in the motoneuronal cell 
groups. These noradrenergic fibers and terminals in the 
motoneuronal cell groups, including those of the spinal 
cord, appeared to have their parent cell bodies in the 
lateral and/or dorsal tegmental noradrenergic cell 
groups. In contrast, fibers in autonomic and 
somatosensory areas were reported to originate 
predominantly from the locus coeruleus proper 
(Grzanna et aI., 1987). This ntight suggest that there is a 
link between the morphology of the fibers and the 
origin of their parent cell bodies. However, in nuclei 
only partly depleted by the neurotoxin, such as the 
principal trigeminal sensory nucleus or the pontine 
nuclei, the remaining noradrenaline fibers were not 
different morphologically from fibers that were affected 
by the drug. Moreover, in the case of dopaminergic 
fibers and tenninals in the spinal cord, the 
morphological differences can not be explained this 
way, since both areas receive their dopaminergic 
innervation solely from the diencephalic All cell 
group, which contains relatively few cells and give rise 
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to highly collateralized projections. Therefore, the fine 
granular aspect of the labeling appears to be dictated by 
the target area, i.e. motoneuronal cell groups, rather 
than the location of the parent cell bodies. A further 
explanation for these morphological differences 
remains to be determined. 
Based on retrograde transport of fluorescent tracers 
combined with the comparison of biosynthetic marker 
enzymes, the catecholaminergic innervations of the 
brain stem nuclei like the (motor) hypoglossal (AIdes et 
al., 1988) and (sensory) cochlear (Klepper and Herbert, 
1991) nuclei are considered to be largely noradrenergic. 
Indeed, there is a noradrenergic projection from locus 
coeruleus to the cochlear nuclei (Kromer and Moore, 
1980; Grzanna and Fritschy, 1991; Klepper and 
Herbert, 1991) and motor nuclei, like the trigeminal and 
facial motor nuclei, also receive a noradrenergic 
innervation (Grzanna et aI., 1987). The results of the 
present study, using a direct method for detection of 
dopamine, indicate that besides noradrenaline dopamine 
is also present in these nuclei, albeit less prominent. A 
serotonergic innervation also has been reported for the 
brain stem motor nuclei (Steinbusch, 1981; Lu et al., 
1993). 
The presence of dopamine fibers in the hypoglossal 
nucleus is in agreement with findings in the cat 
(Maqbool et aI., 1993). Although colocalization of 
dopamine immunoreactive with noradrenaline 
immunoreactive has been reported within fibers 
innervating the hypoglossal nucleus (Alonso et al., 
1995), the presence of D,-receptors (Yokoyama et al., 
1994) implicate the presence of a dopaminergic 
innervation. Widrin the hypoglossal nucleus, dopamine 
immunoreactive is greatest among protrusor 
motoneurons in the caudoventromedial quadrant of this 
nucleus, which also holds true for the noradrenergic 
innervation (AIdes et al., 1988; AIdes et al., 1990). The 
hypoglossal nucleus also receives a serotonergic 
innervation (Lu et aI., 1993). However, the functional 
role of the preferential innervation of this part of 
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hypoglossal nucleus is at present still unknown. 
Thus, motoneuronal cell groups in the brain stem 
are innervated by dopaminergic fibers and tenninals, as 
well as by noradrenergic and serotonergic ones. The 
morphological differences observed in different brain 
stem and spinal cord areas may suggest that different 
subsets of the monoaminergic systems innervate 
sensory, autonomic and motor areas of the brain stem 
and spinal cord. 
Conclusion 
The present immunocytochemical study shows the 
existence of an extensive dopaminergic innervation of 
the brain stem, which constitutes a distinct 
neurotransmitter system separate from the other 
monoamines. Although prominent, the distribution of 
dopamine in the rat brain stem is not as extensive as that 
of (nor)adrenaline. The observed distribution of 
dopaminergic fibers and presumptive terminals in the 
brain stem demonstrates that dopamine is involved in 
modulating a large variety of brain stem functions. In 
many instances dopamine may exert its effects in 
complex interaction with other monoamines, which is 
indicated by their similar distribution and involvement 
within similar functional systems. Obviously, the effect 
of dopamine, and the other monoamines, depend on the 
receptors involved. Knowledge of their distribution in 
the brain stem is still incomplete. 
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Distribution Of Dopamine D2 Receptor In The Rat Brain Stem 
Using Anti-Peptide Antibodies 
Abstract 
In the present study the distribution of dopamine D2 receptors in the rat brain stem was determined 
immunocytochemically using a purified polyclonal antiserum directed against the putative 3'd 
intracellular loop of the dopamine Q, receptor. Immunoreactivity, indicating the presence of D2-receptor 
protein, was observed exclusively in neuronal cell bodies and their proximal dendrites. Neurons 
containing D2-receptor protein showed a highly specific distribution throughout the brain stem. 
Strongest labeling was present in the dorsal motor nucleus of the vagus, the lateral and medial 
parabrachial nuclei, the substantia nigra pars compacta, the medial geniculate nucleus, and most 
monoaminergic cell groups including the raphe nuclei, the locus coeruleus and several other 
(nor)adrenergic cell groups. Areas that showed substantial labeling were the gigantocellular nucleus 
pars alpha, the nucleus of the solitary tract, the basal pontine nuclei, the periaqueductal gray, the 
inferior and superior colliculi and the ventral tegmental area. Furthermore, several brain stem nuclei 
contained weakly labeled neurons, including the medullary, pontine and mesencephalic reticular 
formation. D2-receptor protein was not observed in many other brain stem areas, like the external 
cuneate nucleus, the inferior and superior olivary nuclei, the vestibular and cochlear nuclei, substantia 
nigra pars reticulata, the red nucleus and all motor nuclei of the cranial nerves. 
The present anatomical data largely confirm and extend previous findings obtained with 
immunocytochemistry, ligand binding or in situ hybridization, with only a few discrepancies. It is 
concluded that the dopamine D2-receptor plays a major role in the dopaminergic modulation of many 
brain stem functions. The high expression of D2-receptors in most of the brain stem monoaminergic 
cell groups indicates that dopamine interacts with other monoamines not only in their mutual target 
areas, but also by modulating the activity of the brain stem monoaminergic neurons directly at the level 
of their somata and dendrites. 
Introduction 
Dopamine is one of the catecholaminergic 
neurotransmitters in the brain and is present throughout 
the central nervous system (CNS). Dahlstrom and Fuxe 
(1964) were the first to provide a detailed description of 
dopamine neurons and pathways in the brain, by 
visualizing them with the Falck-Hillarp formaldehyde 
histofluorescence technique. Since then, the anatomical 
organization of the major dopamine systems in the eNS 
has been unraveled in considerable detail (reviewed in 
Bjorklund and Lindvall, 1984; Hokfe1t et al., 1984), 
especially by using dopantiae-specific antibodies for 
visualizing dopaminergic neurons, fibers as well as 
terminals (Geffard et al., 1984; Smiley et aI., 1992; 
Maqbool et al., 1993; Moons et al., 1994). Using this 
technique, we recently provided a detailed description 
of the distribution of dopaminergic fibers and terminals 
in the brain stem (van Dijken and Holstege, this thesis) 
and spinal cord (Holstege et al., 1996) of several 
species. 
The actions of dopantiae in the CNS are mediated 
by specific, high-affinity, G protein-coupled dopamine 
receptors (for review see Civelli et aI., 1991; Sibley and 
Monsma, 1992; Gingrich and Caron, 1993; O'Dowd, 
1993). Five subtypes of dopantiae receptors have now 
been identified and termed D,-D,. Based on their 
pharmacology and sequence homology, D, and D,-
receptors are classified as Drlike receptors while the 
D 2• D3, and D4-receptors are classified as D2-like 
receptors. In this classification scheme, Drlike 
receptors are responsible for the stimulation of 
adenylate cyclase, whereas D2-like receptors mediate 
the inhibition of adenylate cyclase, or have no effect on 
it. The dopamine Dz-receptor has been found to exist in 
two isofonns (Dzshort and D21ong). related by alternative 
splicing of a common gene (Strange, 1991; Sibley and 
Monsma, 1992). As a result, a splice insert of 29 amino 
acids in the putative 3rd intracellular loop of the Dr 
receptor is present in the long isofonn, but is lacking in 
the short isofonn. 
In comparison with the other dopamine receptor 
subtypes, the distribution of dopamine Dz-receptors in 
the CNS has been studied most extensively, using 
receptor ligand binding (Boyson et al., 1986; Dubois et 
aI., 1986; Bouthenet et al., 1987; Yokoyama et aI., 
1994), in situ hybridization (Meador-Woodruff et aI., 
1989; Bouthenet et al., 1991) and, more recently, 
immunocytochemistry (Brock et al., 1992; Ariano et 
al., 1993; Levey et al., 1993; van Dijken et al., 1996). 
The distribution of doparaine D,-receptors in the CNS 
has also been studied using receptor ligand binding 
(Boyson et aI., 1986; Dubois et al., 1986; Fremeau et 
al., 1991; Mansour et aI., 1992), in situ hybridization 
(Fremeau et aI., 1991; Mansour et al., 1992), and 
immunocytochemistry (Levey et al., 1993; Ariano and 
Sibley, 1994). Some of these studies have also included 
the distribution of dopamine D3-receptors in the CNS 
detected with in situ hybridization (Bouthenet et aI., 
1991) or immunocytochemistry (Ariano and Sibley, 
1994). 
The use of antibodies to visualize dopamine 
receptor protein has a number of distinct advantages 
over other methods, like ligand binding and in situ 
hybridization. First, the anatomical resolution of 
conventional autoradiographic ligand binding studies 
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Figure 1: Schematic representation showing the distribution of neurons immunoreactive for dopamine D2 receptor 
protein in the rat brain stem, including the medulla oblongata, the pons, and the mesencephalon caudal to the 
substantia nigra. For details see text; for abbreviations see enclosed list of abbreviations and table 1. 
for localization of dopamine receptors is rather limited. 
Second, such methods lack the precision necessary to 
distinguish between receptor subtypes, mostly because 
of differences in the affinity and specificity of the 
ligands used (Boyson ef al., 1986; Dubois ef aI., 1986; 
Bouthenet ef al., 1987; Meador-Woodruff ef al., 1991). 
As a result, the reported distributions of Drreceptor 
ligand binding in the CNS were often inconsistent. On 
the other hand, recent in situ hybridization studies 
detected dopamine D,-receptor mRNA with 
considerable reliability and reproducibility (Meador-
Woodruff ef al., 1989; Savasta ef al., 1989; Bouthenet 
ef al., 1991; Meador-Woodruff ef al., 1991; Weiner ef 
al., 1991; van Dijken ef al., 1996), but provided little 
information about the distribution of the encoded 
receptor proteins. Moreover, the distribution and levels 
of protein may not match that of their mRNA's 
(Mansour ef aI., 1990; Mansour ef al., 1992). Therefore, 
immunocytochemical methods may provide a better 
tool for the direct identification and localization of 
dopamine receptors in the brain. After discovery of the 
sequence of the D,-receptor (Bunzow ef al., 1988) it 
became possible to prepare specific antibodies against 
the Drreceptor, using fusion proteins or synthetic 
peptides corresponding to a specific part of the 0,-
receptor (McVittie ef al., 1991; Plug ef al., 1992; 
Ariano ef al., 1993; Boundy ef al., 1993b; Boundy ef 
al., 1993a; Chazot ef al., 1993; Sesack ef al., 1994; 
Smiley ef aI., 1994). In a similar manner antibodies 
against other dopamine receptors, including the D}-, Dr 
and D,-receptors were prepared (Ariano and Sibley, 
1994; Smiley ef aI., 1994; Defagot ef al., 1997). 
The distribution of D2-receptors in the brain stem 
was examined in only a few studies, using receptor 
ligand binding (Bouthenet ef aI., 1987; Yokoyama ef 
aI., 1994; Lawrence ef aI., 1995) andlor in situ 
hybridization (Bouthenet ef al., 1991). These studies 
showed several brain stem areas that expressed D2-
receptors. In contrast, a previous immunocytochemical 
study (Levey ef aI., 1993), using specific antibodies 
directed against dopamine Drreceptor protein, 
disclosed only few regions in the brain stem with O2-
receptors, suggesting rather low levels of dopamine Dr 
receptor protein in the hind brain as compared to 
forebrain. Similarly, in our previous study on the D 2-
receptor in rat spinal cord it was noticed that the levels 
of Drreceptors in spinal cord were low, both at the 
protein and mRNA level (van Dijken ef al., 1996). 
Owing to these low expression levels in hindbrain and 
spinal cord the total number of cells expressing 
dopamine Drreceptors might be underestimated when 
using immunocytochemistry. This shortcoming may be 
(partly) overcome by refinement of the methods used to 
detect these low receptor protein levels. The recent 
introduction of powerful signal amplification methods 
based on deposition of biotinylated tyramine on the 
tissue through the enzymatic action of horseradish 
peroxidase (Adams, 1992), enabled investigators to 
substantially increase the sensitivity of their staining 
procedures. In the present study we have used this 
signal amplification method in order to obtain a !tigher 
yield of dopamine D,-receptor staining in the rat brain 
Drreceptor in brain stem 
stem. 
Materials and methods 
Immunocytochemistry 
Adult, male Wistar rats were deeply anaesthetized with 
sodium pentobarbital and perfused transcardially with 
50 mi saline, followed by 500-750 ml of 4% (wtlvo1) 
freshly prepared paraformaldehyde in 0.1 M phosphate 
buffer (pH 7.4). After perfusion, brain stems were 
removed immediately and stored overnight at 4 °C in 
phosphate buffer containing 25-30% (wtlvo1) sucrose. 
Frozen sections (40 ~m) were cut and collected in 0.1 
M Tris buffered saline (PH 8.6). All subsequent 
procedures were performed on free-floating sections at 
room temperature, except where specified otherwise. 
Between steps, sections were thoroughly rinsed with 
Tris buffered saline. Sections were first incubated with 
a solution of 5% (vol/vol) normal goat serum (Gibco) in 
Tris buffered saline containing 0.3% (vol/vol) Triton X-
100 for 90 minutes to reduce background staining. 
Next, sections were incubated for 24-48 hours at 4 °C 
with purified polyclonal D,-receptor anti-peptide 
antibody from rabbit (Plug ef aI., 1992; van Dijken ef 
al., 1996) diluted 1:1000-1:4000 in a solution of 1 % 
(vol/vol) normal goat serum (Gibco) in Tris buffered 
saline containing 0.1 % (vol/vol) Triton X-lOO. Then the 
sections were incubated for 120 minutes in biotinylated 
goat-anti-rabbit (Vector) diluted 1:200, followed by the 
ABC procedure (ABC Elite kit, Vector). After 
completion of the ABC procedure a tyramide signal 
amplification step (TSA-Indirect, NEN Dupont) was 
perfonned: sections were placed in biotinylated 
tyramide (1:200) for 10 minutes, thoroughly rinsed with 
Tris buffered saline, and incubated in streptavidin 
labeled conjugate (SA-HRP, 1:400) for 30 minutes at 
room temperature. In all sections, the horseradish 
peroxidase complex was visualized with 0.05% (wtlvol) 
3,3'-diaminobenzidine (Sigma) in 0.05 M Tris-HeI 
solution (PH 7.6) in the presence of 0.01 % (vol/vol) 
hydrogen peroxide, which yields a brown precipitate. 
After completion of the immunocytochemical 
procedure, sections were mounted onto glass slides with 
gelatin-chrome alum adhesive and allowed to dry at 
room temperature. Next, sections were dehydrated in 
graded ethanol baths, transferred to xylene, and cover 
slipped with Permount. In a few cases, slides were 
counter stained with cresyl violet. Sections were 
examined light microscopically with bright-field 
illumination. 
Immunocytochemical controls 
The controls that were used for the immunocyto-
chemical procedure included (i) substitution of the anti-
peptide antiserum with pre~immune serum in the same 
concentration, (ii) omission of the primary antiserum, 
(ill) adding an excess of antigen (1 mglml) to the 
antiserum prior to incubation, and (iv) omission of the 
tyramide amplification step. Omission of the primary 
antibody or substitution of pre-immune serum for the 
anti-peptide antibody resulted in clean sections without 
staining. Preadsorption of the antiserum with an excess 
of its peptide antigen prior to incubation prevented 
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Figure 2: Light micrographs of dopamine D, receptor immunoreactivity in the rat brain stem. A. A large number of 
strongly labeled cells are present in the dorsal motor nucleus of the vagus with (at this level) only a few cells in the 
nucleus of the solitary tract. Scale bar = 1 00 ~m. B. Labeled cells are present in the nucleus raphe magnus and 
pallidus. Laterally labeled cells are present in the lateral paragigantocellular nucleus. Scale bar = 200 ~m. c. 
Strongly labeled cells are present in the dorsal raphe nucleus and adjacent parts of the ventrolateral central gray. 
Scale bar = 200 ~m. 
neuronal staining, except for some white matter glia, 
which is, therefore, considered as background staining. 
Omission of the signal amplification step resulted in a 
staining pattern which was nearly identical in regional 
distribution and cellular localization when compared to 
the staining after signal amplification, except that fewer 
cells were stained and most of them were weakly 
stained. We therefore concluded that the amplified 
immunocytochemical labeling of neuronal elements 
obtained in the present study represented D2-receptor 
protein. 
Results 
General Observations 
In the present study the anatomical localization of 
dopamine D2-receptors in the rat brain stem was 
investigated by means of signal amplified 
immunocytochemistry. Dz-receptor labeling was 
associated primarily with neuronal cell bodies and their 
proximal dendrites. Occasionally dendritic processes 
could be followed for some distance within a section. 
The pattern of the immunocytochemical labeling was 
not suggestive for the presence of D2-receptor in axons 
or terminals, although ultrastructural studies are needed 
to confirm this. 
In several brain stem nuclei numerous strongly 
labeled cells were observed, but in most cases neuronal 
labeling was weak to moderate. Signal amplification 
resulted in darker staining of labeled neurons and 
disclosed additional neurons that stained weakly. In 
order to categorize the brain stem (sub )nuclei that 
showed neurons that were immunoreactive for the Dz-
receptor, five relative densities were distinguished: level 
0, labeling absent or uncertain; level 1, some 
moderately to weakly labeled neurons; level 2, many 
moderately to weakly labeled neurons; level 3, some 
strongly labeled and many moderately to weakly 
labeled neurons and level 4, many strongly labeled 
neurons. The results are schematically represented in 
fig. 1. 
MeduDa Oblongata 
In the medial medulla oblongata, the most prominent 
labeling was observed in the dorsal motor nucleus of 
the vagus, where numerous strongly labeled neurons 
were observed (fig. 2a). The nucleus of the solitary 
tract, especially its caudal part, contained several 
strongly labeled cells (level 3), located mainly 
dorsomedially. At the "head" of the nucleus of the 
solitary tract strongly labeled cells were present in the 
presumed catecholaminergic C2 cell group (level 4). In 
the area postrema some moderately to weakly labeled 
cells were observed (level 2). Labeled cells were also 
observed in the periventricular gray (level 3, not shown 
in fig. I). The hypoglossal nucleus was devoid of 
labeled cells, whereas some moderate to weald y labeled 
cells were present within the rostrally situated nucleus 
prepositus hypoglossus (level I). Medially within the 
medulla oblongata, many moderately to weakly labeled 
cells were lining the 4th ventricle (level 3, not shown in 
fig. I). 
In the inferior olivary nucleus no labeled cells were 
Dz-receptor in brain stem 
observed. The vestibular complex was also devoid of 
D2-labeled neurons, except for a few labeled neurons in 
the medial vestibular nucleus (level 1). The dorsal 
column nuclei (gracile, cuneate and external cuneate) 
were devoid of Dz-receptor labeling. Within the caudal 
part of the spinal trigeminal nucleus, a few prominently 
labeled cells (level 1-2) were observed, especially in the 
ventral part. Labeled cells in more rostral parts of the 
trigeminal nucleus were rare. 
In the reticular formation, most of the strongly 
labeled cells were located ventrally. In the midline the 
serotonergic nuclei raphe obscurus, pallidus and 
magnus and the adjacent gigantocellular nucleus pars 
alpha (fig. 2b), contained many strongly labeled 
neurons (level 3-4). More laterally there were strongly 
labeled neurons in the lateral paragigantocellular 
nucleus and the adjacent ventral gigantocellular nucleus 
(level 4). In addition, the area of the (retro)ambiguus, 
contained many labeled neurons, which were observed 
close to, but not within, the nucleus ambiguus (level 4). 
The majority of these cells presumably belonged to the 
catecholarninergic Al and CI groups. The lateral 
reticular nucleus, which is also present in this area 
appeared devoid of D2 labeling. Throughout the 
reticular fonnation labeled cells were seen, which 
occasionally formed small clusters (level 2), which 
were too small to be associated with a particular 
nucleus. In fig. 1 the reticular area containing these 
scattered labeled neurons is indicated as level 1. 
Pons and mesencephalon 
In this area, strongest labeling (level 3 - 4) was found in 
the serotonergic and noradrenergic cell groups. The 
serotonergic cell groups included the raphe nuclei (the 
raphe pontis, the median and paramedian raphe nuclei, 
and the dorsal raphe nucleus (fig. 2c) as well as the 
serotonergic cell group B9, as defined by Dahlstrom 
and Fuxe (1964). The labeled noradrenergic cell groups 
included the locus coeruleus and subcoeruleus (fig. 4), 
the AS (fig. 3) and A7 cell groups, which all contained 
numerous strongly labeled cells (level 4). 
In the pons, strongly labeled neurons were also 
present in the medial part of the medial parabrachial 
nucleus (level 4), whereas many weakly labeled 
neurons were observed within the rest of the medial 
parabrachial nucleus (level 2). The lateral parabrachial 
nucleus almost completely stained level 3. The oral part 
of the pontine reticular nucleus showed few labeled 
neurons (level I). No labeled cells were observed in the 
area of the Kolliker-Fuse nucleus. The basal pons and 
the cerebellar nuclei were devoid of D2 labeling. 
In the mesencephalon, at levels caudal from the 
substantia nigra, strongest labeling was found in 
neurons located in specific regions of the 
periaqueductal gray, most prominently in its posterior 
(level 3) and dorsal (level 2) parts. Other areas of the 
mesencephalon containing labeled neurons included the 
inferior and superior colliculus and the nucleus of the 
brachium of the inferior colliculus. The superficial gray 
layer and the presumed optic nerve layer of the superior 
colliculus displayed level 1-2 stairting, whereas the 
lateral parts of the superior colliculus were somewhat 
stronger labeled. Strongly labeled neurons were present 
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in the ventral tegmental area (level 3) and substantia 
nigra pars compacta (level 4; fig. 5), while no labeliug 
was present within the substantia nigra pars reticulata. 
Strong labeling was also observed in the marginal zone 
of the medial geniculate nucleus (level 4; fig. 5). No 
labeled neurons were observed in the red nucleus. 
Discussion 
In the present study, the distribution of dopamine D,-
receptors has been examined in the rat brain stem using 
a purified polyclonal antiserum generated against the 
putative 3rd intracellular loop of the native receptor 
protein. 
Methodological considerations 
The observation that Drreceptor immunoreactivity was 
located mainly within the somata and proximal 
dendrites of labeled neurons is in agreement with 
previous immunocytochemical studies (Brock et al., 
1992; Ariano et aI., 1993). At the electron 
microscopical level Drreceptor immunoreactivity in 
neostriatal neurons was reported to be uniformly 
present throughout the cytoplasm (Fisher et ai., 1994; 
Hersch et aI., 1995) and did not appear to be associated 
with a particular cellular organelle. Only a small part of 
the labeling was associated with postsynaptic densities 
suggesting that the antibody preferentially recognized 
Dz-receptor protein before its incorporation as a 
functional receptor into the neuronal membrane or that 
the amount of cytoplasmic Drreceptor protein is much 
higher than the amount of membrane incorporated 
protein. If this also holds true for the antibody used in 
the present study, it would explain the diffuse staining 
of cell somata and proximal dendrites. 
It was noticed that, compared to the forebrain, the 
brain stem contained relatively few cells that were 
immunoreactive for the Dz-receptor and that most of 
them were not strongly labeled, suggesting that the 
level of Dz-receptors in the brain stem is low. Owing to 
these low expression levels the total number of cells 
expressing Dz-receptors may have been underestimated. 
Anatomical distribution 
The results of the present study showed that the 
dopamine Dz-receptor is expressed in several areas of 
the rat brain stem. Previous immunocytochemical 
studies on Dz-receptors in brain, did either not include 
the brain stem, or it was concluded that most hindbrain 
regions displayed no or little D2-imrnunoreactivity 
(Levey et ai., 1993). The distribution of D,-receptors in 
the brain stem was given attention only in one study 
(Brock et ai., 1992), which did not include the lower 
brain stem. This study described moderate densities of 
Dz-receptor protein in several areas of the upper brain 
stem, including the substantia nigra pars compacta, 
central gray area, medial geniculate nucleus, superior 
coHiculus (superficial layers), inferior coHiculus and 
periaqueductal gray area. Other studies on the regional 
distribution of Dz-receptors in brain, which have 
included the brain stem, mostly used receptor ligand 
binding (Bouthenet et aI., 1987; Yokoyama et aI., 1994; 
Qian et ai., 1997) or in situ hybridization (Bouthenet et 
ai.,1991). 
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Figure 3: Light micrograph showing cells in the 
AS noradrenergic cell group that are strongly 
immunoreactive for the dopamine D2 receptor. 
Scale bar= 100 ~m. 
In table I the available data on the distribution of 
dopamine Dz-receptor protein and its mRNA as well as 
ligand binding data are compared with the results of the 
present study. In most areas of the brain stem there is a 
high degree of overlap between the distribution of D,-
receptors obtained with immunocytochemistry and the 
distributions obtuined with ligand binding and in situ 
hybridization. Brain stem areas containing Dz-receptor 
protein, Dz-receptor mRNA as well as functional 
binding sites are the dorsal motor nucleus of the vagus, 
the gigantoceUular nucleus pars alpha, the nucleus of 
the solitary tract, the locus coeruleus, the lateral and 
medial parabrachial nuclei, the basal pontine nuclei, the 
periaqueductal gray, the deep mesencephalic nucleus, 
the inferior and superior colliculi, the substantia nigra 
pars compacta, and the ventral tegmental area. Since the 
presence of Drreceptors in the aforementioned brain 
stem nuclei was suggested by several different detection 
techniques, it is highly probable that D,-receptors are 
actually present in these areas and play an important 
functional role. 
In some areas there were obvious discrepancies 
between the distribution of dopamine D2-receptor 
protein, obtained with immunocytochemistry and the 
distribution obtained with ligand binding or in situ 
hybridization. In these cases it must be kept in mind that 
the binding pattern may differ from the ceUular 
distribution obtained with immunocytochemistry, 
because the functional Dz-receptors, i.e. the binding 
sites, may be located on dendrites or the terminal axons 
of neurons which have their cell somata elsewhere in 
the brain stem. On the other hand, the ligands may also 
bind to other Dz-like receptors, due to a lack of 
pharmacological selectivity that is inberent to the 
Figure 4: Light micrograph showing neurons 
strongly immunoreactive for the dopamine D2 
receptor. Many densely packed neurons are 
present in the locus coeru!eus, close to the 
aqueduct (IV). More ventrally, labeled neurons are 
present in the nucleus subcoeruleus. Arrows point 
at neurons of the trigeminal mesencephalic tract 
that are unlabeled. Scale bar = 1 00 ~m. 
receptor ligand binding technique. Comparison of our 
immunocytochemical results with the available data on 
D,-receptor ligand binding reveals that the distribution 
of D,-protein mostly resembles that of the highly 
selective D,-antagonist ligand YM-091S1-2 
(Yokoyama et al., 1994; see also table I), extending the 
results of earlier studies on the distribution of Dz-
receptor in the rat brain stem (table I). The additional 
areas in which D,-receptor protein and YM-09IS1-2 
binding was observed include the reticular fonnation, 
the raphe magnus, the raphe pallidus, the dorsal and the 
median raphe nuclei. In other areas, like the cuneate and 
the inferior olivary nuclei, D2-receptor protein is absent 
and YM-09IS1-2 binding is either weak or not 
described. In the latter areas these results are in contrast 
with the results of other ligand binding (Bouthenet et 
al., 1987; Qian et al., 1997) and in situ hybridization 
(Bouthenet et al., 1991) studies, which describe weak to 
high signals. Although there is a possibility that, due to 
Drreceptor in brain stem 
a lack of pharmacological selectivity, D,-receptor 
ligands also bind to dopamine D,-receptors, which are 
present in the inferior olive (Bouthenet et al., 1991), it 
is also possible that in this region the concentration of 
Dz-receptor protein is very low and, therefore, 
undetectable with immunocytochemistry. Finally, it 
should be mentioned that the existence of strain 
differences in the distribution of dopamine Drreceptor 
distribution in rat cannot be excluded, since different 
strains of rats were used in the studies that were 
compared. 
It is concluded that most of the brain stem areas 
described contain functional D2-receptors, as indicated 
by the presence of mRNA, protein, and ligand binding. 
There are discrepancies between the results of different 
techniques in a few brain stem areas, which can be 
partially explained by the nature of the different 
detection methods used. 
Functional implications 
The existence of a dopaminergic projection to the 
nucleus tractus solitarius and dorsal motor nucleus of 
the vagus is now well established (see e.g. van Dijken 
and Holstege, this thesis). Studies that focused on the 
functional role of dopamine in the nucleus tractus 
solitarius (Zandberg et aI., 1979; Granata and 
Woodruff, 1982; Kessler and Jean, 1986; van 
Giersbergen et al., 1992) have reported opposite effects 
of dopamine on heart rate and blood pressure. The 
presence of high densities of Drreceptors in the nucleus 
tractus solitarius indicates that the effects of dopamine 
are, in part, mediated by Dz-receptors. In accordance, 
microinjection of the Dz-receptor agonist (quinpirole) 
into the posterior region of nucleus tractus solitarius 
caused a consistent increase in mean arterial pressure 
(Yang et al., 1990), suggesting that D,-receptors are 
especially involved in producing an increase in blood 
pressure. On the other hand, microinjection of 
dopamine into the (right) nucleus ambiguus elicits a 
dose-dependent decrease in heart rate, which is 
mediated by excitation of vagal preganglionic 
cardioinhibitory neurons. This effect was blocked by a 
D,-receptor specific antagonist (sulpiride) and not by a 
D1-receptor antagonist (SCH-23390) (Chitravanshi and 
Calaresu, 1992). The presence of D,-receptor 
containing neurons in the area of the nucleus ambiguus, 
as found in the present study, may explain these effects. 
The above data show that the effects of dopamine on 
cardiovascular functions are complex and occur at 
different brainstem sites. The exact role of Dz-receptors 
in producing cardiovascular effects are still unclear. 
Within the trigeminal complex, cells containing D,-
receptor protein were few and located exclusively in the 
caudal part of the spinal trigeminal nucleus. The 
cytoarchitectonic organization of this area is very 
similar to that of the spinal dorsal hom, with which it is 
continuous. Both areas are involved in the processing 
sensory information, in particular pain and temperature. 
In the spinal dorsal horn Dz-receptors are present in the 
dorsal hom (van Dijken et al., 1996) and their agonists 
exert an inhibitory effect on the transmission of 
nociceptive inputs (Barasi et aI., 1987; Fleetwood-
Walker et aI., 1988; Liu et al., 1992), whereas D1-
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Figure 5: Ught m'lcrograph showing neurons strongly immunoreactive for the dopamine D2 receptor. Arrows point 
at strongly labeled neurons in the sUbstantia nigra, pars compacta. The marginal zone of the medial geniculate 
nucleus is also strongly labeled (arrowheads). Scale bar = 200 ~m. 
receptor agonists are without effect (Barasi et al., 1987; 
Liu et at., 1992). The distribution of dopantine (van 
Dijken and Holstege, this thesis) and its D2,receptor 
(Bouthenet et at., 1987; Yokoyama et at., 1994; 
Lawrence et at., 1995) in the caudal spinal trigeminal 
nucleus is similar to that of the dorsal hom. Therefore it 
seems likely that the Dz-receptors in the caudal spinal 
trigeminal nucleus are involved especially in 
modulating the transmission of pain and temperature 
impulses derived from the head and neck region. 
Dopantinergic fibers are densely distributed in the 
principal nucleus of the inferior olivary nucleus and its 
ventrolateral outgrowth (van Dijken and Holstege, this 
thesis), In the present study Dz-receptor protein was 
undetectable in the inferior olive, suggesting a more 
prominent role fOf dopamine Drreceptors. However, 
DJ,receptor (SCH,23982) binding appears not to be 
present in the inferior olive (Qian et at., 1997). 
Furthennore, weak to high Drreceptor binding 
(Bouthenet et at., 1987; Yokoyama et aI., 1994; Qian et 
at., 1997) and in situ hybridization signals (Bouthenet et 
aI., 1991) were found in the inferior olivary nucleus of 
rat, especially in its central and medial part (Lawrence 
et aI., 1995). Since no further details were given and the 
possibility of strain differences cannot be excluded, the 
presence of Drreceptors in the inferior olivary nucleus 
remains unsettled. A number of studies have indicated a 
possible interaction between dopamine and the 
vestibular system (see e.g. Hozawa and Takasaka, 
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1993). In the present study, only weak Drreceptor 
protein staining was observed in the vestibular complex, 
mainly represented by a few stained cells in the medial 
vestibular nucleus. This is in accordance with a study in 
guinea,pig brain slices (Vibert et at., 1995) showing 
that medial vestibular nucleus neurons depolarized after 
application of dopamine as well as after application of 
selective Drreceptor agonists, while application of 
selective D1-receptor agonists had no effects on neurons 
located within the medial vestibular nucleus. 
In the pons, the most prominent labeling was found 
in the noradrenergic locus coeruleus and subcoeruleus 
(see below) and the parabrachial nuclei. It has been 
proposed that part of the catecholaminergic innervation 
of the lateral parabrachial nucleus is dopaminergic 
(Hedreen, 1980), which we have recently confirmed 
(van Dijken and Holstege, this thesis). The presence of 
Dz-receptors in the parabrachial nuclei further 
substantiates the involvement of dopamine in the 
processing of information in this area. 
In the mesencephalon, Dz-receptor was found in the 
substantia nigra pars compacta, periaqueductal gray, 
inferior and superior colliculi and dorsal raphe. In the 
dorsal raphe nucleus (B6 and B7 areas) ligand binding 
density is fairly high for D2,receptors, but not for D J, 
receptors (Bouthenet et at., 1987). Microdialysis 
showed an inhibitory dopantinergic control of 
ascending serotonergic pathways, mediated by Dz-
receptors at the somatodendritic level in the dorsal 
raphe nucleus (Ferre ef al., 1994). The results of the 
present study further emphasize the role of Dr 
receptors, which are abundantly present within the 
dorsal raphe nucleus. 
Monoaminergic cell groups in the brain stem 
Noradrenergic and serotonergic cell groups in the brain 
stem usually show a prominent network of 
dopaminergic fibers and tenninals around cell bodies 
and dendrites (van Dijken and Holstege, this thesis). In 
the present study neurons containing dopamine Dr 
receptors were observed in many monoaminergic cell 
groups, including the serotonergic raphe nuclei (raphe 
pallidus, raphe obscurus, raphe magnus, raphe centralis, 
and raphe dorsalis) and the noradrenergic locus 
coeruleus and subcoeruleus, as well as the AI, AS and 
A 7 cell groups. These findings are in agreement with 
reports showing Dz-receptor binding (Bouthenet et al., 
1987; Bouthenet ef al., 1991; Yokoyama ef al., 1994) 
and D,-receptor mRNA (Bouthenet ef al., 1991) in 
several of these areas. 
The existence of a substantial dopaminergic 
innervation of the monoaminergic cell groups in the 
brain stem, and more particularly the presence of Dr 
receptors, suggests that dopamine interacts with other 
monoaminergic cell groups, not only at the level of their 
terminal fields, but also by directly affecting the activity 
Drreceptor in brain stem 
of the parent cell bodies of the monoaminergic fibers. 
Conclusion 
The present study, together with previous studies using 
different techniques, further establishes the presence of 
Drreceptors in specific regions of the rat brain stem. 
Although prominent, the distribution of D,-receptors in 
the brain stem is not as extensive as in other parts of the 
brain, more particularly the forebrain. The specific 
distribution of Drreceptors supports the involvement of 
dopamine in the modulation of many brain stem 
functions, including the interaction with other 
monoaminergic systems. In view of the widespread 
dopaminergic innervation of the brain stem, it seems 
likely that the effects of dopamine on brain stem 
functions depend not only on D2-receptors but also on 
other types of dopamine receptors. Detailed knowledge 
about their distribution in the brain stem is still 
incomplete. 
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Table 1: A comparison of the relative densities of dopamine D2-receptor labeling in the brain stem, obtained with different 
labelin~ techniques. Data from present study (02 protein): Oian et al., 1997 ([ 511NCO-298, fmol/mg): Yokoyama et al., 
1994 ( H1YM-09151-2, fmol/mg): Brock et al., 1992 (02 protein): Bouthenet et al., 1991 (D2 mRNA): Bouthenet et al., 1991 
([ 12511iodosulpiride), respectively. 
l. Medulla Oblongata D2 protein [ '25llNCQ-298 [3HlYM- D2 protein D, [l25lliodo 
" .. "-.. ".--.-.-~~. 
09151-2 mRNA sul~irjde 
10 Dorsal motor nucleus of the 4+ 3+ (7.1) 3+ (36) 3+ 1+ 
vagus 
12 Hypoglossal nucleus 0 0 (0) 4+ (51) 
Cu Cuneate nucleus 0 2-4+ (5.0-8.9) 4+ 3+ 
DC Dorsal cochlear nu 0 0-1+ (2.2-3.4) 1+ 2+ 
ECu External cuneate nu 0 0 (0) 1+ 1+ 
GiA Gigantocellular reticular nu, 3+ 2+ (21) 2+ 1+ 
alpha 
10 Inferior olive 0 4+ (9.5) 1+ (16) 4+ 2-4+ 
MdD Medullary reticular nu, dorsal 1+ 2+ (4.2) 3+ 3+ 
part 
MdV Medullary reticular nu, ventral 1+ 1+ (1.9) 3+ 3+ 
part 
MVe Medial vestibular nu 0 2+ 0 
MVPO Medioventral preolivary nu 1+ 0 
RF Reticular formation of medulla 1-2+ 1+ (12) 
oblongata 
RMg Raphe magnus nu 4+ 2+ (19) 
RPa Raphe pallidus nu 4+ 2+ (28) 
501 Nucleus of the solitary tract 2-3+ 1-3+ (3.1-7.1) 2+ (27) 2+ 3+ 
5PO Superior paraolivary nu 2+ 0 
50 Superior olive 0 1+ (10) 
5psC Spinal trigeminal, caudal part 1-2+ 2-3+ (3.6-6.7) 
5ps Spinal trigeminal, medial/lateral 3-4+ (7.4-8.8) 
part 
5psI Spinal trigeminal, interpolar part 0 3+ (6.1) 
AP Area postrema 2+ 2+ (4.0) 
~--,-"""= 
II. Pons D2 protein [ '25llNCQ-298 ['HlYM- D2 protein D, [12SI]iodo 
~~~-~,. ~,_"<~.~'"'"~,,~_O~'o~"'~~ 
•..•.•. ~Q21s1-2_~ _____ ._ •• _r1),,!J!' ___ ?""Q~lcl!'_ 
n7 Facial nu 0 2+ (31) 
Amb Nucleus ambiguus 0 2+ (28) 
Co Cochlear nu 0 1+ (10) 
LC Locus coeruleus 4+ 2+ (31) 3+ 4+ 
LPB Lateral parabrachial nu 3+ 3+ 3+ 
LVe Lateral vestibular nu 0 1+ (16) 
Mos Motor trigeminal nu 0 2+ (29) 
Mes Mesencephalic trigeminal nu 0 3+ 2+ 
MPB Medial parabrachial nu 3-4+ 2+ 3+ 
MVe Medial vestibular nu 0 1+ (17) 
PnC Pontine reticular nu, caudal part 1+ 2+ 2+ 
PnO Pontine reticular nu, oral part 1+ 2+ 2+ 
Prs Principal sensory nu 0 1+ (11) 
5ps Spinal trigeminal nu 1-2+ 1+ (20) 
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Table 1: (continued) 
III. Mesencephalon D2 protein ['25I]NCQ-298 [3H]YM- D2 protein D, C25I]iodo 
09151-2 mRNA suJEt~!.9~._ .. ...................................................................................... --.---~~~-............... '"" ............................................. 
--(37) ......................................... _ .n3 Oculomotor nu 0 3+ 
CG Central gray 2-3+ 2+ (19) Moderate 3+ 3+ 
Cli Caudal linear nu of raphe 2+ (23) 
DpM Deep mesencephalic nu 1+ 3+ 3+ 
e 
DR Dorsal raphe nucleus 4+ 4+ (51) 
IC Inferior colliculus (external cortex) 2-3+ 2+ (24) Moderate 3+ 2+ 
IF Interfascicular nu (AlO) 0 2+ (31) 
IPR Interpeduncular nu rostral 4+ (46) 
IPC Interpeduncular nu caudal 1+ (18) 
MG Medial geniculate nu 4+ Moderate 
(ventral border) 
MnR Median raphe nu 3+ 1+ (13) 
OT Nu of the optic tract 4+ 3+ 
Rli Rostral linear nu of raphe 2+ 1+ (11) 
RN Red nu 0 1+ (14) 
RRF Retrorubral field (A8) 1+ (14) 4+ 2+ 
SNC Substantia nigra compacta (A9) 4+ 3+ (40) Dense 4+ 4+ 
SNL Substantia nigra compacta, lateral 4+ 0 4+ 
part 
SNR Substantia nigra reticulata 0 1+ (9) 
Su Superior colliculus 2+ 2+ (25) Moderate 3+ 3+ 
(superficial grey layer) 
VTA Ve_ntral tegmental area (AlO) 3+ 1+ (12) Moderate 4+ 4+ 
-
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Summary and General Discussion 
Summary 
This thesis, which describes an anatomical study of the 
dopamine innervation of the brain stem and spinal cord 
and one of the receptors involved, may be regarded as 
an anatomical study of a chemically identified system, 
i.e. characterized by using the transmitter dopamine. 
In Chapter I these aspects are described separately: first 
a short description of the anatomy of the spinal cord and 
brain stem is given, followed by a description of the 
chemical anatomy of the nervous system, with the 
emphasis on the dopaminergic system and its receptors. 
Chapter II describes the distribution of dopaminergic 
fibers and (presumed) terminals in all segments of the 
rat, cat and monkey spinal cord as identified by light 
microscopy immunocytochemistry using antibodies 
directed against dopamine. 
Strongest dopamine labeling was present in the 
sympathetic intermedio-lateral cell column (IML). 
Strong dopamine labeling, consisting of many varicose 
fibers, was found in all laminae of the dorsal horn, 
including the central canal area (region X), but with the 
exception of the substantia gelatinosa, which was only 
sparsely labeled, especially in rat and monkey. In the 
motoneuronal cell groups dopamine labeling was also 
strong, showing a fine granular appearance. The 
sexually dimorphic cremaster nucleus and Onufs 
nucleus (or its homologue) showed a much stronger 
labeling than the surrounding somatic rnotoneurons. In 
the parasympathetic area at sacral levels, labeling was 
moderate. The remaining areas, like the intermediate 
zone (lamina VI-VIII), were ouly sparsely innervated. 
The dorsal nucleus (column of Clarke) showed the 
fewest dopamine fibers as did the central cervical 
nucleus, suggesting that cerebellar projecting cells were 
avoided by the dopamine projection. In all species, the 
descending fibers were located mostly in the 
dorsolateral funiculus, but laminae I and III also 
contained many rostro-caudally oriented fibers. 
It is concluded that dopamine is widely distributed 
within the spinal cord, with few differences between 
species, emphasizing that dopamine plays an important 
role as one of the monoamines that influences sensory 
input as well as autonomic and motor output at the 
spinal level 
Chapter III describes the distribution of dopamine 
D2-receptors in rat spinal cord as determined by means 
of inununocytochemistry using an anti-peptide 
antibody, directed against the putative 3rd intracellular 
loop of the D 2-receptor, and by means of in situ 
hybridization (ISH) using a ["S)UTP labeled anti-sense 
riboprobe. 
With the inununocytochemical technique, labeling 
was confined to neuronal cell bodies and their proximal 
dendrites. Strongest labeling was present in the 
parasympathetic area of the sacral cord and in two 
sexually dimorphic motor nuclei of the lumbosacral 
cord, the spinal nucleus of the bulbocavernosus, and the 
dorsolateral nucleus. Moderately labeled cells were 
present in the intermediolateral cell column, the area 
around the central canal and lanaina I of the dorsal horn. 
Weak labeling was present in the lateral spinal nucleus 
and lanainae VII and VIII of the ventral horn. Except for 
the two sexually dimorphic motor nuclei of the 
lumbosacral cord labeled motoneurons were not 
encountered. 
With the ISH technique radioactive labeling was 
present in many neurons, indicating that they contained 
D 2-receptor mRNA. The distribution of these neurons 
was very similar to the distribution obtained with 
immunocytochemistry, but with ISH additionallabe1ed 
cells were detected in laminae III and IV of the dorsal 
hom, which were never labeled with 
immunocytochemistry. 
Thus, the expression of Drreceptor in specific areas 
of the rat spinal cord provides anatomical support for 
the involvement of Dz-receptors in modulating 
nociceptive transmission and autonomic control. Our 
data further indicate that Drreceptors are not directly 
involved in modulating motor neurons with the 
exception of those located in the sexually dimorphic 
motor nuclei. 
Chapter IV describes the distribution of dopamine 
immunoreactive fibers and (preswnptive) temrinals as 
identified at the light microscopical level in the rat brain 
stem. The distribution of dopamine immunoreactivity is 
compared with that of dopanaine:/l-hydroxylase (DBH), 
the (nor)adrena1ine synthesizing enzyme. 
The dopaminergic fibers and terminals showed a 
specific distribution within the brain stem. They were 
present in many brain stem nuclei with various labeling 
densities. Strongest dopamine labeling was found in the 
dorsal motor nucleus of the vagus, principal nucleus of 
the inferior olive and dorsal raphe nucleus. Other areas, 
like the nucleus of the solitary tract, raphe pallidus and 
obscurus, lateral parabrachial nuclei, and the 
periaqueductal gray, were strongly labeled, whereas the 
sensory trigeminal complex, the medial parabrachial 
nucleus, the locus coeruleus and the noradrenergic AS 
cell group were labeled moderate to strong. 
Furthermore, dopamine immunoreactive fibers and 
terminals were present in many other areas of the brain 
stem, including the inferior and superior colliculi, deep 
mesencephalic nuclei, pontine reticular nuclei, 
prepositus hypoglossal nuclei, cochlear nuclei, cuneate 
and gracile nuclei. In most nuclei, dopamine was not 
distributed randomly, but aimed at specific subnuclei. 
DBH containing fibers and ternainals were distributed 
more ubiquitously throughout the brain stem. In most 
areas the distribution of DBH labeling overlapped with 
the dopamine labeling, but the regional innervation 
pattern differed. In other areas like the area postrema, 
cerebellum, anterior portion of the ventral cochlear 
nucleus and external cuneate nucleus, which were all 
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sparsely innervated by dopaminergic fibers, the 
(nor)adrenaline synthesizing enzyme was abundantly 
present. 
These results demonstrated that there exist an 
extensive dopaminergic fibers system in the rat brain 
stem, which is independent from the (nor)adrenergic 
fiber system. As a consequence, the influence of 
dopamine in the brain stem should be considered of 
equal importance to other monoarnines like 
(nor)adrenaline and serotonin. 
Chapter V describes the distribution of dopamine D,-
receptors in rat brain stem as detennined by signal 
amplified inununocytochemistry using a polyclonal 
antiserum with antibodies directed against the putative 
3"' intracellular loop of the dopamine D,-receptor. The 
labeling was mostly associated with neuronal cell 
bodies and their proxinnal dendrites, regardless whether 
amplification was used or not. Neurons containing Dr 
receptor protein were observed throughout the rat brain 
stem in specific regions. like the dorsal motor nucleus 
of the vagus, the gigantocellular nucleus pars alpha, the 
nucleus of the solitary tract, the locus coeruleus, the 
lateral and medial parabrachial nuclei, the basal pontine 
nuclei, the central gray, the deep mesencephalic 
nucleus, the inferior and superior colliculi, substantia 
nigra pars compacta, and ventral tegmental area. 
Furthermore, additional brain stem nuclei were 
observed that contained Drreceptor protein, including 
the reticular formation and all raphe nuclei. In other 
brain stem areas, like the cuneate and the inferior 
olivary nuclei, Drreceptor protein was undetectable, 
indicating that in these regions of the brain stem the 
concentration of Drreceptor protein may be very low 
and, therefore undetectable with inununocytochemistry. 
These results are in general agreement and further 
extend the results of previous studies on D2-receptor in 
rat brain stern, using the ligand binding or in situ 
hybridization technique. 
The widespread distribution of Drreceptors in the 
rat brain stem provides anatomical support for the 
involvement of Drreceptors in modulating a large 
variety of brain stern functions, further emphasizing the 
innportant role of the dopamine system in the brain 
stern. 
Chapter VI discusses the anatontical and fimctional 
significance of the dopaminergic system in brain stem 
and spinal cord, It is concluded that the present thesis 
definitively establishes the existence of a widespread 
dopaminergic neurotransmission in the brain stem and 
spinal cord, independent from the other monoaminergic 
neurotransmitters in which dopamine acts as a 
precursor. Dopamine projections are found in nearly all 
the sensory infonnation processing areas, motoneuronal 
cell groups and many areas that subserve various 
autonomic functions, suggesting that dopamine is 
involved in various brain stem and spinal cord 
fimctions. Its distribution further suggests that 
dopamine interacts with the other monoaminergic cell 
groups, not only at the level of the tenninal fields in the 
target areas, but also by directly affecting the activity of 
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the parent cell bodies of the monoaminergic fibers. The 
high degree of collateralization in the dopamine 
diencephalo-spinal projection implies that dopamine is 
released simultaneously in many different areas of the 
brain stem and spinal cord, which suggest that 
individual All neurons subserve integrative functions. 
The role of dopamine in different behavioral states like 
fight and flight and sexual behavior are discussed, At 
present, there is no evidence that All plays a role in 
Parkinson's disease. 
Taken together the present thesis emphasizes that 
besides noradrenaline and serotonin, dopamine should 
also be included when considering the monoaminergic 
effects on brain stem and spinal processing. In fact, the 
interaction between the various monoamines may be of 
even greater importance than the effect of the respective 
transmitters alone. Investigations along this line may 
prove worthwhile. 
General Discussion 
Introduction 
The studies presented in this thesis provide a 
comprehensive description of the localization of the 
neurotransmitter dopamine and one of its major 
receptors, the dopamine Drreceptor, in the brainstem 
and spinal cord. Chapter II and IV describe the 
existence of a distinct and extensive dopaminergic 
innervation of specific areas of the brainstem and spinal 
cord. In chapter III and V the localization of D,-
receptors in the spinal cord and brainstem is described 
in detail, Together these studies establish dopamine as a 
distinct and extensive neurotransmitter system in the 
brainstem and spinal cord and provide the anatomical 
basis for detailed studies on the involvement of 
dopamine in the modulation of the many functions that 
are organized in brain stem and spinal cord. Below, the 
various aspects of the dopaminergic innervation as 
described in this thesis will be discussed, including the 
methodological aspects, the interaction of dopamine 
with other transmitters and its possible roles in the 
various functions of the spinal cord and brainstem. 
Methodological aspects 
Dopamine 
Like most of the identified neurotransmitter systems in 
the brain (see e.g. Nieuwenhuys, 1985) dopamine is 
widely distributed throughout the brainstem and spinal 
cord, although the density of the dopamine innervation 
is generally less than that of (nor)adrenaline and 
serotonin, the distribution is generally similar (table 1). 
For a long time it has been difficult to demonstrate that 
dopamine in the brain stem and spinal cord functions as 
a neurotransmitter in its own right and not only as a 
precursor for the biosynthesis of the catecholamines 
noradrenaline and adrenaline. Theoretically, the 
possibility exists that noradrenergic and adrenergic 
fibers and terminals contain levels of precursor 
dopamine that are detected by dopamine 
immunocytochemistry. As a consequence, these fibers 
would be falsely identified as dopaminergic, i.e. using 
dopamine as a transmitter. However, several lines of 
evidence suggest that the large majority of the 
dopamine immunoreactive fibers and tenninals 
identified in the brain stem and spinal cord are indeed 
dopantinergic. 
Firstly, it was shown in biochemical studies of areas 
with a high noradrenaline and a low dopamine 
innervation, like the cerebellum and lateral 
hippocampus, that the dopamine concentration was 
only 1-3% of the noradrenaline concentration 
(Commissiong et al., 1978; Westerink and Mulder, 
1981; Westerink and de Vries, 1985; Verhage et al., 
1992). Destruction of the locus coeruleus, and 
consequently the noradrenaline innervation of several 
brain areas, including the cerebellum and hippocampus, 
had no effect on dopamine levels in those areas 
(Westerink and De Vries, 1985). Thus, even in areas 
with a relatively high noradrenaline and a low 
dopamine concentration, dopamine represents a 
"transmitter pool" rather than a "precursor pool" of 
noradrenaline, as confinned by additional biochemical 
and/or anatomical studies in cerebellum (Panagopoulos 
et aI., 1991; Ikai et al., 1992) and hippocampus (Verney 
et aI., 1985; Verhage et al., 1992; Gasbarri et al., 1994). 
In this thesis areas of the brain stem with a relatively 
dense DBH immunoreactive innervation (like the 
cerebellum, the area postrema, the anterior portion of 
the ventral cochlear nucleus, and the external cuneate 
nucleus, see also table 1) showed virtually no dopamine 
immunoreactive fibers and terminals. This finding 
showed that a dopamine "precursor pool II in 
(nor)adrenergic terminals could not be identified by the 
dopamine antibody. The most probable explanation for 
this observation is the very high turnover rate of 
dopantine in (nor)adrenergic terminals, leading to very 
low "free" dopamine levels in these tenninals. 
Secondly, in our control experiments with the 
neurotoxin DSP-4, which affects a specific subset of 
noradrenergic fibers and terminals, a selective loss of 
DBH staining was observed in brain stem and spinal 
cord, due to the degeneration of noradrenergic fibers 
(Fritschy and Grzanna, 1989). In alternate sections, 
however, the dopamine immunoreactivity remained 
unaffected by the drug, showing that the 
immunoreactive dopamine was not present in 
noradrenergic fibers. Similarly, the use of the 
neurotoxin 6-0HDA, which causes a specific 
degeneration of noradrenergic tenninals, resulted in the 
disappearance of noradrenaline immunoreactivity from 
the spinal cord of rats, sparing the dopanrine 
immunoreactive fibers (Mouchet et al., 1992). These 
selective lesion studies using the neurotoxins DSP-4 
and 6-0HDA thus indicate that precursor dopamine in 
noradrenergic fibers and terminals is not detected with 
the immunocytochemical method used in the studies of 
this thesis. Alonso et al. (1995), using a IgG 
monoclonal antibody against dopamine, confirmed that 
in most brainstem nuclei precursor dopamine is 
undetectable by dopanrine immunocytochemistry. 
However they also reported that precursor dopamine 
can actually be detected by immunohistochemistry in 
areas that receive a very dense catecholaminergic 
Summary and Discussion 
innervation and are not, or only partially, affected in 
lesion studies using a catecholamine-selective 
neurotoxin (regions like the locus coeruleus, the dorsal 
motor nucleus of the vagus, the area postrcma, the 
nucleus of the solitary tract and the hypoglossal 
nucleus). Thus, In some areas with a dense 
noradrenergic and dopaminergic innervation, some 
dopamine immunoreactivity may have been produced 
by noradrenergic tenninals. The existence of a 
dopaminergic transmitter system in areas that contain 
dopantine fibers is supported by the presence of 
dopantine DI and/or D, dopamine receptors (Bouteneth 
et ai, 1987; Bouteneth et ai, 1991; Yokoyama, 1994) in 
the large majority of those areas. Although mismatches 
between the distribution of a transmitter and its receptor 
occur (see below), it seems most likely that areas that 
express dopamine receptors also receive a 
dopaminergic innervation. In addition, the presence of 
dopamine transporters, i.e. molecules that are involved 
in the transmembrane transport of dopamine, may also 
be used to indicate the presence of a dopaminergic 
neurotransmission. There are two basic transporters that 
are essential for normal dopamine neurotransmission: 
the vesicular monoamine transporter (in rat: VMAT2) 
and the plasma membrane dopanrine transporter (DAT) 
(see Hoffman et aI., 1998 for review). VMAT2 loads 
cytoplasmic dopamine into vesicles for storage and 
subsequent release. However VMA T2 is not specific 
for dopamine but also transports other monoamines. 
Thus in dopanrinergic terminals VMA T2 is used to load 
vesicles with dopamine, while in noradrenergic 
terminals VMAT2 is used to load vesicles with 
noradrenaline. Therefore VMA T2 cannot be used to 
differentiate between monoaminergic fibers and is 
therefore not suitable to specifically identify 
dopantinergic fibers. In contrast, DAT, which takes up 
dopantine from the intercellular space by transporting it 
into the neuronal cytoplasm, is specific for dopamine 
and does not transport any of the other monoamines. 
DAT is considered to play an important role in the 
termination of the actions of dopamine after its release 
by rapidly removing dopamine from the intercellular 
space, including the synaptic cleft. Thus, DAT may be 
used to specifically identify dopanrinergic fibers. 
However, studies using in situ hybridization combined 
with tyrosine hydroxylase immunocytochemistry have 
shown that, in contrast to the majority of the 
dopaminergic cell groups, All dopanrinergic neurons 
do not express DAT mRNA (Lorang et al., 1994) nor 
DAT protein (Ciliax et aI., 1995; 1999). Since the 
dopantinergic projection to the brain stem and spinal 
cord largely originates from the All group, DAT 
immunoreactive fibers are not encountered in these 
brain regions. As a consequence, the localization of 
VMAT2 or DAT cannot be used to verify the presence 
of dopaminergic innervation in brainstem and spinal 
cord systems, as studied in this thesis. 
It may thus be concluded that virtually all dopantine 
immunoreactive fibers and terminals, detected in the 
present study, contained dopamine, not as a precursor, 
but as a neurotransmitter. However, it can not be 
completely excluded that in a few areas dopanrine 
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immunoreactivity was produced by dopamine in 
noradrenergic terminals. Although our control 
experiments with DSP-4 have shown that it is unlikely 
that this methodological problem has in any way 
compromised our results, it cannot be completely 
excluded that in a minority of the fibers in a few areas 
immunoreactivity was produced by dopamine in 
noradrenergic terminals. 
Dopamine D2 receptor 
The amount of dopamine in the brain stem and spinal 
cord is generally low, especially in comparison with 
dopamine levels in the forebrain (Westerink and de 
Vries, 1985; Batten et aI., 1990), Similarly, a 
comparison of the available data on dopamine receptor 
levels (Boyson et al., 1986; Dubois et al., 1986; 
Yokoyama et al., 1994) indicates that the levels of 
dopamine Dr and Drreceptors are 5-20 times lower 
than those measured in the forebrain. The amount of 
dopamine D3-receptors in the central nervous system 
appears to be several orders of magnitude lower than 
that of D,-receptors and they are not found in spinal 
cord (Bouthenet et aI., 1991). The distribution of 
dopamine D4-receptors in the central nervous system 
has been studied by immunocytochemistry (Khan et al., 
1998); according to biochemical assays it was found to 
be concentrated in cerebral cortex, hippocampus, 
caudate-putamen and, in the mesencephalon, the 
inferior colliculus and to a much lesser extent in the 
colliculus inferior. Some labeling was also found in the 
cerebellum. However, in other areas of the brain stem 
D4 labeling was very low or absent. Dopamine D,-
receptors are expressed at very low levels in the central 
nervous system (Grandy and Civelli, 1992) and, 
therefore, probably are not detectable in brain stem or 
spinal cord. Thus, in brain stem and spinal cord 
dopamine exerts its effects primarily via dopamine DI 
and Dz-receptors. 
Few data are available on the detailed localization of 
D J and Dz-receptors in brainstem and spinal cord. The 
studies presented in this thesis have focussed on the 
distribution of Dz dopamine receptors and are the first 
to identify a consistent regional distribution of the 
Dz-receptors in spinal cord and brain stem. It was 
noticed that, compared to the forebrain, the brain stem 
and the spinal cord contained relatively few cells that 
were immunoreactive for the D 2-receptor and that most 
of them were not strongly labeled. Furthermore, the 
relatively long exposure times that were needed to 
visualize the radioactively labeled riboprobe in spinal 
cord indicated that the hybridization signal was 
relatively low. These findings indicate that, in 
comparison with other brain areas, the level of 
Dz-receptors in rat brain stem and spinal cord is low, 
both with respect to the protein and its mRNA. If the 
expression of Dz-receptors is constitutively low and 
difficult to detect, the number of cells expressing D,-
receptors may have been underestimated. 
The observation that Dz-receptor immunoreactivity 
was located mainly within the somata and proximal 
dendrites of labeled neurons, rather than in tenninals, is 
in agreement with other studies using different 
D,-receptor (Brock et al., 1992; Ariano et aI., 1993), 
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D'A-receptor or D3-receptor antibodies (Ariano, 1994). 
In neostriatal neurons, the Dz-receptor immuno-
reactivity was uniformly present throughout the somatic 
cytoplasm, became less strong towards the periphery 
and appeared not to be associated with a particular 
cellular organelle (Fisher et aI., 1994; Hersch et aI., 
1995). Furthermore, only a small part of the labeling 
was associated with postsynaptic densities. The typical 
localization of Dz-receptor immunoreactivity in somata 
and proximal dendrites, as we also observed, may 
indicate that the antibody preferentially recognized D2-
receptor protein before its incorporation as a functional 
receptor into the neuronal membrane. On the other 
hand, if the antibody would recognize both functional 
and nonfunctional receptors, our results would indicate 
that the highest proportion of D2-receptor protein is 
located within the cell body and proximal dendrites 
whereas only minute amounts of functional receptors 
are present in more distal dendrites. The amount of 
cytoplasmic Dz-receptor protein appears to be much 
higher than the amount of membrane incorporated 
protein. Antibodies against other receptors or their 
subunits also primarily stain neuronal somata and 
dendrites at the light microscopical level (see e.g. 
glutamate receptor subunits; Kennis and Holstege 
1997), although at the ultrastructural level incorporation 
into membranes has also been identified (Baude et al., 
1995). The antibody that we have used is able to shift 
the affinity of the D,-receptor for dopamine from ltigh 
to low (plug et al., 1992), suggesting that the antibody 
does react with functional receptors. 
It may be concluded that several nuclei in spinal 
cord and brain stem express Dz-receptors, usually at a 
relatively low level. Physiological studies in a few 
areas, both in the brain stem and spinal cord (see 
below), have shown that Dz-receptor activation has 
substantial functional effects. The present description of 
the distribution of Dz-receptors supports an important 
role of dopamine and its receptors in the brainstem and 
spinal cord and provides a finn anatomical basis for 
future functional studies. 
The anatomical distribution of dopamine 
and its receptors: the mismatch problem 
A comparison of the distribution of dopamine with that 
of its D,-receptor (see table 2) shows that generally the 
distribution of dopamine is more widespread. This 
anatomical discrepancy (or mismatch) between the 
distribution of dopamine and its Dz-receptor can be 
explained by a complementary distribution of the D,-
receptor. Analysis of the available data on the 
localization of dopamine receptors in spinal cord 
(Dubois et aI., 1986; Yokoyama et ai, 1994) indicates 
that Dz-receptors are more prominent in the superficial 
dorsal horn, whereas Dl-receptors are more prominent 
in central and ventral regions of the spinal cord. The 
few data that are available on the distribution of D,-
receptors indicate that this explanation is also valid for a 
number of dopamine-innervated areas in the brainstem, 
like motoneurons in the brain stem, which lack Dz-
receptors (see table 2), but do express D,-receptors 
(Dubois et al., 1986; Levey et al., 1993). 
Two types of mismatch may occur. In one the 
corresponding receptor is found to be lacking in a 
region where the receptor is present. In the other the 
receptor is present, but the corresponding 
neurotransmitter cannot be identified. In areas where 
the localization of a transmitter does not correspond 
with that of its receptors, a number of explanations have 
been proposed (see e.g. Herkenham, 1987). However, 
the precise reasons for such a mismatch in a particular 
region usually remain difficult to establish. 
Explanations include (I) methodological problems and 
(2) points of interpretation. (I) Mismatches caused by 
various methodological problems (see methodological 
aspects) may be subdivided in two categories: 
selectivity problems and sensitivity problems. A 
selectivity problem may occur when a probe is used 
which only recognizes a subset of the structures it is 
supposed to identify or, instead, recognizes additional 
structures. With respect to receptors, selectivity 
problems may occur with the identification of occupied 
receptors, spare receptors, low-affinity receptors, non-
functional receptors etc. Cross reactivity of an antibody 
or the identification of dopamine in noradrenergic 
tenninals, as discussed above, may also be regarded as 
a selectivity problem. Sensitivity problems mainly 
occur when a probe does not identify low levels of a 
receptor. The finding in the present receptor studies, 
that cell somata and dendrites are labeled rather than 
axons and terminals, may be due to a selectivity 
problem, i.e. that Drreceptors incorporated in the 
(terminal) membrane may not be recognized. On the 
other hand, the number of dopamine's incorporated in 
the membrane may be too low to detect, in which case 
there would be a sensitivity problem. The latter 
possibility may playa role in the brain stem and spinal 
cord since expression levels of Dz-receptors are 
generally low. (2) Mismatches may be caused by 
problems of interpretation. These mismatches are not 
due to technical problems, but to problems in the 
interpretation of the morphological data from 
innnunocytochemical studies. Some neurons which 
only present immunoreactivity of their cell body, where 
the receptor is synthesized, may express their functional 
receptors only at their terminals in distant projection 
areas. If a dopantioergic projection is lacking in the 
region containing receptor-immunoreactive neurons, 
this may be interpreted as a mismatch (presence of 
receptors but not the appropriate transmitter). The 
reverse situation, i.e. the presence of dopamine but not 
(one of) its receptors may occur if transmitter molecules 
can "travel tl through the intercellular space after their 
release and act on target receptors located at a distance 
of their release site. This phenomenon has been termed 
non-synaptic or volume-transmission (see Zoli et at., 
1999 for review). In the spinal dopamine system there is 
evidence that dopamine terminals in the dorsal horn 
show very few synapses, and may therefore 
communicate through volume transmission, while the 
dopamine tenninals in the ventral horn show classical 
synaptic structures and may therefore commwricate 
through conventional synaptic release (Ridet et aI., 
1992). Since D2-rcceptors are predominantly localized 
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in the dorsal hom and D1-receptors in the ventral horn, 
this would suggest that in spinal cord especially D,-
receptors are involved in volume transmission. Thus the 
phenomenon of volume transmission may explain a 
mismatch in some cases. 
In the present studies, we found that nearly all areas 
expressing Drreceptors also received a dopaminergic 
projection. On the other hand there are several areas 
that receive a dopamine projection, but do not contain 
D2-receptors (table 2). In some of these areas the D1-
receptor is expressed, e.g. in motoneuronal cell groups. 
However, the present data on the distribution of Dr 
receptors are incomplete, and a detailed mapping of the 
D1-receptor in brain stem and spinal cord is needed to 
detennine whether or not there is a mismatch between 
dopamine and its receptors. The present data 
(summarized in table 2) on the localization of dopantioe 
and its receptors in brain stem and spinal cord indicate 
that, if a mismatch exists, it is only limited. 
The origin of the dopaminergic fibers in 
spinal cord and brainstem (the All cell 
group) 
Retrograde tracing studies have shown that the 
dopantioergic fibers in brain stem (Takada, 1993; 
Maeda et al., 1994) and spinal cord (Bjorklund and 
Skagerberg, 1979; Skagerberg and Lindvall, 1985; 
Hokfelt et aI., 1979; Skagerberg et al., 1988) largely 
originate in the All cell group located in the caudal 
diencephalon. The spinal-cord projecting dopantioe 
neurons are found in dorsal and caudal hypothalanaic 
areas scattered along the dorsal and medial aspects of 
the fasciculus mammillothalamicus and, more caudally, 
in between the fasciculus retroflexus and the third 
ventricle. 
Although the All group should be considered as a 
major diencephalic cell system it is very small in 
comparison with the mesencephalic dopamine cell 
groups. The number of dopantioe cells in the A II group 
(about 130 cells on each side) only amounts to about 1-
2% of that in the substantia nigra or AIO (Skagerberg 
and Lindvall, 1985). In contrast to the total population 
of All dopamine cells, most of which are found 
rostrally, the dopanaine cells projecting to the spinal 
cord are more evenly distributed along the antero-
posterior axis of the All group (Skagerberg and 
Lindvall, 1985). They thus seem to constitute a 
relatively greater proportion of the population of All 
cells at caudal levels. Due to the small number of 
dopamine cells and their scattered distribution, 
physiological and tracing experiments are difficult to 
perform in the All group. 
The route of the descending dopamine fibers is not 
completely known. There is some evidence that at least 
part of the axons may descend within the dorsal 
longitudinal fasciculus of Schutz in the periaqueductal 
and periventricular gray of the mesencephalon, pons, 
and medulla oblongata (Mouchet et al., 1981; Lindvall 
et aI., 1983). Accordingly, in longitudinal sections we 
have observed fibers running in the rostro-caudal 
direction in this area, a finding that is also reported by 
others (Bjorklund and Skagerberg, 1982). Retrograde 
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tracing studies have shown that the descending 
diencephalospinal dopamine system is totally uncrossed 
(Bjorklund and Skagerberg, 1979; Hokfelt ef al., 1979; 
Bjorklund and Skagerberg, 1982; Skagerberg ef aI., 
1982; Lindvall ef al., 1983). In the spinal cord, we have 
shown that the axons descend partly within lamina I of 
the dorsal hom and the adjoining parts of the 
dorsolateral funiculus, and partly along the central canal 
(see also Skagerberg ef al., 1982; Lindvall ef aI., 1983). 
The former pathways probably give rise to the 
dopamine terminals in the dorsal horn and possibly the 
ventral horns at all levels of the cord, while the latter 
may contribute to the innervation of the 
intermediolateral cell column and associated parts of 
the intennediate zone in the thoracic and upper lumbar 
segments. The presence of radiating fibers in the white 
matter destined for the intermediolateral column also 
suggests the possibility of dopamine fibers descending 
within the lateral funiculus. 
Since the dopamine projections to the brainstem and 
spinal cord originate from a relatively small group of 
cells that project to a very wide area, they show a high 
degree of collateralization leading to a diffuse mode of 
projection. This feature is shared with the other 
biogenic amines, which also show a high degree of 
collateralization, but contrasts with the projection mode 
of many other spinal projecting systems, e.g. those 
originating in the cortex, the red nucleus, parts of the 
pontine and medullary reticular formation and the 
vestibular nuclei (Kuypers, 1981), which are often more 
focussed. The functional significance of a diffuse 
projection from the All nucleus depends on 
collateralization profile and the activity pattern of the 
individual All neurons. It is possible that different All 
neurons project to different target areas and thus are 
involved in specific functions. In analogy with the 
serotonergic system, a subset of All neurons may 
influence sensory tranSlTIlSSlOn by projecting 
specifically to the trigeminal nucleus and the spinal 
dorsal hom, while another subset may project to the 
motoneurons and pre-motor areas in the brainstem and 
spinal cord (Tallaksen-Greene ef al., 1993; Halliday ef 
al., 1995). However, the few data available favor the 
existence of a diffuse, aspecific collateralization of the 
axons from the All neurons. Indeed, single 
dopaminergic neurons in the subparafascicular 
fasciculus belonging to the diencephalic All dopamine 
cell group, give rise to collateral projections to the 
neocortex and spinal cord in the rat (Takada et aI., 
1988). Similarly, spinal projecting All cells send their 
axons through most of the length of the cord and the 
long main axons of the All cells give off collateral 
tenninal branches at most or all segmental levels 
(Skagerberg and Lindvall, 1985). 
The available evidence on collateralization suggests 
that individual All neurons modulate a wide range of 
different functions. Functions influenced by the All 
group constitute behaviorally relevant combinations. 
For example, in threatening situations or under 
conditions when pain is perceived or is anticipated, 
cognitive functions like attention to specific 
environmental aspects and the planning of motor 
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actions as well as more basic functions like respiration, 
heart rate, blood pressure, motor activity and the 
threshold for pain may all increase simultaneously. 
Under these circumstances a collateralized projection 
system may be the most suitable organization for 
modulating simultaneously the diverse functions that 
constitute a complex behavioral response to specific 
external stimuli. In order to gain more insight in the 
functional role of the All neurons, experimental data 
on the activity pattern of (individual) All dopamine 
neurons in different environmental conditions and 
identification and activity of the afferent projections 
they receive, are essential. Presently these data area 
lacking, probably due to technical difficulties associated 
with the small number of All dopamine neurons and 
their scattered distribution. 
The relation of dopamine with other 
monoamines and glutamate 
Dopamine and the other monoamines 
Many structures in the brain stem and spinal cord 
receive a dopaminergic (Yoshida and Tanaka, 1988; 
Mouchet ef aI., 1992; Ridet ef al., 1992; Maqbool ef aI., 
1993) as well as a noradrenergic (Westlund ef aI., 1983; 
Fritschy and Grzanna, 1990; Hagihira ef al., 1990; 
Rajaofetra ef aI., I 992b; Doyle and Maxwell, 1991; 
Westlund ef al., 1984; Grzanna and Fritschy, 1991) and 
a serotonergic (Marlier ef al., 1991; Ruda ef al., 1982; 
Kojima and Sano, 1983; LaMotte and Lanerolle, 1983; 
Dahlstrom and Fuxe, 1964; Steinbusch, 1981; 
Tallaksen-Greene ef al., 1993; Halliday ef al., 1995) 
innervation. In table I a summary is made of areas in 
the brainstem and spinal cord that receive a 
dopaminergic innervation. The noradrenergic and 
serotonergic innervations in these areas are also shown 
for comparison. The anatomical data show that in most 
areas of the brainstem the three monoamines are all 
present. Exceptions are the different subnuclei of the 
inferior olivary complex, vestibular complex, area 
postrema, dorsal periaqueductal gray, superior 
colliculus, cerebellar nuclei and cerebellum. The 
similarity in the distribution of the three monoamines 
indicate that they are all involved in regulating neural 
activity in the innervated areas. It is not known, 
however, whether the different monoaminergic 
projections are also simultaneously active, or whether 
they have opposite or synergistic effects. 
A complex interaction between dopamine and the 
other monoamines, noradrenaline and serotonin has 
been suggested by a number of studies, most of which 
have focussed on the effect of dopamine on the release 
of other monoamines. In the frontal cortex of freely-
moving rats a complex interaction between different 
monoamines was found (Gobert ef al., 1998). Most 
notably, activation of presynaptic az-adrenergic 
receptors inhibited the release of noradrenaline, 
dopamine and serotonin. Stimulation of 5lIT lA 
receptors suppressed serotonin, yet facilitated 
noradrenaline and dopamine release. In addition, 
dopamine D2/D3 autoreceptors restrained dopamine 
release, while (terminal-localized) 5HTIB receptors 
reduced serotonin release. In a similar fashion, 
dopamine inhibited the activity of serotonergic dorsal 
raphe neurons projecting to the striatum via Dz-
receptors (Ferre ef al., 1992; Ferre ef aI., 1994) and D,-
receptors were also involved in the apomorpbine-
induced facilitation of forebrain serotonin output 
(Mendlin et aI., 1998). Also, studies in the superior 
colliculus showed that the release of noradrenaline was 
inhibited by dopamine through presynaptic D,-receptors 
(Wichmann and Starke, 1988). 
The dopaminergic irmervation of the mono-
aminergic cell groups located in the brain stem further 
suggest that dopamine interacts with the other 
monoaminergic cell groups, not only at the level of their 
terminal fields in the various target areas, but also by 
directly affecting the activity of the parent cell bodies of 
the monoaminergic fibers. Dopamine fibers are present 
in all the raphe nuclei, which contain the serotonergic 
cells, in the locus coeruleus and the other noradrenergic 
cell groups, including the A5 and A 7 with their 
extensive spinal projections, and the adrenergic cell 
groups in the lower brainstem. This emphasizes that the 
interaction between the various monoamines is 
extensive and complex. If these complex interactions 
occur throughout the brainstem and spinal cord, it may 
be difficult to determine the effect of e.g. dopamine 
alone without considering the effects of the other 
monoamines and vice versa. In fact, the effect of a 
monoamine in a particular area may vary, depending on 
other monoamines present in that area at that time. This 
highly interactive behavior of the monoamines is 
important and should be kept in mind when considering 
the effect of a single monoamine. 
Dopamine and glutamate 
Since the original observation of Kaneko et al. (1990) 
that immunoreactivity for glutamate or glutaminase (a 
glutamate synthesizing enzyme) is present in 
catecholaminergic and serotonergic neurons subsequent 
studies have confirmed the presence of glutamate in 
serotonergic neurons of the raphe nuclei (Nicholas et 
al., 1992) and noradrenergic neurons in the locus 
coeruleus area (Fung et al., 1994; Liu ef al., 1995). 
More recently the presence of glutamate in 
dopaminergic neurons was confirmed (Sulzer et at., 
1998), indicating that there may indeed exist an 
extensive co-localization of glutamate with dopamine, 
serotonin and noradrenaline. The presence of 
glutaminase in dopaminergic neurons of the All cell 
group (Kaneko ef al., 1990) suggests that glutamate is 
present in the dopaminergic terminals in the spinal cord 
and brain stem. If true, dopamine neurons may exert 
rapid synaptic actions via the release of glutamate and 
slower modulatory actions via the release of dopamine, 
as suggested for the dopaminergic neurons in substantia 
nigra pars compacta which exert their excitatory and 
inhibitory synaptic effects upon caudate nucleus 
neurons by using glutamate and dopamine, respectively 
(Kaneko ef al., 1990). This suggests that glutamatergic 
cotransmission may be the rule for central 
monoaminergic neurons, and, if carried one step further, 
the monoaminergic projections may be considered as a 
glutamatergic system with monoamines as co-released 
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modulators. Obviously, more detailed investigations are 
needed to detennine if this is indeed the case. 
The functional role of dopamine in spinal 
cord and brainstem 
General remarks 
There are several distinct dopamine systems in the 
central nervous system. Those that have been studied 
most extensively are the nigrostriatal and the so-called 
mesocorticolimbic projections which originate 
primarily in the substantia nigra pars compacta and the 
ventral tegmental area, respectively (for review see 
Bjorklund and Lindvall, 1984). The primary projection 
of the nigrostriatal system is to the striatum. The 
mesocorticolimbic system projects to much of the 
limbic system, including the frontal and cingrtlate 
cortex, septum, accumbens nucleus and olfactory 
tubercle. In addition there are projections to the 
pituitary and median eminence from dopamine neurons 
in the hypothalamus. Most studies on the effects of 
dopamine on behavior have focussed on the 
nigrostriatal and mesocorticolimbic dopamine systems, 
while the contributions of other brain dopamine 
systems, like the diencephalospinal dopamine system 
(All), have been the subject of less systematic 
investigation. It is likely that the effects of systemically 
injected drugs that act on the dopamine system, like L-
DOPA, will influence all the central dopamine systems, 
including those in the brainstem and spinal cord. 
Similarly, the different dopamine receptor subtypes are 
pharmacologically similar, making it difficult to 
selectively stimulate or block a specific receptor 
subtype in vivo. In view of this, the use of highly 
selective genetic approaches to alter the expression of 
individual dopamine receptor subtypes has produced 
new insights into dopaminergic receptor function, 
which would have been difficult to obtain through other 
approaches (for review see Sibley, 1999). Obviously it 
is difficult to determine the contribution of the 
brainstem and spinal cord to changes that are observed 
after general applications of drugs or use of receptor 
gene alteration that influence the dopamine system. To 
determine the role of the dopamine system in the 
brainstem and spinal cord in normal brain functioning, 
two experimental approaches can be used: 1) 
monitoring nonnal activity or using selective activation 
of All neurons that project to the brainstem and spinal 
cord and 2) studying the effects of dopamine in the 
caudal projection areas of the All neurons. The most 
direct way to answer the first question can be obtained 
by monitoring the activity of the All dopaminergic 
cells in conscious, freely moving animals for a 
prolonged period of time and in different circumstances. 
This experimental approach has been used for 
noradrenergic cells in the locus coernleus (Singewald 
and Philippu, 1998; Vankov et al., 1995) and for 
serotonergic cells in the raphe nuclei (Jacobs and 
Fornal, 1999; Rueter et al., 1997), but similar 
experiments have not yet been done for the All 
dopaminergic cells. The second experimental approach 
has been used in several studies on the effects of 
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dopamine in the spinal cord and brainstem. The results 
of some of these studies will be summarized below. 
Dopamine effects on sensory systems 
There are extensive dopaminergic projections to spinal 
cord and brainstem areas that are involved in sensory 
processing. These areas include the caudal spinal 
trigeminal nucleus and the spinal superficial dorsal horn 
which are involved in nociception, and the principal, 
mesencephalic and spinal trigeminal nuclei, the dorsal 
column nuclei and the nucleus proprius of the dorsal 
horn, which are mainly involved in the processing of 
non-nociceptive sensory input. Many other brainstem 
areas, like the cochlear nuclei and the superior and 
inferior colliculus, involved in audio-visual processing, 
also receive a dopamine input. Dopamine Dz-receptors 
are mainly expressed in the areas processing 
nociceptive information and in the colliculi, but are 
much less prominent in the other areas. Studies 
investigating the functional role of dopamine in sensory 
transmission are scarce. Most studies have been 
perfonned in the spinal cord, where dopamine exerts an 
inhibitory effect on nociceptive transmission, mediated 
by D2-receptors (Barasi et al., 1987; Fleetwood-Walker 
el aI., 1988; Liu et al., 1992), while the effects on non-
nociceptive transmission and the involvement of D 1-
receptors appears to be less prominent (Barasi et al., 
1987; Liu et al., 1992). It can be concluded that there 
are extensive dopamine projections to nearly all 
primary areas involved in the processing of sensory 
infonnation. The effects of dopamine in these areas 
have not been studied yet. with the exception of the 
inhibitory effect on nociceptive transmission. 
Dopamine effects on motor systems 
Dopamine is also involved in processing motor output 
at the motoneuronallevel. Probably the most prominent 
anatomical feature of the dopaminergic, as well as 
noradrenergic, fibers located in motoneuronal cell 
groups is their fine granular aspect, caused by a large 
number of fibers with small varicosities and thin, or 
lightly stained, intervaricose segments (Grzanna et ai., 
1987; Fritschy and Grzanna, 1989, this thesis). Thus, it 
appears that, throughout the neuraxis, there is a 
consistent dopaminergic and noradrenergic innervation 
of motor nuclei by fibers with a similar morphology in 
immunocytochemical preparations. Dopamine Dz-
receptors were not found in motoneurons, which is 
consistent with the finding that they express D1-
receptors (Dubois et al., 1986; Levey el aI., 1993). 
The reported effects of dopamine on somatic motor 
functions at the spinal level are contradictory (Carp and 
Anderson, 1982; Ono and Fukuda. 1984; Kamijo et al., 
1993). In some cases facilitation was found (Dupelj and 
Geber, 1981), while others reported an inhibitory effect 
(Carp and Anderson, 1982; Ono and Fukuda, 1984; 
Pehek et al.. 1989). It has been suggested that Dl and 
D2-receptors are functionally coupled at the spinal level 
in modulating spinal motor output (Gajendiran et al., 
1996). Since D1-receptors couple to stimulation of 
adenylate cyclase activity and D2 either inhibit enzyme 
activity or are not coupled to this enzyme, the presence 
ofDI-receptors in the absence of Dz-receptors indicates 
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that the direct effect of dopamine on motoneurons is 
facilitatory. 
Dopamine effects on autonomic systems 
In brain stern and spinal cord the strongest 
dopaminergic innervation is found in nuclei known to 
be involved in autonomic control. Most studies on the 
role of dopamine in central autonomic systems have 
focussed on the regulation of heart rate and blood 
pressure. These studies have reported substantial 
hemodynamic effects of dopamine both at the level of 
the nucleus tractus solitarius (Zandberg el al., 1979; 
Granata and Woodruff, 1982; Kessler and Jean, 1986; 
van Giersbergen el aI., 1992), the nucleus arnbiguus 
(Chitravanshi and Calaresu, 1992). and the intermedio-
lateral cell column, containing the spinal preganglionic 
sympathetic neurons (petigean et al., 1984; Clatworthy 
and Barasi, 1987; Pellissier and Demenge. 1991; 
Lahlou and Demenge, 1993). However. the reported 
effects of dopamine on blood pressure and heart rate are 
not straightforward. Low doses of dopamine elicit a 
dose dependent decrease in blood pressure and heart 
rate (Zandberg et aI., 1979) and higher doses of 
dopamine (Granata and Woodruff, 1982) or a Dr 
receptor agonist (quinpirole) (Yang elal., 1990) cause a 
consistent increase in mean arterial pressure, suggesting 
that dopamine may produce an increase in blood 
pressure via its Dz-receptors. These findings suggest 
that the concentration of dopamine determines which 
receptors are activated and which hemodynamic effect 
emerges at the level of the brainstem and spinal cord. 
Thus, the effects of dopamine may depend not only on 
the types of receptors involved, but also on the 
concentration of the transmitter at the receptor and on 
the interaction with many other transmitters that are 
present in these cardiovascular brain stem and spinal 
cord regions. 
The presence of a dopaminergic innervation of areas 
known to be involved in respiratory control, like the 
nucleus of the solitary tract, lateral parabrachial nucleus 
and the phrenic nucleus, suggest that dopamine may be 
involved in respiratory control. The phrenic nucleus of 
the spinal cord (C4-C6), which contains the motor 
neurons innervating the diaphragm, receives strong 
descending connections from the ventrolateral nucleus 
of the solitary tract (called the dorsal respiratory group). 
The nucleus of the solitary tract is reciprocally 
connected with the far lateral parts of the dorsal and 
central lateral parabrachial nuclei (Herbert el al., 1990). 
It receives pulmonary and tracheal afferents through the 
vagus nerve (van Giersbergen el al., 1992). Since these 
nuclei are tightly interconnected and all receive a 
dopaminergic innervation suggest that dopamine may 
play an important role in respiratory control at the level 
of the brain stern and spinal cord, which is also 
indicated by a few studies. Dopamine accelerated the 
respiratory frequency when applied by perfusion to the 
in vitro brain stern (Murakoshi et aI., 1985), which may 
be dependent on co-activation of alpha adrenergic 
receptors (Johnson el al.. 1998). Local perfusion of D1-
receptor blocker into the region of the nucleus of the 
solitary tract had no effect (Srinivasan et al., 1991), 
suggesting that Dz-receptors may playa more important 
role in this brain stem area. 
To date, research on the central control of 
micturition has concentrated on noradrenergic 
influences at the level of the brain stem and spinal cord. 
Besides noradrenaline (de Groat et al., 1999) there is 
some evidence that serotonin (Espey et al., 1998) and 
dopamine (Kontani ef al., 1990) may be inhibitory to 
micturition at the spinal level. Interestingly, sacral 
parasympathetic preganglionic neurons receive a strong 
dopaminergic innervation and express dopamine Dr 
receptors. These findings suggest that it may be 
promising to include dopamine in future research on the 
central control of micturition. 
In conclusion, dopamine plays an important role in 
diverse autonomic reflexes, among which 
hemodynamic control, respiration and micturition. 
Further investigations are needed get more insight in the 
effects of dopamine on other autonomic functions that 
are organized in the brain stem and spinal cord. 
Dopamine and the cerebellwn 
Although an extensive examination of the cerebellum 
was not attempted in this thesis, a limited dopaminergic 
innervation was observed in the cerebellar cortex, more 
particularly the medial extension of the ventral 
paraflocculus. The functional role of the limited 
dopaminergic innervation still is obscure (Panagopoulos 
ef aI., 1991; Ikai ef al., 1992). The dopantinergic fibers 
projecting to the cerebellar cortex terminate mainly in 
the granular layer, additionally in the Purki'1ie cell 
layer, but not at all in the molecular layer (Ikai et al., 
1992). Dopamine receptor binding, especially for the D, 
subtype, occurs in both the molecular and granular 
layers (Dubois etal., 1986; Mansour etal., 1992), while 
dopamine receptor mRNA's for both the Dl and D2 
subtypes are present in the granular layer ouly 
(Bouthenet et al., 1991; Mansour et al., 1992). 
Thus the function of the limited dopaminergic 
projection to the cerebellum remains obscure. The 
paucity of dopamine suggests that in the cerebellum 
other monoamines, like noradrenaline and serotonin, 
play a more important role. In this respect it is 
interesting to note that many cerebellar-projecting 
neurons, like the dorsal nucleus (column of Clarke) and 
central cervical nucleus, appear to be avoided by the 
dopamine system. The reason for the avoidance by 
dopamine of spinal nuclei projecting to the cerebellum 
is still unclear. 
The role of dopamine in different behavioral states 
The dense and specific regional distribution of 
dopamine in the PAG suggests that dopamine is 
involved in regulating various P AG functions. The 
strong dopamine projection to the ventrolateral PAG 
may be implied in modulating quiescent behavior, i.e. a 
strong decrease in spontaneous activity and 
responsiveness to the environment, together with 
hypotension, bradycardia and pain inhibition, which 
occurs after deep visceral and muscular pain stimuli 
(like after a fight or internal pains). This type of 
behavior appears to be useful in circumstances of 
wound healing or recuperating from disease and is 
organized in the ventrolateral part of the PAG (Bandler 
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and Shipley, 1994). The predominant dopaminergic 
innervation of the dorsal PAG, on the other hand, would 
suggest the involvement of dopamine in organizing 
behavior associated with fear and anxiety, like threat 
display associated with vocalization and strong fight or 
flight responses (Behbehani, 1995). However, 
application of agonists or antagonists of doparninergic, 
as well as adrenergic and serotonergic receptors had no 
effect on vocalization per se (Lu et al., 1993). 
Nevertheless, it may be concluded that dopamine is 
involved not only in modulating basic autonomic 
functions in the lower brainstem and spinal cord as 
described earlier, but is also involved in modulating 
more complex behavior in more rostral areas of the 
brainstem, like the PAG and the parabrachial nuclei, 
where these basic autonomic functions are regulated 
depending on the environmental situation. 
Dopamine is among the central neurotransmitters 
involved in the control of sexual behavior, which may 
be conceptualized as consisting of both motivational 
and perronnance components (for review see Sachs, 
1995). At the level of the brain stem and spinal cord, the 
strong dopaminergic innervation of the sexually 
dimorphic nuclei in the lumbosacral spinal cord is most 
conspicuous and suggests that dopamine receptors are 
directly involved in regulating male sexual 
perfonnance, as also indicated by studies (Stefanick ef 
al., 1982; Pehek ef aI., 1989) showing that dopamine 
agonists inhibit specific sexual motor functions like 
penile reflexes. Our finding that Drreceptors are 
present in (the homologue of) Onufs nucleus in the rat 
would strengthen this idea, although the specific 
function of dopamine in this case is unclear. 
Relation with Parkinson's disease 
Parkinson's disease is one of the major 
neurodegenerative diseases of the nervous system. It 
leads to a variety of motor disturbances and is caused 
by selective degeneration of dopaminergic neurons in 
the substantia nigra. Although the dopaminergic 
projections of the substantia nigra are aimed rostrally at 
the striatum, rather than caudally, the presence of 
dopamine in the motoneuronal cell groups of the 
brainstem and spinal cord may suggest that part of the 
disturbed motor performance in Parkinson's disease is 
due to changes in dopamine neurotransmission at the 
level of the brain stem and spinal cord (Lindvall ef al., 
1983). However, there is no evidence that All 
dopaminergic neurons are affected in Parkinson's 
disease and in addition it was shown that the dopamine 
concentration in the spinal cord of Parkinsonian patients 
(Scatton ef al., 1986; Sofic ef al., 1991) was the same as 
in healthy subjects. 
Therefore, it seems unlikely that changes in brain 
stem or spinal dopamine levels are involved in 
producing the motor deficits associated with 
Parkinson's disease. 
Conclusions 
In conclusion, the present thesis definitively establishes 
the existence of an extensive dopaminergic innervation 
in the brain stem and spinal cord, which constitutes a 
distinct neurotransmitter system separate from the other 
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monoamines. The distribution of dopamine is more 
widespread than that of its D2-receptor. This anatomical 
discrepancy may be largely explained by a 
complementary distribution of the Dj-receptor. The 
levels of D3, D4, and D,-receptors in the brain appear to 
be several orders of magnitude lower than that of Dj 
and D,-receptors. Although D3 and D4-receptors are 
reported in a few brain stem areas, they do not exist in 
the spinal cord. 
The dopaminergic projection to the monoaminergic 
cell groups located in the brain stem suggest that 
dopamine interacts with the other monoaminergic cell 
groups, not only at the level of the terminal fields in the 
target areas, but also by directly affecting the activity of 
the parent cell bodies of the monoantinergic fibers. The 
high degree of collateralization in the dopantine 
diencephalo-spinal projection would imply that 
dopamine is released simultaneously in many different 
areas of the brain stem and spinal cord, which suggest 
that individual All neurons subserve integrative 
functions. Dopamine neurons may also use glutamate as 
a transmitter and thus exerts rapid synaptic actions via 
the release of glutamate and slower modulatory actions 
via the release of dopamine. 
There are extensive dopamine projections to nearly 
all the sensory infonnation processing areas, but the 
effects of dopamine in these areas is largely unclear, 
except for an inhibitory effect on nociceptive 
transmission in which Drreceptors are involved. 
Motoneuronal cell groups receive an extensive 
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dopamine projection and express Dl rather than Dr 
receptors, indicating that the effect of dopamine on 
rnotoneurons is facilitatory. 
The cerebellum receives only a very limited 
dopantinergic projection, the functional role of which is 
still obscure. Dopamine is also observed in many areas 
that sub serve various autonomic functions, including 
hemodynamic, respiratory and micturition control at the 
brain stem and spinal level. More rostral areas, like the 
periaqueductal gray and the parabrachial nuclei, which 
are involved in organizing the different autonomic 
control centers, also receive a strong dopaminergic 
projection. The role of dopamine in different behavioral 
states like fight and flight and sexual behavior are 
discussed. At present, there is no evidence that All 
plays a role in Parkinson's disease. 
Taken together the present thesis emphasizes that 
besides noradrenaline and serotonin, dopamine should 
also be included when considering the monoaminergic 
effects on brain stem and spinal processing. In fact, the 
interaction between the various monoamines may be of 
even greater importance than the effect of the respective 
transmitters alone. Investigations along this line may 
prove worthwhile. Hopefully, the studies presented in 
this thesis will contribute to these future studies on the 
role of dopamine and the other monoamines in the 
nervous system by providing a firm basis in the 
anatomy, which is always needed when searching to 
nnderstand the brain 
Summary and Discussion 
Table 1: Overview of the distribution of dopamine (this thesis), noradrenaline (Mouchet et a/., 1992; Rajaofetra et 
a/., 1992; this thesis) and serotonin (Steinbusch, 1981; Tallaksen-Greene et a/., 1993; Halliday et a/., 1995) in 
brain stem and spinal cord. + = present, - = absent. 
~~~~~-.~~~~-.~~----~~~~--~~~--~~~ 
... I:?pi~~ISQrcJ 
Dorsal Horn 
Dopamine Noradrenaline Serotonin 
.............................................. _ .... _ ....._ ...... ----~= 
Intermediate zone 
Ventral Horn 
Specialized areas 
Region around the central canal 
Sympathetic preganglionic neurons 
Dorsal nucieus (column of Clarke) 
Lumbosacral motoneurons 
+ 
+ 
+ 
+ 
+ 
+ 
V"~·W"M··."'''·''"''"·· ....................... _. 
+ + 
+ + 
+ + 
+ + 
+ + 
+ + 
""~",""""--~-~---~-=-,~=~== 
II. Brain stem 
•. -.-•.. -..... -.~.- .-;-:;:-----: 
Sensory Trigeminal Complex 
Dorsal motor nucieus of the vagus 
Hypoglossal nucieus 
Solitary Complex 
Dorsal column nuciei 
Inferior olive, Principal nu 
Inferior olive, VLO 
Inferior olive, DAO 
Inferior olive, MAO 
Cerebellar nuciei 
Cerebellum 
Motor nuciei of the cranial nerves 
Locus coeruleus 
Raphe nuciei 
Vestibular complex 
Area postrema 
Para brachial complex, LPB 
Periaqueductal gray 
Periaqueductal gray, dorsal 
Inferior Colliculus 
Superior Colliculus, superficial layers 
Superior Colliculus, inner layers 
Dopamine 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
-/+ 
+ 
+ 
+ 
+ 
+ 
Noradrenaline Serotonin 
--_._--_. 
+ + 
+ + 
+ + 
+ + 
+ + 
+ -/+ 
+ 
-/+ + 
-/+ + 
+ + 
+ + 
+ + 
+ + 
+ + 
+ + 
+ + 
+ + 
+ + 
+ 
+ + 
+ + 
+ 
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Chapter Six 
Table 2: A comparison of dopamine (this thesis), dopamine D1-receptor (Dubois et ai, 1986), dopamine D2-
receptor (Bouthenet et aI., 1987; Bouthenet et aI., 1991; this thesis) and dopamine D,-receptor (Bouthenet et 
aI., 1991) in the brain stem and spinal cord. + = present, - = absent. 
J. Spina'Cl ",co",r",d __ ~ _____ . 
Dorsal Horn 
Lamina I 
Lamina II (substantia gelatinosa) 
Lamina III 
Lamina IV 
Lamina V 
Lamina VI 
Intermediate zone 
Lamina VII 
Lamina VIII 
Ventral Horn 
Lamina IX 
Specialized areas 
Central cervical nucleus 
Lateral Cervical nucleus 
Region around the central canal 
Phrenic nucleus 
Sympathetic preganglionic neurons 
Dorsal nucleus (column of Clarke) 
Cremaster nucleus 
Lumbosacral motoneurons 
Sacral parasympathetic area 
II. Cerebellum 
Purkinje cells in lobule 10 
Molecular layer 
Possibly non-specific 
.~~-~~ .. ~ ...• ---
III. Medulla Oblongata 
motor nucleus of 
12 Hypoglossal nucleus 
Cu Cuneate nucleus 
DC Dorsal cochlear nu 
Ecu External cuneate nu 
vagus 
GiA Gigantocellular reticular nu, alpha 
10 Inferior olive 
MdD Medullary reticular nu, dorsal part 
MdV Medullary reticular nu, ventral part 
Mve Medial vestibular nu 
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2+ 
1 + present 
3+ 
3+ 
3+ 
3+ 
1+ 
1+ 
3+ 
+/-
2+ 
3+ 
3+ 
4+ 
4+ 
3+ 
3+ 
Dopamine 
Dopamine 
2-3+ 
2+ 
1-2+ 
1+ 
0-4+ 
1+ 
1+ 
1+ 
present 
present 
Dcreceptor 
present 
present 
Dcreceptor 
3+ 
1+ 
1+ 
1+ 
2+ 
2+ 
3+ 
3+ 
3+ 
4+ 
D,-receptor 
1+ 
D,-receptor 
4+ 
0-4+ 
0-1+ 
0-1+ 
3+ 
0-4+ 
0-2+ 
D,-receptor 
4+ 
D,-receptor 
3+ 
2+ 
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Table 2: (continued) 
III. Medulla Oblongata Dopamine D,-receptor D,-receptor D,-receptor 
•••••••••••••••••••••••••••••••••••••••••••••• <0 ........ <0 .... .................. ~ .... ".~ .. ~ .... ~~ 
RF Reticular formation of medulla oblongata 
-,..----,1 + .. -.-.. ----............. .. · .. · .. · ............ "'· .. ·-.. -~1~-2~+--·-......................... ~~--
-
~,=-~ 
IV. Pons 
---~ .. --...... 
n7 Facial nu 
Amb Nucleus ambiguous 
Co Cochlear nu 
LC Locus coeruleus 
LPB Lateral para brachial nu 
LVe Lateral vestibular nu 
MoS Motor trigeminal nu 
MeS Mesencephalic trigeminal nu 
MPB Medial para brachial nu 
MVe Medial vestibular nu 
PnC Pontine reticular nu, caudal part 
PnO Pontine reticular nu, oral part 
PrS Principal sensory nu 
SpS Spinal trigeminal nu 
_ V. _t1_~sgns~phalon 
N3 Oculomotor nu 
CG Central gray 
DpMe Deep mesencephalic nu 
DR Dorsal raphe nucleus 
IC Inferior colliculus (external cortex) 
IF Interfascicular nu (A10) 
MG Medial geniculate nu(ventral border) 
MnR Median raphe nu 
RLi Rostral linear nu of raphe 
RN Red nu 
SNC Substantia nigra compacta (A9) 
SNL Substantia nigra compacta, lateral part 
SNR Substantia nigra reticulata 
Su Superior colliculus(superfcial grey layer) 
VTA 
----
Ventral tegmental area (AW) 
Dopamine 
2-3+ 
1+ 
1+ 
2-3+ 
4+ 
+/-
2-3+ 
2-3+ 
4+ 
1+ 
1+ 
1+ 
0-1+ 
1+ 
4+ 
4+ 
2-3+ 
2+ 
2+ 
1+ 
.--:--.~--:-- ~~----
Dcreceptor D,-receptor D,-receptor 
4+ 
3+ 
0-3+ 
3-4+ 
1-2+ 
1-2+ 
0-2+ 
1-2+ 
_~ __ ~=o=,,=~== 
Dopamine 
__ [).r~g~~P~oL D,-receptor ___ g1:r~ceptor 
2-3+ 0-4+ 1+ 
1-2+ present 2-3+ 
1+ 1-2+ 
4+ 4+ 
1-2+ 2-3+ 
1-2+ 0-2+ 
1-2+ 4+ 
1+ 3+ 
1-2+ 2+ 
1+ 0-2+ 
1+ present 4+ 1+ 
1+ 0-4+ 3+ 
4+ present 0-4+ 
1-2+ present 2+ 2+ 
1+ preser;,L 3+ 1+ 
III 
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Samenvatting 
Dit proefschrift omvat verschillende studies naar de 
dopaminerge innervatie van de hersenstarn en het 
ruggenmerg en een van de daarbij betrokken 
receptoren, de Dz-receptor. Het resultaat geeft een 
gedetailleerd inzicht in een chemisch ge'identificeerd 
systeem, gekarakteriseerd door het gebruik van de 
neurotransmitter dopamine. 
In Hoofdstuk I wordt een korte bescbrijving van de 
anatomie van het ruggenmerg en de hersenstam 
gegeven. Dit wordt gevolgd door een kart overzicht van 
de chemische anatomie van het centraal zenuwstelsel, 
waarbij de nadruk ligt op het dopaminerge systeem en 
haar receptoren. 
Hoofdstuk I! bescbrijft de verdeling van dopaminerge 
vezels en (veronderstelde) eindigingen in aBe 
segmenten van het ruggenmerg van de rat, kat en aap. 
De vezels en eindigingen zijn immunocytochemisch 
geldentificeerd op lichtrnicroscopisch niveau, gebruik 
makend van antilichamen gericht tegen dopamine. 
De sterkste dopamineldeuring werd gevonden in de 
sympathische zijhoorn (IML). Sterke dopamine-
kleuring, bestaande uit een groat aantal varicose vezels, 
werd gevonden in alle laminae van de dorsale hoorn, 
inclusief het gebied rond het centrale kanaal (lamina X). 
Een uitzondering vonnde de substantia gelatinosa, die 
met name in rat en aap slechts beperkt gekleurd was. 
Vezels in de motoneuronale celgroepen vertoonden 
eveneens een sterke dopaminekleuring en lieten een fijn 
granulair aspect zien. De seksueel dimorfe cremaster 
kern en Onufs nucleus (of zijn homoloog) waren vee! 
sterker gekIeurd dan de omliggende somatische 
motoneuronen. In het parasympathische gebied op 
sacraal niveau was de kleuring van gemiddelde sterkte. 
De rest van de gebieden, waaronder de intermediaire 
zone (lamina VI-VIII), werden slechts in beperkte mate 
gefunerveerd. Het kleinste aantal dopamine vezels werd 
gevonden in de dorsale kern (kolom van Clarke) en de 
centrale .cervicale kern, hetgeen aangeeft dat cellen die 
projecteren naar het cerebellum werden gemeden door 
de dopaminerge projectie. In zowel rat, kat als aap 
waren de meeste afdalende vezels aanwezig in de 
dorsolaterale funiculus, alhoewel laminae I en II ook 
veel rostrocaudaal georienteerde vezels bevatten. 
Vit de resultaten van deze studie kan worden 
geconcludeerd dat de verdeling van dopamine in het 
ruggenmerg wijdverspreid is, met slechts kleine 
verschillen tussen de onderzochte diersoorten. Dit 
benadrukt de belangrijke rol die dopamine speelt als een 
van de monoaminen die, zowel sensorische input, als 
autonome en motor output op het niveau van het 
ruggenmerg bei'nvloeden. 
Hoofdstuk II! bescbrijft de lokalisatie van dopamine Dz-
receptoren in het ruggenmerg van de rat. Hierbij werd 
gebruik gemaakt van immunocytochemie met een anti-
peptide antilichaam gericht tegen de veronderstelde 3' 
Ius van de Dz-receptor, en in situ hybridisatie (ISH) met 
een [35S)UTP gelabelde anti-sense riboprobe. 
Na gebruik van de innnunocytochemie techniek 
bleek dat de kIeuring beperkt bleef tot de neuronale 
cellichamen en hun proximale dendrieten. De sterkst 
geldeurde neuronen werden gevonden in het 
parasympathische gebied van het sacrale ruggenmerg 
en in de twee seksueel dimorfe motorische kernen van 
het lumbosacrale ruggemnerg (de spinale kern van de 
bulbocavernosus en de dorsolaterale kern). Cellen met 
een kleuring van gemiddelde sterkte waren aanwezig in 
de sympathische zijhoorn, het gebied rond het centrale 
karmal en in lamina I van de dorsale hoorn. Ben zwakke 
ldeuring werd gevonden in de laterale spinale kern en in 
laminae VII en VIII van de ventrale hoom. Naast de 
twee seksueel dimorfe motorische kemen van het 
lumbosacrale gebied werden verder geeD. geldeurde 
motoneuronen aangetroffen. 
Wanneer de ISH techniek gebruikt wordt, wordt een 
groat aantal radioactief gelabelde neuronen 
aangetroffen. Dit geeft aan dat deze neuronen Dr 
receptor mRNA bevatten. De verdeling van deze 
neuronen was vergelijkbaar met de gevonden verdeling 
bij immunocytochemie. Een verschil tussen beide 
technieken betrof de laminae III en IV. Gebruik makend 
van de ISH techniek werden ook cellen gelabeld in deze 
gebieden, terwijl een vergelijkbare kIenring in deze 
gebieden gebaseerd op immunocytochemie niet 
aangetroffen werd. 
De lokalisatie van de neuronen die D 2-receptoren tot 
expressie brengen in het ruggenmerg suggereert dat D2-
receptoren met name betrokken zijn bij de modulatie 
van nociceptieve transmissie en het autonome systeem. 
De resultaten geven verder aan dat Drreceptoren niet 
direct betrokken zijn bij de modulatie van 
motoneuronen, met uitzondering van motoneuronen in 
de seksueel dimorfe kernen. 
Hoofdstuk IV bescbrijft de verdeling van dopamine 
immunoreactieve vezels en hun (veronderstelde) 
eindigingen op licht microscopisch niveau in de 
hersenstam van de rat. De verdeling van dopamine 
immunoreactiviteit wordt vergeleken met die van 
dopamine-~-hydroxylase (DB H), het noradrenaline 
synthetiserend enzym. 
De dopaminerge vezels en eindigingen vertoonden 
een specifieke verdeling binnen de hersenstam. Ze 
waren aanwezig in een groot aantal hersenstam kernen 
en Heten verschillende niveaus van van 
ldeuringsintensiteit zien . De sterkste dopamineldeuring 
werd aangetroffen in de dorsale motor kern van de 
nervus vagus, de hoofdkern van de oliva inferior en de 
dorsale raphe kern. Andere gebieden, zoals de kern van 
de tractus solitarius, de raphe pallidus en obscurus, de 
laterale parabrachiale kern en het periaqueductale grijs 
vertoonden eveneens een sterke kleuring, terwijl het 
sensorische trigeminus complex, de locus coeruleus en 
de noradrenerge AS groep gemiddeld tot sterk gekleurd 
waren. Verder waren ook in vele andere gebieden van 
de hersenstam dopamine immunoreactieve vezels en 
eindigingen aanwezig, waaronder de colliculi inferior 
en superior, de diepe mesencephalische kern, de 
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reticulaire pons kern, de kern van de prepositus 
hypoglossus, de cochleaire kernen en de cuneatus en 
gracilis kernen. Binnen een kern is de dopamine niet 
willekeurig verspreid, maar vaak gericht op specifieke 
sub-kernen. Hoewel de verspreiding van vezels en 
eindigingen die met DBH waren gekleurd over het 
algemeen uitgebreider was dan de dopaminerge 
kleuring, bleek in vele hersenstam gebieden een 
duidelijke overlap tussen de DBH en dopamine 
gekleurde vezels en eindigingen. Er was echter weI een 
verschil in het regionale innervatie patroon. In andere 
gebieden, zoals de area postrema, cerebellum, het 
anterior gedeelte van de ventrale cochleaire kern en de 
externe cuneatus kern is DBH overvloedig aanwezig, 
terwijl dopaminerge vezels slechts in beperkte mate 
aangetoond konden worden. 
Deze resultaten tonen aan dat er een uitgebreid 
dopamine vezelsysteem aanwezig is in de hersenstam 
van de rat, dat, in tegenstelling tot hetgeen lange tijd 
werd aangenomen, onathankelijk is van het 
(nor)adrenerge vezelsysteem. Dit betekent dat de 
invloed van dopamine in de hersenstam te vergelijken is 
met dat van de andere monoaminen, zoals (nor) 
adrenaline en serotonine. 
In Hoofdstuk V wordt de verdeling van dopamine D, 
receptoren in de hersenstam van de rat beschreven, 
zoals bepaald met signaalversterkte immuno-
cytochentie. Hierbij werd gebroik gemaakt van een 
polyklonaal antiserum met antilichamen gericht tegen 
de veronderstelde 3e Ius van de dopamine D2 receptor. 
De resulterende kleuring was in de meeste gevallen 
geassocieerd met neuronale cellichamen en hun 
proximale dendrieten. Dit resultaat was onafhankelijk 
van het al dan niet toepassen van signaalversterking. In 
de hersenstam van de rat werden neuronen met het D2-
receptor-eiwit waargenomen in specifieke gebieden, 
zoals de dorsale motor kern van de nervus vagus, de 
gigantocellulaire kern (pars alpha), de kern van de 
tractus solitarius, de locus coeruleus, de laterale en 
mediale parabrachiale kern, de basale pons kern, het 
centrale grijs, de diepe mesencephalische kern, de 
colliculi inferior en superior, de substantia nigra pas 
compacta en het ventraal tegmentum. Daarnaast werd 
ook in andere hersenstam kernen het Drreceptor-eiwit 
waargenomen, waaronder de reticulaire fonnatie en aile 
raphe kernen. In andere hersenstamgebieden, zoals de 
cuneatus kern en de oliva inferior, kon het Drrecepter-
eiwit niet worden aangetoond met de gebruikte 
immunocytochemie techniek, wat aangeeft dat in deze 
gebieden de Drreceptor-eiwit met, of nagenoeg met, 
aanwezig was. 
De gevonden resultaten zijn in overeenstemming 
met, en zijn een uitbreiding op, de resultaten van 
eerdere studies naar de Drreceptor in de hersenstam 
van de rat, waarbij gebroik gemaakt werd van ligand 
binding of in situ hybridisatie. De wijdverspreide 
verdeling van Drreceptoren in de hersenstam van de rat 
ondersteunt de hypothese dat Drreceptoren betrokken 
zijn bij de modulatie van een groot aantal verschillende 
hersenstamfuncties. Dit resultaat benadrukt nogmaals 
de belangrijke rol van het dopaminerge systeem in de 
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hersenstam. 
In Hoofdstuk VI wordt de anatontische en functionele 
betekenis van het dopaminerge systeem in de 
hersenstam en het ruggenmerg besproken met als 
belangrijkste conelusie dat in dit proefschrift het 
bestaan van een wijdverspreide dopaminerge 
neurotransmissie systeem in de hersenstarn en het 
ruggenmerg onomstotelijk wordt aangetoond. Deze 
neurotransmissie is onathankelijk van de andere 
monoaminerge neurotransmitters waar dopamine als 
precursor aanwezig is. Doparninerge vezels worden 
gevonden in vrijwel aile gebieden, die sensorische 
infonnatie verwerken, in de motoneuronale celgroepen 
en in vele gebieden die verschillende autonome functies 
verzorgen. Dit suggereert dat dopamine is betrokken bij 
verschillende hersenstam- en ruggenmergfuneties. De 
verdeling geeft tevens aan dat dopamine een interaetie 
aangaat met de andere monoaminerge celgroepen, met 
alleen op het niveau van de eindigingen maar ook door 
direct de activiteit van de moeder cellichamen van de 
monoaminerge vezels te bei'nvloeden. Een relatief laag 
aantal dopaminerge neuronen in de All groep in het 
meso-diencefale overgangsgebied vonnen de oorsprong 
van de dopaminerge projeeties naar de hersenstam en 
het ruggenmerg. De hoge graad van collateraHsatie in 
deze projecties suggereert dat dopamine tegelijkertijd 
wordt afgegeven in veel verschillende gebieden in de 
hersenstam en het ruggenmerg. Dit suggereert een rol 
voor individuele All neuronen in de integratie van 
diverse functies, bijvoorbeeld in gedragingen zoals 
gedurende 'flight and fight' en seksueel gedrag. Er is wt 
op heden geen bewijs dat de All een rol speel! in de 
ziekte van Parkinson. 
Dit proefschrift benadrukt dat dopamine, naast 
noradrenaline en serotonine, beschouwt dient te worden 
als een belangrijke neurotransmitter binnen het 
monoaminerge systeem in de hersenstam en het 
ruggenmerg. Het is zelfs aannemelijk dat de interactie 
tussen de verschillende monoaminen in de hersenstam 
en het ruggenmerg van groter belang is dan het effect 
van de afzonderlijke monoaminen. Dit proefschrift 
vonnt een belangrijke anatomische basis voor 
toekornstig onderzoek in deze riehring. 
Abbreviations 
AADC 
ABC 
DA 
DBH 
DSP-4 
NA 
PAP 
PNMT 
SA-HRP 
TBS 
aromatic L-amino acid decarboxylase 
avidin biotin complex 
dopamine( ergic) 
dopamine-B-hydroxylase 
N-(2-chloroethyl)-N-ethyl-2-bromo-
benzylamine 
noradrenaline 
peroxidase-antiperoxidase 
phenylethanol-N-methyltransferase 
streptavidin-horseradish peroxidase 
Tris buffered saline 
Brainstem areas: 
3 principal oculomotor nucleus 
4n trochlear nerve 
6 abducens nucleus 
7 facial nucleus 
7n facial nerve 
7n facial nerve 
8cn cochlear root vestibulocochlear nerve 
8n cochlear nerve 
8vn vestibulocochIear nerve 
10 dorsal motor nucleus of vagus 
12 hypoglossal nucleus 
Al Al noradrenaline cells 
AS A5 noradrenaline cells 
A7 A 7 noradrenaline cells 
Amb ambiguus nucleus 
AP area postrema 
APT anterior pretectal nucleus 
Aq aqueduct 
Atg anterior tegmental nucleus 
ATg anterior tegmental nucleus 
B9 B9 serotonergic cells 
Bar Barrington's nucleus 
BIC nucleus brachium inferior colliculus 
Cl Cl adrenaline cells 
C2 C2 adrenaline cells 
CG central gray 
CGD central gray, dorsal 
CGLD central gray, lateral dorsal 
CGLV central gray, lateral ventral 
CGM central gray, medial 
CIC central nucleus inferior colliculus 
CLI caudal linear nucleus raphe 
Cll commissure lateral lemniscus 
CnF cuneiform nucleus 
Cp cerebral peduncle, basal 
Cp cerebral peduncle, basal 
Csc commissure superior colliculus 
Cu cuneate nucleus 
cu cuneate fasciculus 
CVL caudoventrolateral reticular nucleus 
das dorsal acoustic stria 
DC dorsal cochlear nucleus 
DCIC dorsal cortex of inferior colliculus 
DLL dorsal nucleus lateral lemniscus 
DMTg dorsomedial tegmental area 
DpG deep gray layer superior colliculus 
TH tyrosine hydroxylase 
TSA tyramide signal amplification 
DLN dorsolateral nucleus 
RNA messenger ribonucleic acid 
UTP uridine-5'-triphosphate 
Spinal cord areas: 
IML intermediolateral cell column 
SNB spinal nucleus of the bulbocavernosus 
DPGi dorsal paragigantocellular nucleus 
DpWh deep white layer superior colliculus 
DR dorsal raphe nucleus 
Dsc dorsal spinocerebellar tract 
DTg dorsal tegmental nucleus 
ECIC external cortex inferior colliculus 
Ecu external cuneate nucleus 
EW Edinger-Westphal nucleus 
Fl flocculus 
Gi gigantocellular reticular nucleus 
GiA gigantocellular reticular nucleus, alpha 
GiV gigantocellular reticular nucleus, ventral 
Gr gracile nucleus 
GrC granular layer cochlear nucleus 
Icp inferior cerebellar peduncle 
IF interfascicular nucleus 
ILL intermediate nucleus lateral lemniscus 
In intercalated nucleus 
InG intermediate gray layer superior 
colliculus 
IntA interposed cerebellar nucleus, anterior 
InWh intermediate white layer superior 
colliculus 
10 inferior olive 
lOA subnucleus a of medial nucleus 
IOB subnucleus b of medial nucleus 
IOC subnucleus c of medial nucleus 
IOD dorsal nucleus 
IODM dorsomedial nucleus 
10K cap of Kooy of medial nucleus 
IOM medial nucleus 
IOPr principal nucleus 
IOVL ventrolateral outgrowth 
IPC interpeduncular nucleus, caudal 
subnucleus 
Irt intermediate reticular nucleus 
K nucleus K 
KF Kolliker-Fuse nucleus 
Lat lateral cerebellar nucleus 
LatPC lateral cerebellar nucleus, parvocellular 
LC locus coeruleus 
LDTg laterodorsal tegmental nucleus 
Lfp longitudinal fasciculus pons 
Ifp longitudinal fasciculus pons 
Li linear nucleus medulla 
11 lateral lemniscus 
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LPB 
LPBC 
LPBD 
LPBE 
LPBI 
LPBS 
LPGi 
LRt 
Lve 
mcp 
MdD 
MeS 
Med 
MGD 
MGV 
MiTg 
MI 
ml 
mlf 
MnR 
MoS 
MPB 
Mve 
MVeV 
Op 
OT 
PaS 
Pa6 
PCGS 
PCRt 
PCRlA 
PDTg 
PL 
PMR 
PN 
Pn 
PnC 
PnO 
PPT 
PrS 
PrSDM 
PrSVL 
Prb 
PrH 
py 
Pyx 
R 
Ramb 
RAmb 
Rli 
RMg 
Ro 
ROb 
Rpa 
RPn 
RPO 
RR 
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lateral parabrachial nucleus 
lateral parabrachial nucleus, central 
lateral parabrachial nucleus, dorsal 
lateral parabrachial nucleus, external 
lateral parabrachial nucleus, internal 
lateral parabrachial nucleus, superior 
lateral paragigantocellular reticular 
nucleus 
lateral reticular nucleus 
lateral vestibular nucleus 
middle cerebellar peduncle 
reticular nucleus medulla, dorsal 
nucleus mesencephalic tract trigeminal 
nerve 
medial cerebellar nucleus 
medial geniculate nucleus, dorsal 
medial geniculate nucleus, ventral 
Microcellular tegmental nucleus 
medial lemniscus 
medial lemniscus 
medial longitudinal fasciculus 
Median raphe nucleus 
motor trigeminal nucleus 
medial parabrachial nucleus 
medial vestibular nucleus 
medial vestibular nucleus, ventral part 
optic nerve layer superior colliculus 
Nucleus optic tract 
Paratrigeminal nucleus 
Paraabducens nucleus 
Paracochlear glial substance 
Parvocellular reticular nucleus 
Parvocellular reticular nucleus, pars 
alpha 
Posterodorsal tegmental nucleus 
Paralemniscal nucleus 
Paramedian raphe 
Paranigral nucleus 
Pontine nuclei 
Pontine reticular nucleus, caudal 
Pontine reticular nucleus, oral 
Posterior pretectal nucleus 
Principal sensory trigeminal nucleus 
Principal sensory trigeminal nucleus, 
dorsalomedial part 
Principal sensory trigeminal nucleus, 
ventrolateral part 
Probst bundle 
Prepositus hypoglossal nucleus 
Pyramidal tract 
Pyramidal tract decussation 
red nucleus 
Retroambiguus nucleus 
Retroambiguus nucleus 
rostral linear nucleus raphe 
raphe magnus nucleus 
Nucleus of Roller 
raphe obscurus nucleus 
raphe pallidus nucleus 
raphe pontis nucleus 
rostral periolivary region 
Retrorubral nucleus 
RRF 
rs 
RVL 
sS 
scp 
SNC 
SNL 
SNR 
SO 
Sol 
SolC 
SoiL 
SolM 
spS 
SpSC 
SpSI 
SpSO 
Sph 
Sph 
SPTg 
SpVe 
SUS 
SubB 
SubCA 
SubCD 
SubCV 
SuG 
SuVe 
Tz 
Unc 
VCA 
VCP 
VLL 
VLPB 
VLTg 
VTA 
VTg 
X 
xscp 
y 
Zo 
Retrorubral field 
Rubrospinal tract 
Rostroventrolateral reticular nucleus 
Sensory root trigeminal nerve 
Superior cerebellar peduncle 
Substantia nigra, pars compacta 
Substantia nigra, pars lateralis 
Substantia nigra, pars reticulata 
Superior olive 
Nucleus solitary tract 
Nucleus solitary tract, commissural part 
Nucleus solitary tract, lateral part 
nucleus solitary tract, medial part 
spinal tract trigeminal nerve 
spinal trigeminal nucleus, caudal 
division 
spinal trigeminal nucleus, interpolar 
division 
spinal trigeminal nucleus, oral division 
sphenoid nucleus 
sphenoid nucleus 
subpeduncular tegmental nucleus 
spinal vestibular nucleus 
superior trigeminal nucleus 
subbrachial nucleus 
subcoeruleus nucleus, alpha 
subcoeruleus nucleus, dorsal 
subcoeruleus nucleus, ventral 
superficial gray layer superior colliculus 
superior vestibular nucleus 
nucleus trapezoid body 
uncinate fasciculus 
ventral cochlear nucleus, anterior 
ventral cochlear nucleus, posterior 
ventral nucleus lateral lemniscus 
ventrolateral parabrachial nucleus 
ventrolateral tegmental nucleus 
ventral tegmental area 
ventral tegmental nucleus 
X nucleus 
Decussation superior cerebellar 
peduncle 
Y nucleus 
Zonal layer superior colliculus 
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Nawoord 
Na 5 jaar voltijd onderzoek in Rotterdam en 3Y2jaar lang s'avonds en in het weekend doorploeteren aan de afronding van 
mijn proefschrift is het eindeJijk zover: het is af! Graag wil ik iedereen bedanken die heef! bijgedragen aan het tot stand 
komen van dit proefschrift. Enkele personen wil ik in het bijzonder noemen. Joan Holstege, copromotor en dagelijks 
begeleider. Jan Voogd. mijn promotor. Mijn dank voor het gestelde vertrouwen in het slagen van dit project. Paul Luiten, 
ik ben verheugd dat je wilde deelnemen in de kleine promotiecommissie. Chris de Zeeuw, mijn enige "echte" collega. 
Erika, Richard en Corlinda. Jullie hebben mij terzijde gestaan op het lab. Erika, ook naast het werk ben je een gezellige 
babbeltante. Collega-AIO's Thea en Pierre. Jullie promotie heef! mij erg gestimuleerd bij de afronding van mijn 
proefschrift. Pierre, bedankt voor het wijzen op de in situ hybridisatie techrtiek. Pieter Voorn, bedankt voor de 
samenwerking bij de in situ experimenten. Doortje Voorhuis, bedankt voor het wijzen op het dopamine Dz antilichaam. 
Jan Dijk, dank voor het D2 antilichaam en het zwveren daarvan. Eddie en Hans, ik benjullie beiden zeer erkentelijk voor 
de assistentie bij de operaties en de voorbereidingen daarvan. Eddie, oak bedankt voor je assistentie bij al het afdrukwerk, 
al dan niet in digitale vorm. Edith, bedankt voor secretariele ondersteuuing en de gezelligheid. 
Tot slot: rrrijn meeste dank gaat uit naar Mechteld, omdat je me tot het eind toe bent blijven (onder)steunen. 
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Henk van Dijken werd op 13 april 1966 te Emmen geboren. Hij bezocht de Openbare Scholengemeenschap in 
Stadskanaal en legde in 1983 het eindexamen HA VO met goed gevolg af. In datzelfde jaar began hij met de studie HLO-
medisch aan de IHEO te Emmen. De medische laboratoriumopleiding werd afgerond in 1987 met aIs hoofdrichting 
klinische chemie. Na zijn militaire dienst aIs medisch laborant in de Militair Geneesknndige Dienst te Wezep began hij in 
1988 aan de studie Biologie aan de RijksUniversiteit Groningen. Tijdens de doctoraalfase verrichtte hij een 
doctoraalonderwerp neuroanatomie bij de vakgroep Dierfysiologie, subfaculteit Biologie, RUG onder supervisie van Dr. 
P.G.M. Luiten. Een tweede doctoraaIonderwerp werd gedaan bij de vakgroep Kindergeneesknnde onder leiding van Prof. 
Dr. R.J. Vonk. Het doctoraalexamen Medische Biologie werd afgelegd in augustus 1991. Vanaf 1 september 1991 was 
hij werkzaam aIs assistent in opleiding op de afdeJing Anatomie (Hoofd: Prof. Dr. 1. Voogd) aan de Erasmus Universiteit 
van Rotterdam, aIwaar hij de dopaminerge innervatie van de hersenstam en ruggemerg onderzocht onder begeleiding van 
Dr. 1. C. Holstege. De resultaten hiervan zijn beschreven in dit proefschrift. In oktober 1994 ondernam hij een 5 weekse 
werkbezoek aan het laboratorium van Dr. A.I. Levey, Department of Neurology, Emory University, Atlanta middels een 
SIR-beurs van NWO. In november 1996 is hij begonnen aIs software ontwikkelaar bij XCESS expertise center, aIwaar 
hij momenteel de functie Manager Research & Development heeft. 
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